% ------------------------------------------------------------------------
% SAMPLE BIBLIOGRAPHY FILE
% ------------------------------------------------------------------------
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%% pAD chapter%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@ARTICLE{Thomas2022-nb,
  title     = "{PANTHER}: Making genome-scale phylogenetics accessible to all",
  author    = "Thomas, Paul D and Ebert, Dustin and Muruganujan, Anushya and
               Mushayahama, Tremayne and Albou, Laurent-Philippe and Mi, Huaiyu",
  abstract  = "Phylogenetics is a powerful tool for analyzing protein
               sequences, by inferring their evolutionary relationships to
               other proteins. However, phylogenetics analyses can be
               challenging: they are computationally expensive and must be
               performed carefully in order to avoid systematic errors and
               artifacts. Protein Analysis THrough Evolutionary Relationships
               (PANTHER; http://pantherdb.org) is a publicly available,
               user-focused knowledgebase that stores the results of an
               extensive phylogenetic reconstruction pipeline that includes
               computational and manual processes and quality control steps.
               First, fully reconciled phylogenetic trees (including ancestral
               protein sequences) are reconstructed for a set of ``reference''
               protein sequences obtained from fully sequenced genomes of
               organisms across the tree of life. Second, the resulting
               phylogenetic trees are manually reviewed and annotated with
               function evolution events: inferred gains and losses of protein
               function along branches of the phylogenetic tree. Here, we
               describe in detail the current contents of PANTHER, how those
               contents are generated, and how they can be used in a variety of
               applications. The PANTHER knowledgebase can be downloaded or
               accessed via an extensive API. In addition, PANTHER provides
               software tools to facilitate the application of the
               knowledgebase to common protein sequence analysis tasks:
               exploring an annotated genome by gene function; performing
               ``enrichment analysis'' of lists of genes; annotating a single
               sequence or large batch of sequences by homology; and assessing
               the likelihood that a genetic variant at a particular site in a
               protein will have deleterious effects.",
  journal   = "Protein Sci.",
  publisher = "Wiley",
  volume    =  31,
  number    =  1,
  pages     = "8--22",
  month     =  jan,
  year      =  2022,
  keywords  = "gene ontology; genome analysis; hidden Markov model; molecular
               evolution; omics data analysis; phylogenetic tree; protein
               function annotation; protein function evolution",
  copyright = "http://onlinelibrary.wiley.com/termsAndConditions\#vor",
  language  = "en"
}

@ARTICLE{Gillespie2022-jr,
  title     = "The reactome pathway knowledgebase 2022",
  author    = "Gillespie, Marc and Jassal, Bijay and Stephan, Ralf and Milacic,
               Marija and Rothfels, Karen and Senff-Ribeiro, Andrea and Griss,
               Johannes and Sevilla, Cristoffer and Matthews, Lisa and Gong,
               Chuqiao and Deng, Chuan and Varusai, Thawfeek and Ragueneau,
               Eliot and Haider, Yusra and May, Bruce and Shamovsky, Veronica
               and Weiser, Joel and Brunson, Timothy and Sanati, Nasim and
               Beckman, Liam and Shao, Xiang and Fabregat, Antonio and
               Sidiropoulos, Konstantinos and Murillo, Julieth and Viteri,
               Guilherme and Cook, Justin and Shorser, Solomon and Bader, Gary
               and Demir, Emek and Sander, Chris and Haw, Robin and Wu,
               Guanming and Stein, Lincoln and Hermjakob, Henning and
               D'Eustachio, Peter",
  abstract  = "The Reactome Knowledgebase (https://reactome.org), an Elixir
               core resource, provides manually curated molecular details
               across a broad range of physiological and pathological
               biological processes in humans, including both hereditary and
               acquired disease processes. The processes are annotated as an
               ordered network of molecular transformations in a single
               consistent data model. Reactome thus functions both as a digital
               archive of manually curated human biological processes and as a
               tool for discovering functional relationships in data such as
               gene expression profiles or somatic mutation catalogs from tumor
               cells. Recent curation work has expanded our annotations of
               normal and disease-associated signaling processes and of the
               drugs that target them, in particular infections caused by the
               SARS-CoV-1 and SARS-CoV-2 coronaviruses and the host response to
               infection. New tools support better simultaneous analysis of
               high-throughput data from multiple sources and the placement of
               understudied ('dark') proteins from analyzed datasets in the
               context of Reactome's manually curated pathways.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  50,
  number    = "D1",
  pages     = "D687--D692",
  month     =  jan,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Westra2013-mm,
  title     = "Systematic identification of trans {eQTLs} as putative drivers
               of known disease associations",
  author    = "Westra, Harm-Jan and Peters, Marjolein J and Esko, T{\~o}nu and
               Yaghootkar, Hanieh and Schurmann, Claudia and Kettunen, Johannes
               and Christiansen, Mark W and Fairfax, Benjamin P and Schramm,
               Katharina and Powell, Joseph E and Zhernakova, Alexandra and
               Zhernakova, Daria V and Veldink, Jan H and Van den Berg, Leonard
               H and Karjalainen, Juha and Withoff, Sebo and Uitterlinden,
               Andr{\'e} G and Hofman, Albert and Rivadeneira, Fernando and 't
               Hoen, Peter A C and Reinmaa, Eva and Fischer, Krista and Nelis,
               Mari and Milani, Lili and Melzer, David and Ferrucci, Luigi and
               Singleton, Andrew B and Hernandez, Dena G and Nalls, Michael A
               and Homuth, Georg and Nauck, Matthias and Radke, D{\"o}rte and
               V{\"o}lker, Uwe and Perola, Markus and Salomaa, Veikko and
               Brody, Jennifer and Suchy-Dicey, Astrid and Gharib, Sina A and
               Enquobahrie, Daniel A and Lumley, Thomas and Montgomery, Grant W
               and Makino, Seiko and Prokisch, Holger and Herder, Christian and
               Roden, Michael and Grallert, Harald and Meitinger, Thomas and
               Strauch, Konstantin and Li, Yang and Jansen, Ritsert C and
               Visscher, Peter M and Knight, Julian C and Psaty, Bruce M and
               Ripatti, Samuli and Teumer, Alexander and Frayling, Timothy M
               and Metspalu, Andres and van Meurs, Joyce B J and Franke, Lude",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  45,
  number    =  10,
  pages     = "1238--1243",
  month     =  oct,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Van_Dam2017-vm,
  title     = "Gene co-expression analysis for functional classification and
               gene--disease predictions",
  author    = "van Dam, Sipko and V{\~o}sa, Urmo and van der Graaf, Adriaan and
               Franke, Lude and de Magalh{\~a}es, Jo{\~a}o Pedro",
  journal   = "Brief. Bioinform.",
  publisher = "Oxford University Press (OUP)",
  pages     = "bbw139",
  month     =  jan,
  year      =  2017
}

@ARTICLE{Tian2016-hy,
  title     = "The dissection of expression quantitative trait locus hotspots",
  author    = "Tian, Jianan and Keller, Mark P and Broman, Aimee Teo and
               Kendziorski, Christina and Yandell, Brian S and Attie, Alan D
               and Broman, Karl W",
  abstract  = "Studies of the genetic loci that contribute to variation in gene
               expression frequently identify loci with broad effects on gene
               expression: expression quantitative trait locus hotspots. We
               describe a set of exploratory graphical methods as well as a
               formal likelihood-based test for assessing whether a given
               hotspot is due to one or multiple polymorphisms. We first look
               at the pattern of effects of the locus on the expression traits
               that map to the locus: the direction of the effects and the
               degree of dominance. A second technique is to focus on the
               individuals that exhibit no recombination event in the region,
               apply dimensionality reduction (e.g., with linear discriminant
               analysis), and compare the phenotype distribution in the
               nonrecombinant individuals to that in the recombinant
               individuals: if the recombinant individuals display a different
               expression pattern than the nonrecombinant individuals, this
               indicates the presence of multiple causal polymorphisms. In the
               formal likelihood-based test, we compare a two-locus model, with
               each expression trait affected by one or the other locus, to a
               single-locus model. We apply our methods to a large mouse
               intercross with gene expression microarray data on six tissues.",
  journal   = "Genetics",
  publisher = "Oxford University Press (OUP)",
  volume    =  202,
  number    =  4,
  pages     = "1563--1574",
  month     =  apr,
  year      =  2016,
  keywords  = "data visualization; eQTL; gene expression; multivariate
               analysis; pleiotropy",
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}

@ARTICLE{Schadt2003-ei,
  title     = "Genetics of gene expression surveyed in maize, mouse and man",
  author    = "Schadt, Eric E and Monks, Stephanie A and Drake, Thomas A and
               Lusis, Aldons J and Che, Nam and Colinayo, Veronica and Ruff,
               Thomas G and Milligan, Stephen B and Lamb, John R and Cavet, Guy
               and Linsley, Peter S and Mao, Mao and Stoughton, Roland B and
               Friend, Stephen H",
  abstract  = "Treating messenger RNA transcript abundances as quantitative
               traits and mapping gene expression quantitative trait loci for
               these traits has been pursued in gene-specific ways. Transcript
               abundances often serve as a surrogate for classical quantitative
               traits in that the levels of expression are significantly
               correlated with the classical traits across members of a
               segregating population. The correlation structure between
               transcript abundances and classical traits has been used to
               identify susceptibility loci for complex diseases such as
               diabetes and allergic asthma. One study recently completed the
               first comprehensive dissection of transcriptional regulation in
               budding yeast, giving a detailed glimpse of a genome-wide survey
               of the genetics of gene expression. Unlike classical
               quantitative traits, which often represent gross clinical
               measurements that may be far removed from the biological
               processes giving rise to them, the genetic linkages associated
               with transcript abundance affords a closer look at cellular
               biochemical processes. Here we describe comprehensive genetic
               screens of mouse, plant and human transcriptomes by considering
               gene expression values as quantitative traits. We identify a
               gene expression pattern strongly associated with obesity in a
               murine cross, and observe two distinct obesity subtypes.
               Furthermore, we find that these obesity subtypes are under the
               control of different loci.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  422,
  number    =  6929,
  pages     = "297--302",
  month     =  mar,
  year      =  2003,
  language  = "en"
}

@ARTICLE{Brem2002-zj,
  title     = "Genetic dissection of transcriptional regulation in budding
               yeast",
  author    = "Brem, Rachel B and Yvert, Ga{\"e}l and Clinton, Rebecca and
               Kruglyak, Leonid",
  abstract  = "To begin to understand the genetic architecture of natural
               variation in gene expression, we carried out genetic linkage
               analysis of genomewide expression patterns in a cross between a
               laboratory strain and a wild strain of Saccharomyces cerevisiae.
               Over 1500 genes were differentially expressed between the parent
               strains. Expression levels of 570 genes were linked to one or
               more different loci, with most expression levels showing complex
               inheritance patterns. The loci detected by linkage fell largely
               into two categories: cis-acting modulators of single genes and
               trans-acting modulators of many genes. We found eight such
               trans-acting loci, each affecting the expression of a group of 7
               to 94 genes of related function.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  296,
  number    =  5568,
  pages     = "752--755",
  month     =  apr,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Ribeiro2021-xj,
  title     = "The molecular basis, genetic control and pleiotropic effects of
               local gene co-expression",
  author    = "Ribeiro, Diogo M and Rubinacci, Simone and Ramisch, Anna and
               Hofmeister, Robin J and Dermitzakis, Emmanouil T and Delaneau,
               Olivier",
  abstract  = "Nearby genes are often expressed as a group. Yet, the
               prevalence, molecular mechanisms and genetic control of local
               gene co-expression are far from being understood. Here, by
               leveraging gene expression measurements across 49 human tissues
               and hundreds of individuals, we find that local gene
               co-expression occurs in 13\% to 53\% of genes per tissue. By
               integrating various molecular assays (e.g. ChIP-seq and Hi-C),
               we estimate the ability of several mechanisms, such as
               enhancer-gene interactions, in distinguishing gene pairs that
               are co-expressed from those that are not. Notably, we identify
               32,636 expression quantitative trait loci (eQTLs) which
               associate with co-expressed gene pairs and often overlap
               enhancer regions. Due to affecting several genes, these eQTLs
               are more often associated with multiple human traits than other
               eQTLs. Our study paves the way to comprehend trait pleiotropy
               and functional interpretation of QTL and GWAS findings. All
               local gene co-expression identified here is available through a
               public database ( https://glcoex.unil.ch/ ).",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "4842",
  month     =  aug,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{hapmap,
  title     = "A second generation human haplotype map of over 3.1 million
               {SNPs}",
  author    = "{The International HapMap Consortium}",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  449,
  number    =  7164,
  pages     = "851--861",
  month     =  oct,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Bulik-Sullivan2015-ts,
  title     = "An atlas of genetic correlations across human diseases and
               traits",
  author    = "Bulik-Sullivan, Brendan and Finucane, Hilary K and Anttila,
               Verneri and Gusev, Alexander and Day, Felix R and Loh, Po-Ru and
               {ReproGen Consortium} and {Psychiatric Genomics Consortium} and
               {Genetic Consortium for Anorexia Nervosa of the Wellcome Trust
               Case Control Consortium 3} and Duncan, Laramie and Perry, John R
               B and Patterson, Nick and Robinson, Elise B and Daly, Mark J and
               Price, Alkes L and Neale, Benjamin M",
  abstract  = "Identifying genetic correlations between complex traits and
               diseases can provide useful etiological insights and help
               prioritize likely causal relationships. The major challenges
               preventing estimation of genetic correlation from genome-wide
               association study (GWAS) data with current methods are the lack
               of availability of individual-level genotype data and widespread
               sample overlap among meta-analyses. We circumvent these
               difficulties by introducing a technique-cross-trait LD Score
               regression-for estimating genetic correlation that requires only
               GWAS summary statistics and is not biased by sample overlap. We
               use this method to estimate 276 genetic correlations among 24
               traits. The results include genetic correlations between
               anorexia nervosa and schizophrenia, anorexia and obesity, and
               educational attainment and several diseases. These results
               highlight the power of genome-wide analyses, as there currently
               are no significantly associated SNPs for anorexia nervosa and
               only three for educational attainment.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  11,
  pages     = "1236--1241",
  month     =  nov,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Bulik-Sullivan2015-fk,
  title     = "{LD} Score regression distinguishes confounding from
               polygenicity in genome-wide association studies",
  author    = "Bulik-Sullivan, Brendan K and {Schizophrenia Working Group of
               the Psychiatric Genomics Consortium} and Loh, Po-Ru and
               Finucane, Hilary K and Ripke, Stephan and Yang, Jian and
               Patterson, Nick and Daly, Mark J and Price, Alkes L and Neale,
               Benjamin M",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  47,
  number    =  3,
  pages     = "291--295",
  month     =  mar,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Qin2015-jb,
  title     = "Quantitating and dating recent gene flow between European and
               East Asian populations",
  author    = "Qin, Pengfei and Zhou, Ying and Lou, Haiyi and Lu, Dongsheng and
               Yang, Xiong and Wang, Yuchen and Jin, Li and Chung, Yeun-Jun and
               Xu, Shuhua",
  abstract  = "Historical records indicate that extensive cultural, commercial
               and technological interaction occurred between European and
               Asian populations. What have been the biological consequences of
               these contacts in terms of gene flow? We systematically
               estimated gene flow between Eurasian groups using genome-wide
               polymorphisms from 34 populations representing Europeans, East
               Asians, and Central/South Asians. We identified recent gene flow
               between Europeans and Asians in most populations we studied,
               including East Asians and Northwestern Europeans, which are
               normally considered to be non-admixed populations. In addition
               we quantitatively estimated the extent of this gene flow using
               two statistical approaches, and dated admixture events based on
               admixture linkage disequilibrium. Our results indicate that most
               genetic admixtures occurred between 2,400 and 310 years ago and
               show the admixture proportions to be highly correlated with
               geographic locations, with the highest admixture proportions
               observed in Central Asia and the lowest in East Asia and
               Northwestern Europe. Interestingly, we observed a North-to-South
               decline of European gene flow in East Asians, suggesting a
               northern path of European gene flow diffusing into East Asian
               populations. Our findings contribute to an improved
               understanding of the history of human migration and the
               evolutionary mechanisms that have shaped the genetic structure
               of populations in Eurasia.",
  journal   = "Sci. Rep.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  5,
  number    =  1,
  pages     = "9500",
  month     =  apr,
  year      =  2015,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Zheng2021-ss,
  title     = "Genome-wide analysis of 944 133 individuals provides insights
               into the etiology of haemorrhoidal disease",
  author    = "Zheng, Tenghao and Ellinghaus, David and Juzenas, Simonas and
               Cossais, Fran{\c c}ois and Burmeister, Greta and Mayr, Gabriele
               and J{\o}rgensen, Isabella Friis and Teder-Laving, Maris and
               Skogholt, Anne Heidi and Chen, Sisi and Strege, Peter R and Ito,
               Go and Banasik, Karina and Becker, Thomas and Bokelmann, Frank
               and Brunak, S{\o}ren and Buch, Stephan and Clausnitzer, Hartmut
               and Datz, Christian and {DBDS Consortium} and Degenhardt, Frauke
               and Doniec, Marek and Erikstrup, Christian and Esko, T{\~o}nu
               and Forster, Michael and Frey, Norbert and Fritsche, Lars G and
               Gabrielsen, Maiken Elvestad and Gr{\"a}{\ss}le, Tobias and Gsur,
               Andrea and Gross, Justus and Hampe, Jochen and Hendricks,
               Alexander and Hinz, Sebastian and Hveem, Kristian and Jongen,
               Johannes and Junker, Ralf and Karlsen, Tom Hemming and
               Hemmrich-Stanisak, Georg and Kruis, Wolfgang and Kupcinskas,
               Juozas and Laubert, Tilman and Rosenstiel, Philip C and
               R{\"o}cken, Christoph and Laudes, Matthias and Leendertz, Fabian
               H and Lieb, Wolfgang and Limperger, Verena and Margetis,
               Nikolaos and M{\"a}tz-Rensing, Kerstin and N{\'e}meth,
               Christopher Georg and Ness-Jensen, Eivind and Nowak-G{\"o}ttl,
               Ulrike and Pandit, Anita and Pedersen, Ole Birger and Peleikis,
               Hans G{\"u}nter and Peuker, Kenneth and Rodriguez, Cristina Leal
               and R{\"u}hlemann, Malte Christoph and Schniewind, Bodo and
               Schulzky, Martin and Skieceviciene, Jurgita and Tepel,
               J{\"u}rgen and Thomas, Laurent and Uellendahl-Werth, Florian and
               Ullum, Henrik and Vogel, Ilka and Volzke, Henry and von Fersen,
               Lorenzo and von Sch{\"o}nfels, Witigo and Vanderwerff, Brett and
               Wilking, Julia and Wittig, Michael and Zeissig, Sebastian and
               Zobel, Myrko and Zawistowski, Matthew and Vacic, Vladimir and
               Sazonova, Olga and Noblin, Elizabeth S and {23andMe Research
               Team} and Farrugia, Gianrico and Beyder, Arthur and Wedel, Thilo
               and Kahlke, Volker and Schafmayer, Clemens and D'Amato, Mauro
               and Franke, Andre",
  abstract  = "OBJECTIVE: Haemorrhoidal disease (HEM) affects a large and
               silently suffering fraction of the population but its aetiology,
               including suspected genetic predisposition, is poorly
               understood. We report the first genome-wide association study
               (GWAS) meta-analysis to identify genetic risk factors for HEM to
               date. DESIGN: We conducted a GWAS meta-analysis of 218 920
               patients with HEM and 725 213 controls of European ancestry.
               Using GWAS summary statistics, we performed multiple genetic
               correlation analyses between HEM and other traits as well as
               calculated HEM polygenic risk scores (PRS) and evaluated their
               translational potential in independent datasets. Using
               functional annotation of GWAS results, we identified HEM
               candidate genes, which differential expression and coexpression
               in HEM tissues were evaluated employing RNA-seq analyses. The
               localisation of expressed proteins at selected loci was
               investigated by immunohistochemistry. RESULTS: We demonstrate
               modest heritability and genetic correlation of HEM with several
               other diseases from the GI, neuroaffective and cardiovascular
               domains. HEM PRS validated in 180 435 individuals from
               independent datasets allowed the identification of those at risk
               and correlated with younger age of onset and recurrent surgery.
               We identified 102 independent HEM risk loci harbouring genes
               whose expression is enriched in blood vessels and GI tissues,
               and in pathways associated with smooth muscles, epithelial and
               endothelial development and morphogenesis. Network
               transcriptomic analyses highlighted HEM gene coexpression
               modules that are relevant to the development and integrity of
               the musculoskeletal and epidermal systems, and the organisation
               of the extracellular matrix. CONCLUSION: HEM has a genetic
               component that predisposes to smooth muscle, epithelial and
               connective tissue dysfunction.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  70,
  number    =  8,
  pages     = "1538--1549",
  month     =  apr,
  year      =  2021,
  keywords  = "anal canal histopathology; anorectal disorders; genetics",
  language  = "en"
}

@ARTICLE{Price2010-zb,
  title     = "New approaches to population stratification in genome-wide
               association studies",
  author    = "Price, Alkes L and Zaitlen, Noah A and Reich, David and
               Patterson, Nick",
  abstract  = "Genome-wide association (GWA) studies are an effective approach
               for identifying genetic variants associated with disease risk.
               GWA studies can be confounded by population
               stratification--systematic ancestry differences between cases
               and controls--which has previously been addressed by methods
               that infer genetic ancestry. Those methods perform well in data
               sets in which population structure is the only kind of structure
               present but are inadequate in data sets that also contain family
               structure or cryptic relatedness. Here, we review recent
               progress on methods that correct for stratification while
               accounting for these additional complexities.",
  journal   = "Nat. Rev. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  11,
  number    =  7,
  pages     = "459--463",
  month     =  jul,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Kraft2009-xg,
  title     = "Replication in genome-wide association studies",
  author    = "Kraft, Peter and Zeggini, Eleftheria and Ioannidis, John P A",
  abstract  = "Replication helps ensure that a genotype-phenotype association
               observed in a genome-wide association (GWA) study represents a
               credible association and is not a chance finding or an artifact
               due to uncontrolled biases. We discuss prerequisites for exact
               replication; issues of heterogeneity; advantages and
               disadvantages of different methods of data synthesis across
               multiple studies; frequentist vs. Bayesian inferences for
               replication; and challenges that arise from multi-team
               collaborations. While consistent replication can greatly improve
               the credibility of a genotype-phenotype association, it may not
               eliminate spurious associations due to biases shared by many
               studies. Conversely, lack of replication in well-powered
               follow-up studies usually invalidates the initially proposed
               association, although occasionally it may point to differences
               in linkage disequilibrium or effect modifiers across studies.",
  journal   = "Stat. Sci.",
  publisher = "Institute of Mathematical Statistics",
  volume    =  24,
  number    =  4,
  pages     = "561--573",
  month     =  nov,
  year      =  2009,
  language  = "en"
}


@ARTICLE{Hirsch2016-mw,
  title     = "{ICD-10}: History and context",
  author    = "Hirsch, J A and Nicola, G and McGinty, G and Liu, R W and Barr,
               R M and Chittle, M D and Manchikanti, L",
  abstract  = "In recent months, organized medicine has been consumed by the
               anticipated transition to the 10th iteration of the
               International Classification of Disease system. Implementation
               has come and gone without the disruptive effects predicted by
               many. Despite the fundamental role the International
               Classification of Disease system plays in health care delivery
               and payment policy, few neuroradiologists are familiar with the
               history of its implementation and implications beyond coding for
               diseases.",
  journal   = "AJNR Am. J. Neuroradiol.",
  publisher = "American Society of Neuroradiology (ASNR)",
  volume    =  37,
  number    =  4,
  pages     = "596--599",
  month     =  apr,
  year      =  2016,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%% Splicing chapter%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
@UNPUBLISHED{macromap-eqtl,
  title    = "Gene expression {QTL} mapping in stimulated {iPSC-derived}
              macrophages provides insights into common complex diseases",
  author   = "Panousis, Nikolaos I and Garwany, Omar El and Knights, Andrew and
              Rop, Jesse Cheruiyot and Kumasaka, Natsuhiko and Imaz, Maria and
              Vilarino, Lorena Boquete and Tsingene, Anthi and Barnett, Alice
              and Gomez, Celine and Anderson, Carl A and Gaffney, Daniel J",
  abstract = "AbstractMany disease-associated variants are thought to be
              regulatory but are not present in existing catalogues of
              expression quantitative trait loci (eQTL). We hypothesise that
              these variants may regulate expression in specific biological
              contexts, such as stimulated immune cells. Here, we used human
              iPSC-derived macrophages to map eQTLs across 24 cellular
              conditions. We found that 76\% of eQTLs detected in at least one
              stimulated condition were also found in naive cells. The
              percentage of response eQTLs (reQTLs) varied widely across
              conditions (3.7\% - 28.4\%), with reQTLs specific to a single
              condition being rare (1.11\%). Despite their relative rarity,
              reQTLs were overrepresented among disease-colocalizing eQTLs. We
              nominated an additional 21.7\% of disease effector genes at GWAS
              loci via colocalization of reQTLs, with 38.6\% of these not found
              in the Genotype--Tissue Expression (GTEx) catalogue. Our study
              highlights the diversity of genetic effects on expression and
              demonstrates how condition-specific regulatory variation can
              enhance our understanding of common disease risk alleles.",
  journal  = "bioRxiv",
  month    =  may,
  year     =  2023
}

@ARTICLE{Maurano2012-yw,
  title     = "Systematic localization of common disease-associated variation
               in regulatory {DNA}",
  author    = "Maurano, Matthew T and Humbert, Richard and Rynes, Eric and
               Thurman, Robert E and Haugen, Eric and Wang, Hao and Reynolds,
               Alex P and Sandstrom, Richard and Qu, Hongzhu and Brody,
               Jennifer and Shafer, Anthony and Neri, Fidencio and Lee, Kristen
               and Kutyavin, Tanya and Stehling-Sun, Sandra and Johnson, Audra
               K and Canfield, Theresa K and Giste, Erika and Diegel, Morgan
               and Bates, Daniel and Hansen, R Scott and Neph, Shane and Sabo,
               Peter J and Heimfeld, Shelly and Raubitschek, Antony and
               Ziegler, Steven and Cotsapas, Chris and Sotoodehnia, Nona and
               Glass, Ian and Sunyaev, Shamil R and Kaul, Rajinder and
               Stamatoyannopoulos, John A",
  abstract  = "Genome-wide association studies have identified many noncoding
               variants associated with common diseases and traits. We show
               that these variants are concentrated in regulatory DNA marked by
               deoxyribonuclease I (DNase I) hypersensitive sites (DHSs).
               Eighty-eight percent of such DHSs are active during fetal
               development and are enriched in variants associated with
               gestational exposure-related phenotypes. We identified distant
               gene targets for hundreds of variant-containing DHSs that may
               explain phenotype associations. Disease-associated variants
               systematically perturb transcription factor recognition
               sequences, frequently alter allelic chromatin states, and form
               regulatory networks. We also demonstrated tissue-selective
               enrichment of more weakly disease-associated variants within
               DHSs and the de novo identification of pathogenic cell types for
               Crohn's disease, multiple sclerosis, and an electrocardiogram
               trait, without prior knowledge of physiological mechanisms. Our
               results suggest pervasive involvement of regulatory DNA
               variation in common human disease and provide pathogenic
               insights into diverse disorders.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  337,
  number    =  6099,
  pages     = "1190--1195",
  month     =  sep,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Schaub2012-cy,
  title     = "Linking disease associations with regulatory information in the
               human genome",
  author    = "Schaub, Marc A and Boyle, Alan P and Kundaje, Anshul and
               Batzoglou, Serafim and Snyder, Michael",
  abstract  = "Genome-wide association studies have been successful in
               identifying single nucleotide polymorphisms (SNPs) associated
               with a large number of phenotypes. However, an associated SNP is
               likely part of a larger region of linkage disequilibrium. This
               makes it difficult to precisely identify the SNPs that have a
               biological link with the phenotype. We have systematically
               investigated the association of multiple types of ENCODE data
               with disease-associated SNPs and show that there is significant
               enrichment for functional SNPs among the currently identified
               associations. This enrichment is strongest when integrating
               multiple sources of functional information and when highest
               confidence disease-associated SNPs are used. We propose an
               approach that integrates multiple types of functional data
               generated by the ENCODE Consortium to help identify ``functional
               SNPs'' that may be associated with the disease phenotype. Our
               approach generates putative functional annotations for up to
               80\% of all previously reported associations. We show that for
               most associations, the functional SNP most strongly supported by
               experimental evidence is a SNP in linkage disequilibrium with
               the reported association rather than the reported SNP itself.
               Our results show that the experimental data sets generated by
               the ENCODE Consortium can be successfully used to suggest
               functional hypotheses for variants associated with diseases and
               other phenotypes.",
  journal   = "Genome Res.",
  publisher = "Cold Spring Harbor Laboratory",
  volume    =  22,
  number    =  9,
  pages     = "1748--1759",
  month     =  sep,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Vosa2021-pb,
  title     = "Large-scale cis- and {trans-eQTL} analyses identify thousands of
               genetic loci and polygenic scores that regulate blood gene
               expression",
  author    = "V{\~o}sa, Urmo and Claringbould, Annique and Westra, Harm-Jan
               and Bonder, Marc Jan and Deelen, Patrick and Zeng, Biao and
               Kirsten, Holger and Saha, Ashis and Kreuzhuber, Roman and Yazar,
               Seyhan and Brugge, Harm and Oelen, Roy and de Vries, Dylan H and
               van der Wijst, Monique G P and Kasela, Silva and Pervjakova,
               Natalia and Alves, Isabel and Fav{\'e}, Marie-Julie and Agbessi,
               Mawuss{\'e} and Christiansen, Mark W and Jansen, Rick and
               Sepp{\"a}l{\"a}, Ilkka and Tong, Lin and Teumer, Alexander and
               Schramm, Katharina and Hemani, Gibran and Verlouw, Joost and
               Yaghootkar, Hanieh and S{\"o}nmez Flitman, Reyhan and Brown,
               Andrew and Kukushkina, Viktorija and Kalnapenkis, Anette and
               R{\"u}eger, Sina and Porcu, Eleonora and Kronberg, Jaanika and
               Kettunen, Johannes and Lee, Bernett and Zhang, Futao and Qi,
               Ting and Hernandez, Jose Alquicira and Arindrarto, Wibowo and
               Beutner, Frank and {BIOS Consortium} and {i2QTL Consortium} and
               Dmitrieva, Julia and Elansary, Mahmoud and Fairfax, Benjamin P
               and Georges, Michel and Heijmans, Bastiaan T and Hewitt, Alex W
               and K{\"a}h{\"o}nen, Mika and Kim, Yungil and Knight, Julian C
               and Kovacs, Peter and Krohn, Knut and Li, Shuang and Loeffler,
               Markus and Marigorta, Urko M and Mei, Hailang and Momozawa,
               Yukihide and M{\"u}ller-Nurasyid, Martina and Nauck, Matthias
               and Nivard, Michel G and Penninx, Brenda W J H and Pritchard,
               Jonathan K and Raitakari, Olli T and Rotzschke, Olaf and
               Slagboom, Eline P and Stehouwer, Coen D A and Stumvoll, Michael
               and Sullivan, Patrick and 't Hoen, Peter A C and Thiery, Joachim
               and T{\"o}njes, Anke and van Dongen, Jenny and van Iterson,
               Maarten and Veldink, Jan H and V{\"o}lker, Uwe and Warmerdam,
               Robert and Wijmenga, Cisca and Swertz, Morris and Andiappan,
               Anand and Montgomery, Grant W and Ripatti, Samuli and Perola,
               Markus and Kutalik, Zoltan and Dermitzakis, Emmanouil and
               Bergmann, Sven and Frayling, Timothy and van Meurs, Joyce and
               Prokisch, Holger and Ahsan, Habibul and Pierce, Brandon L and
               Lehtim{\"a}ki, Terho and Boomsma, Dorret I and Psaty, Bruce M
               and Gharib, Sina A and Awadalla, Philip and Milani, Lili and
               Ouwehand, Willem H and Downes, Kate and Stegle, Oliver and
               Battle, Alexis and Visscher, Peter M and Yang, Jian and Scholz,
               Markus and Powell, Joseph and Gibson, Greg and Esko, T{\~o}nu
               and Franke, Lude",
  abstract  = "Trait-associated genetic variants affect complex phenotypes
               primarily via regulatory mechanisms on the transcriptome. To
               investigate the genetics of gene expression, we performed cis-
               and trans-expression quantitative trait locus (eQTL) analyses
               using blood-derived expression from 31,684 individuals through
               the eQTLGen Consortium. We detected cis-eQTL for 88\% of genes,
               and these were replicable in numerous tissues. Distal trans-eQTL
               (detected for 37\% of 10,317 trait-associated variants tested)
               showed lower replication rates, partially due to low replication
               power and confounding by cell type composition. However,
               replication analyses in single-cell RNA-seq data prioritized
               intracellular trans-eQTL. Trans-eQTL exerted their effects via
               several mechanisms, primarily through regulation by
               transcription factors. Expression of 13\% of the genes
               correlated with polygenic scores for 1,263 phenotypes,
               pinpointing potential drivers for those traits. In summary, this
               work represents a large eQTL resource, and its results serve as
               a starting point for in-depth interpretation of complex
               phenotypes.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  9,
  pages     = "1300--1310",
  month     =  sep,
  year      =  2021,
  language  = "en"
}

@ARTICLE{The_GTEx_Consortium2020-gg,
  title     = "The {GTEx} Consortium atlas of genetic regulatory effects across
               human tissues",
  author    = "{The GTEx Consortium} and Aguet, Fran{\c c}ois and Anand,
               Shankara and Ardlie, Kristin G and Gabriel, Stacey and Getz, Gad
               A and Graubert, Aaron and Hadley, Kane and Handsaker, Robert E
               and Huang, Katherine H and Kashin, Seva and Li, Xiao and
               MacArthur, Daniel G and Meier, Samuel R and Nedzel, Jared L and
               Nguyen, Duyen T and Segr{\`e}, Ayellet V and Todres, Ellen and
               Balliu, Brunilda and Barbeira, Alvaro N and Battle, Alexis and
               Bonazzola, Rodrigo and Brown, Andrew and Brown, Christopher D
               and Castel, Stephane E and Conrad, Donald F and Cotter, Daniel J
               and Cox, Nancy and Das, Sayantan and de Goede, Olivia M and
               Dermitzakis, Emmanouil T and Einson, Jonah and Engelhardt,
               Barbara E and Eskin, Eleazar and Eulalio, Tiffany Y and Ferraro,
               Nicole M and Flynn, Elise D and Fresard, Laure and Gamazon, Eric
               R and Garrido-Mart{\'\i}n, Diego and Gay, Nicole R and
               Gloudemans, Michael J and Guig{\'o}, Roderic and Hame, Andrew R
               and He, Yuan and Hoffman, Paul J and Hormozdiari, Farhad and
               Hou, Lei and Im, Hae Kyung and Jo, Brian and Kasela, Silva and
               Kellis, Manolis and Kim-Hellmuth, Sarah and Kwong, Alan and
               Lappalainen, Tuuli and Li, Xin and Liang, Yanyu and Mangul,
               Serghei and Mohammadi, Pejman and Montgomery, Stephen B and
               Mu{\~n}oz-Aguirre, Manuel and Nachun, Daniel C and Nobel, Andrew
               B and Oliva, Meritxell and Park, Yoson and Park, Yongjin and
               Parsana, Princy and Rao, Abhiram S and Reverter, Ferran and
               Rouhana, John M and Sabatti, Chiara and Saha, Ashis and
               Stephens, Matthew and Stranger, Barbara E and Strober, Benjamin
               J and Teran, Nicole A and Vi{\~n}uela, Ana and Wang, Gao and
               Wen, Xiaoquan and Wright, Fred and Wucher, Valentin and Zou,
               Yuxin and Ferreira, Pedro G and Li, Gen and Mel{\'e}, Marta and
               Yeger-Lotem, Esti and Barcus, Mary E and Bradbury, Debra and
               Krubit, Tanya and McLean, Jeffrey A and Qi, Liqun and Robinson,
               Karna and Roche, Nancy V and Smith, Anna M and Sobin, Leslie and
               Tabor, David E and Undale, Anita and Bridge, Jason and Brigham,
               Lori E and Foster, Barbara A and Gillard, Bryan M and Hasz,
               Richard and Hunter, Marcus and Johns, Christopher and Johnson,
               Mark and Karasik, Ellen and Kopen, Gene and Leinweber, William F
               and McDonald, Alisa and Moser, Michael T and Myer, Kevin and
               Ramsey, Kimberley D and Roe, Brian and Shad, Saboor and Thomas,
               Jeffrey A and Walters, Gary and Washington, Michael and Wheeler,
               Joseph and Jewell, Scott D and Rohrer, Daniel C and Valley, Dana
               R and Davis, David A and Mash, Deborah C and Branton, Philip A
               and Barker, Laura K and Gardiner, Heather M and Mosavel,
               Maghboeba and Siminoff, Laura A and Flicek, Paul and Haeussler,
               Maximilian and Juettemann, Thomas and Kent, W James and Lee,
               Christopher M and Powell, Conner C and Rosenbloom, Kate R and
               Ruffier, Magali and Sheppard, Dan and Taylor, Kieron and
               Trevanion, Stephen J and Zerbino, Daniel R and Abell, Nathan S
               and Akey, Joshua and Chen, Lin and Demanelis, Kathryn and
               Doherty, Jennifer A and Feinberg, Andrew P and Hansen, Kasper D
               and Hickey, Peter F and Jasmine, Farzana and Jiang, Lihua and
               Kaul, Rajinder and Kibriya, Muhammad G and Li, Jin Billy and Li,
               Qin and Lin, Shin and Linder, Sandra E and Pierce, Brandon L and
               Rizzardi, Lindsay F and Skol, Andrew D and Smith, Kevin S and
               Snyder, Michael and Stamatoyannopoulos, John and Tang, Hua and
               Wang, Meng and Carithers, Latarsha J and Guan, Ping and Koester,
               Susan E and Little, A Roger and Moore, Helen M and Nierras,
               Concepcion R and Rao, Abhi K and Vaught, Jimmie B and Volpi,
               Simona",
  abstract  = "The Genotype-Tissue Expression (GTEx) project dissects how
               genetic variation affects gene expression and splicing.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  369,
  number    =  6509,
  pages     = "1318--1330",
  month     =  sep,
  year      =  2020,
  copyright = "https://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kerimov2021-gh,
  title     = "A compendium of uniformly processed human gene expression and
               splicing quantitative trait loci",
  author    = "Kerimov, Nurlan and Hayhurst, James D and Peikova, Kateryna and
               Manning, Jonathan R and Walter, Peter and Kolberg, Liis and
               Samovi{\v c}a, Marija and Sakthivel, Manoj Pandian and Kuzmin,
               Ivan and Trevanion, Stephen J and Burdett, Tony and Jupp, Simon
               and Parkinson, Helen and Papatheodorou, Irene and Yates, Andrew
               D and Zerbino, Daniel R and Alasoo, Kaur",
  abstract  = "Many gene expression quantitative trait locus (eQTL) studies
               have published their summary statistics, which can be used to
               gain insight into complex human traits by downstream analyses,
               such as fine mapping and co-localization. However, technical
               differences between these datasets are a barrier to their
               widespread use. Consequently, target genes for most genome-wide
               association study (GWAS) signals have still not been identified.
               In the present study, we present the eQTL Catalogue (
               https://www.ebi.ac.uk/eqtl ), a resource of quality-controlled,
               uniformly re-computed gene expression and splicing QTLs from 21
               studies. We find that, for matching cell types and tissues, the
               eQTL effect sizes are highly reproducible between studies.
               Although most QTLs were shared between most bulk tissues, we
               identified a greater diversity of cell-type-specific QTLs from
               purified cell types, a subset of which also manifested as new
               disease co-localizations. Our summary statistics are freely
               available to enable the systematic interpretation of human GWAS
               associations across many cell types and tissues.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  9,
  pages     = "1290--1299",
  month     =  sep,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Chun2017-uz,
  title     = "Limited statistical evidence for shared genetic effects of
               {eQTLs} and autoimmune-disease-associated loci in three major
               immune-cell types",
  author    = "Chun, Sung and Casparino, Alexandra and Patsopoulos, Nikolaos A
               and Croteau-Chonka, Damien C and Raby, Benjamin A and De Jager,
               Philip L and Sunyaev, Shamil R and Cotsapas, Chris",
  abstract  = "Most autoimmune-disease-risk effects identified by genome-wide
               association studies (GWAS) localize to open chromatin with
               gene-regulatory activity. GWAS loci are also enriched in
               expression quantitative trait loci (eQTLs), thus suggesting that
               most risk variants alter gene expression. However, because
               causal variants are difficult to identify, and cis-eQTLs occur
               frequently, it remains challenging to identify specific
               instances of disease-relevant changes to gene regulation. Here,
               we used a novel joint likelihood framework with higher
               resolution than that of previous methods to identify loci where
               autoimmune-disease risk and an eQTL are driven by a single
               shared genetic effect. Using eQTLs from three major immune
               subpopulations, we found shared effects in only 25\% of the
               loci examined. Thus, we show that a fraction of gene-regulatory
               changes suggest strong mechanistic hypotheses for disease risk,
               but we conclude that most risk mechanisms are not likely to
               involve changes in basal gene expression.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  49,
  number    =  4,
  pages     = "600--605",
  month     =  apr,
  year      =  2017,
  language  = "en"
}

@UNPUBLISHED{Mostafavi2022-tg,
  title    = "Limited overlap of {eQTLs} and {GWAS} hits due to systematic
              differences in discovery",
  author   = "Mostafavi, Hakhamanesh and Spence, Jeffrey P and Naqvi, Sahin and
              Pritchard, Jonathan K",
  abstract = "AbstractMost signals in genome-wide association studies (GWAS) of
              complex traits point to noncoding genetic variants with putative
              gene regulatory effects. However, currently identified expression
              quantitative trait loci (eQTLs) explain only a small fraction of
              GWAS signals. By analyzing GWAS hits for complex traits in the UK
              Biobank, and cis-eQTLs from the GTEx consortium, we show that
              these assays systematically discover different types of genes and
              variants: eQTLs cluster strongly near transcription start sites,
              while GWAS hits do not. Genes near GWAS hits are enriched in
              numerous functional annotations, are under strong selective
              constraint and have a complex regulatory landscape across
              different tissue/cell types, while genes near eQTLs are depleted
              of most functional annotations, show relaxed constraint, and have
              simpler regulatory landscapes. We describe a model to understand
              these observations, including how natural selection on complex
              traits hinders discovery of functionally-relevant eQTLs. Our
              results imply that GWAS and eQTL studies are systematically
              biased toward different types of variants, and support the use of
              complementary functional approaches alongside the next generation
              of eQTL studies.",
  journal  = "bioRxiv",
  month    =  may,
  year     =  2022
}

@ARTICLE{Li2016-wu,
  title     = "{RNA} splicing is a primary link between genetic variation and
               disease",
  author    = "Li, Yang I and van de Geijn, Bryce and Raj, Anil and Knowles,
               David A and Petti, Allegra A and Golan, David and Gilad, Yoav
               and Pritchard, Jonathan K",
  abstract  = "RNA splicing links genetics to disease Many genetic variants
               associated with disease have no apparent effect on any specific
               protein coding sequence. Li et al. systematically analyzed the
               effects of DNA variants on the main steps of gene regulation,
               from the chromatin state through protein function. One-third of
               expression quantitative train loci (QTLs) are mediated through
               transcriptional processes, not chromatin. Splice QTLs and
               expression QTLs are about comparable in their complex disease
               risk. Posttranscriptional mechanisms therefore play a large role
               in translating genotype to phenotype. Science , this issue p.
               600",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  352,
  number    =  6285,
  pages     = "600--604",
  month     =  apr,
  year      =  2016,
  copyright = "http://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kim-Hellmuth2020-gz,
  title     = "Cell type--specific genetic regulation of gene expression across
               human tissues",
  author    = "Kim-Hellmuth, Sarah and Aguet, Fran{\c c}ois and Oliva,
               Meritxell and Mu{\~n}oz-Aguirre, Manuel and Kasela, Silva and
               Wucher, Valentin and Castel, Stephane E and Hamel, Andrew R and
               Vi{\~n}uela, Ana and Roberts, Amy L and Mangul, Serghei and Wen,
               Xiaoquan and Wang, Gao and Barbeira, Alvaro N and
               Garrido-Mart{\'\i}n, Diego and Nadel, Brian B and Zou, Yuxin and
               Bonazzola, Rodrigo and Quan, Jie and Brown, Andrew and
               Martinez-Perez, Angel and Soria, Jos{\'e} Manuel and Getz, Gad
               and Dermitzakis, Emmanouil T and Small, Kerrin S and Stephens,
               Matthew and Xi, Hualin S and Im, Hae Kyung and Guig{\'o},
               Roderic and Segr{\`e}, Ayellet V and Stranger, Barbara E and
               Ardlie, Kristin G and Lappalainen, Tuuli and Aguet, Fran{\c
               c}ois and Anand, Shankara and Ardlie, Kristin G and Gabriel,
               Stacey and Getz, Gad A and Graubert, Aaron and Hadley, Kane and
               Handsaker, Robert E and Huang, Katherine H and Kashin, Seva and
               Li, Xiao and MacArthur, Daniel G and Meier, Samuel R and Nedzel,
               Jared L and Nguyen, Duyen T and Segr{\`e}, Ayellet V and Todres,
               Ellen and Balliu, Brunilda and Barbeira, Alvaro N and Battle,
               Alexis and Bonazzola, Rodrigo and Brown, Andrew and Brown,
               Christopher D and Castel, Stephane E and Conrad, Donald F and
               Cotter, Daniel J and Cox, Nancy and Das, Sayantan and de Goede,
               Olivia M and Dermitzakis, Emmanouil T and Einson, Jonah and
               Engelhardt, Barbara E and Eskin, Eleazar and Eulalio, Tiffany Y
               and Ferraro, Nicole M and Flynn, Elise D and Fresard, Laure and
               Gamazon, Eric R and Garrido-Mart{\'\i}n, Diego and Gay, Nicole R
               and Gloudemans, Michael J and Guig{\'o}, Roderic and Hame,
               Andrew R and He, Yuan and Hoffman, Paul J and Hormozdiari,
               Farhad and Hou, Lei and Im, Hae Kyung and Jo, Brian and Kasela,
               Silva and Kellis, Manolis and Kim-Hellmuth, Sarah and Kwong,
               Alan and Lappalainen, Tuuli and Li, Xin and Liang, Yanyu and
               Mangul, Serghei and Mohammadi, Pejman and Montgomery, Stephen B
               and Mu{\~n}oz-Aguirre, Manuel and Nachun, Daniel C and Nobel,
               Andrew B and Oliva, Meritxell and Park, Yoson and Park, Yongjin
               and Parsana, Princy and Rao, Abhiram S and Reverter, Ferran and
               Rouhana, John M and Sabatti, Chiara and Saha, Ashis and
               Stephens, Matthew and Stranger, Barbara E and Strober, Benjamin
               J and Teran, Nicole A and Vi{\~n}uela, Ana and Wang, Gao and
               Wen, Xiaoquan and Wright, Fred and Wucher, Valentin and Zou,
               Yuxin and Ferreira, Pedro G and Li, Gen and Mel{\'e}, Marta and
               Yeger-Lotem, Esti and Barcus, Mary E and Bradbury, Debra and
               Krubit, Tanya and McLean, Jeffrey A and Qi, Liqun and Robinson,
               Karna and Roche, Nancy V and Smith, Anna M and Sobin, Leslie and
               Tabor, David E and Undale, Anita and Bridge, Jason and Brigham,
               Lori E and Foster, Barbara A and Gillard, Bryan M and Hasz,
               Richard and Hunter, Marcus and Johns, Christopher and Johnson,
               Mark and Karasik, Ellen and Kopen, Gene and Leinweber, William F
               and McDonald, Alisa and Moser, Michael T and Myer, Kevin and
               Ramsey, Kimberley D and Roe, Brian and Shad, Saboor and Thomas,
               Jeffrey A and Walters, Gary and Washington, Michael and Wheeler,
               Joseph and Jewell, Scott D and Rohrer, Daniel C and Valley, Dana
               R and Davis, David A and Mash, Deborah C and Branton, Philip A
               and Barker, Laura K and Gardiner, Heather M and Mosavel,
               Maghboeba and Siminoff, Laura A and Flicek, Paul and Haeussler,
               Maximilian and Juettemann, Thomas and Kent, W James and Lee,
               Christopher M and Powell, Conner C and Rosenbloom, Kate R and
               Ruffier, Magali and Sheppard, Dan and Taylor, Kieron and
               Trevanion, Stephen J and Zerbino, Daniel R and Abell, Nathan S
               and Akey, Joshua and Chen, Lin and Demanelis, Kathryn and
               Doherty, Jennifer A and Feinberg, Andrew P and Hansen, Kasper D
               and Hickey, Peter F and Jasmine, Farzana and Jiang, Lihua and
               Kaul, Rajinder and Kibriya, Muhammad G and Li, Jin Billy and Li,
               Qin and Lin, Shin and Linder, Sandra E and Pierce, Brandon L and
               Rizzardi, Lindsay F and Skol, Andrew D and Smith, Kevin S and
               Snyder, Michael and Stamatoyannopoulos, John and Tang, Hua and
               Wang, Meng and Carithers, Latarsha J and Guan, Ping and Koester,
               Susan E and Little, A Roger and Moore, Helen M and Nierras,
               Concepcion R and Rao, Abhi K and Vaught, Jimmie B and Volpi,
               Simona and {GTEx Consortium}",
  abstract  = "Cell type composition, estimated from bulk tissue, maps the
               cellular specificity of genetic variants.",
  journal   = "Science",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  369,
  number    =  6509,
  pages     = "eaaz8528",
  month     =  sep,
  year      =  2020,
  copyright = "https://www.sciencemag.org/about/science-licenses-journal-article-reuse",
  language  = "en"
}

@ARTICLE{Kilpinen2017-qm,
  title     = "Common genetic variation drives molecular heterogeneity in human
               {iPSCs}",
  author    = "Kilpinen, Helena and Goncalves, Angela and Leha, Andreas and
               Afzal, Vackar and Alasoo, Kaur and Ashford, Sofie and Bala,
               Sendu and Bensaddek, Dalila and Casale, Francesco Paolo and
               Culley, Oliver J and Danecek, Petr and Faulconbridge, Adam and
               Harrison, Peter W and Kathuria, Annie and McCarthy, Davis and
               McCarthy, Shane A and Meleckyte, Ruta and Memari, Yasin and
               Moens, Nathalie and Soares, Filipa and Mann, Alice and Streeter,
               Ian and Agu, Chukwuma A and Alderton, Alex and Nelson, Rachel
               and Harper, Sarah and Patel, Minal and White, Alistair and
               Patel, Sharad R and Clarke, Laura and Halai, Reena and Kirton,
               Christopher M and Kolb-Kokocinski, Anja and Beales, Philip and
               Birney, Ewan and Danovi, Davide and Lamond, Angus I and
               Ouwehand, Willem H and Vallier, Ludovic and Watt, Fiona M and
               Durbin, Richard and Stegle, Oliver and Gaffney, Daniel J",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  546,
  number    =  7658,
  pages     = "370--375",
  month     =  jun,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Li2018-ll,
  title     = "Annotation-free quantification of {RNA} splicing using
               {LeafCutter}",
  author    = "Li, Yang I and Knowles, David A and Humphrey, Jack and Barbeira,
               Alvaro N and Dickinson, Scott P and Im, Hae Kyung and Pritchard,
               Jonathan K",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  1,
  pages     = "151--158",
  month     =  jan,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Liu2018-fh,
  title     = "Alternative splicing analysis in human monocytes and macrophages
               reveals {MBNL1} as major regulator",
  author    = "Liu, Hongfei and Lorenzini, Paolo A and Zhang, Fan and Xu,
               Shaohai and Wong, Mei Su M and Zheng, Jie and Roca, Xavier",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  46,
  number    =  12,
  pages     = "6069--6086",
  month     =  jul,
  year      =  2018,
  copyright = "http://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}

@ARTICLE{Green2020-lf,
  title     = "Macrophage development and activation involve coordinated intron
               retention in key inflammatory regulators",
  author    = "Green, Immanuel D and Pinello, Natalia and Song, Renhua and Lee,
               Quintin and Halstead, James M and Kwok, Chau-To and Wong, Alex C
               H and Nair, Shalima S and Clark, Susan J and Roediger, Ben and
               Schmitz, Ulf and Larance, Mark and Hayashi, Rippei and Rasko,
               John E J and Wong, Justin J-L",
  abstract  = "Monocytes and macrophages are essential components of the innate
               immune system. Herein, we report that intron retention (IR)
               plays an important role in the development and function of these
               cells. Using Illumina mRNA sequencing, Nanopore direct cDNA
               sequencing and proteomics analysis, we identify IR events that
               affect the expression of key genes/proteins involved in
               macrophage development and function. We demonstrate that
               decreased IR in nuclear-detained mRNA is coupled with increased
               expression of genes encoding regulators of macrophage
               transcription, phagocytosis and inflammatory signalling,
               including ID2, IRF7, ENG and LAT. We further show that this
               dynamic IR program persists during the polarisation of resting
               macrophages into activated macrophages. In the presence of
               proinflammatory stimuli, intron-retaining CXCL2 and NFKBIZ
               transcripts are rapidly spliced, enabling timely expression of
               these key inflammatory regulators by macrophages. Our study
               provides novel insights into the molecular factors controlling
               vital regulators of the innate immune response.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  48,
  number    =  12,
  pages     = "6513--6529",
  month     =  jul,
  year      =  2020,
  copyright = "http://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}

@ARTICLE{Stenmark2009-ju,
  title     = "Rab {GTPases} as coordinators of vesicle traffic",
  author    = "Stenmark, Harald",
  abstract  = "Membrane trafficking between organelles by vesiculotubular
               carriers is fundamental to the existence of eukaryotic cells.
               Central in ensuring that cargoes are delivered to their correct
               destinations are the Rab GTPases, a large family of small
               GTPases that control membrane identity and vesicle budding,
               uncoating, motility and fusion through the recruitment of
               effector proteins, such as sorting adaptors, tethering factors,
               kinases, phosphatases and motors. Crosstalk between multiple Rab
               GTPases through shared effectors, or through effectors that
               recruit selective Rab activators, ensures the spatiotemporal
               regulation of vesicle traffic. Functional impairments of Rab
               pathways are associated with diseases, such as
               immunodeficiencies, cancer and neurological disorders.",
  journal   = "Nat. Rev. Mol. Cell Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  8,
  pages     = "513--525",
  month     =  aug,
  year      =  2009,
  language  = "en"
}

@ARTICLE{Yoneyama2005-ba,
  title     = "Shared and unique functions of the {DExD/H-box} helicases
               {RIG-I}, {MDA5}, and {LGP2} in antiviral innate immunity",
  author    = "Yoneyama, Mitsutoshi and Kikuchi, Mika and Matsumoto, Kanae and
               Imaizumi, Tadaatsu and Miyagishi, Makoto and Taira, Kazunari and
               Foy, Eileen and Loo, Yueh-Ming and Gale, Jr, Michael and Akira,
               Shizuo and Yonehara, Shin and Kato, Atsushi and Fujita, Takashi",
  abstract  = "The cellular protein retinoic acid-inducible gene I (RIG-I)
               senses intracellular viral infection and triggers a signal for
               innate antiviral responses including the production of type I
               IFN. RIG-I contains a domain that belongs to a DExD/H-box
               helicase family and exhibits an N-terminal caspase recruitment
               domain (CARD) homology. There are three genes encoding
               RIG-I-related proteins in human and mouse genomes. Melanoma
               differentiation associated gene 5 (MDA5), which consists of CARD
               and a helicase domain, functions as a positive regulator,
               similarly to RIG-I. Both proteins sense viral RNA with a
               helicase domain and transmit a signal downstream by CARD; thus,
               these proteins share overlapping functions. Another protein,
               LGP2, lacks the CARD homology and functions as a negative
               regulator by interfering with the recognition of viral RNA by
               RIG-I and MDA5. The nonstructural protein 3/4A protein of
               hepatitis C virus blocks the signaling by RIG-I and MDA5;
               however, the V protein of the Sendai virus selectively abrogates
               the MDA5 function. These results highlight ingenious mechanisms
               for initiating antiviral innate immune responses and the action
               of virus-encoded inhibitors.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  175,
  number    =  5,
  pages     = "2851--2858",
  month     =  sep,
  year      =  2005,
  language  = "en"
}

@ARTICLE{Kato2005-ie,
  title     = "Cell type-specific involvement of {RIG-I} in antiviral response",
  author    = "Kato, Hiroki and Sato, Shintaro and Yoneyama, Mitsutoshi and
               Yamamoto, Masahiro and Uematsu, Satoshi and Matsui, Kosuke and
               Tsujimura, Tohru and Takeda, Kiyoshi and Fujita, Takashi and
               Takeuchi, Osamu and Akira, Shizuo",
  abstract  = "Toll-like receptors (TLRs) play an important role in antiviral
               response by recognizing viral components. Recently, a RNA
               helicase, RIG-I, was also suggested to recognize viral
               double-stranded RNA. However, how these molecules contribute to
               viral recognition in vivo is poorly understood. We show by gene
               targeting that RIG-I is essential for induction of type I
               interferons (IFNs) after infection with RNA viruses in
               fibroblasts and conventional dendritic cells (DCs). RIG-I
               induces type I IFNs by activating IRF3 via IkappaB
               kinase-related kinases. In contrast, plasmacytoid DCs, which
               produce large amounts of IFN-alpha, use the TLR system rather
               than RIG-I for viral detection. Taken together, RIG-I and the
               TLR system exert antiviral responses in a cell type-specific
               manner.",
  journal   = "Immunity",
  publisher = "Elsevier BV",
  volume    =  23,
  number    =  1,
  pages     = "19--28",
  month     =  jul,
  year      =  2005,
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Castanier2012-io,
  title     = "{MAVS} ubiquitination by the {E3} ligase {TRIM25} and
               degradation by the proteasome is involved in type {I} interferon
               production after activation of the antiviral {RIG-I-like}
               receptors",
  author    = "Castanier, C{\'e}line and Zemirli, Naima and Portier, Alain and
               Garcin, Dominique and Bid{\`e}re, Nicolas and Vazquez, Aim{\'e}
               and Arnoult, Damien",
  abstract  = "BACKGROUND: During a viral infection, the intracellular
               RIG-I-like receptors (RLRs) sense viral RNA and signal through
               the mitochondrial antiviral signaling adaptor MAVS (also known
               as IPS-1, Cardif and VISA) whose activation triggers a rapid
               production of type I interferons (IFN) and of pro-inflammatory
               cytokines through the transcription factors IRF3/IRF7 and
               NF-$\kappa$B, respectively. While MAVS is essential for this
               signaling and known to operate through the scaffold protein NEMO
               and the protein kinase TBK1 that phosphorylates IRF3, its
               mechanism of action and regulation remain unclear. RESULTS: We
               report here that RLR activation triggers MAVS ubiquitination on
               lysine 7 and 10 by the E3 ubiquitin ligase TRIM25 and marks it
               for proteasomal degradation concomitantly with downstream
               signaling. Inhibition of this MAVS degradation with a proteasome
               inhibitor does not affect NF-$\kappa$B signaling but it hampers
               IRF3 activation, and NEMO and TBK1, two essential mediators in
               type I IFN production, are retained at the mitochondria.
               CONCLUSIONS: These results suggest that MAVS functions as a
               recruitment platform that assembles a signaling complex
               involving NEMO and TBK1, and that the proteasome-mediated MAVS
               degradation is required to release the signaling complex into
               the cytosol, allowing IRF3 phosphorylation by TBK1.",
  journal   = "BMC Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  1,
  pages     = "44",
  month     =  may,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Al_Hamrashdi2022-pr,
  title     = "Regulation of {IRF3} activation in human antiviral signaling
               pathways",
  author    = "Al Hamrashdi, Mariya and Brady, Gareth",
  abstract  = "The interferon regulatory factor (IRF) family of transcription
               factors play a vital role in the human innate antiviral immune
               responses with production of interferons (IFNs) as a hallmark
               outcome of activation. In recent years, IRF3 has been considered
               a principal early regulator of type I IFNs (TI-IFNs) directly
               downstream of intracellular virus sensing. Despite decades of
               research on IRF-activating pathways, many questions remain on
               the regulation of IRF3 activation. The kinases I$\kappa$B kinase
               epsilon (IKK$\epsilon$) and TANK-binding kinase-1 (TBK1) and the
               scaffold proteins TRAF family member-associated NF-kappa-B
               activator (TANK), NF-kappa-B-activating kinase-associated
               protein 1 (NAP1) and TANK-binding kinase 1-binding protein 1
               (TBKBP1)/similar to NAP1 TBK1 adaptor (SINTBAD) are believed to
               be core components of an IRF3-activation complex yet their
               contextual involvement and complex composition are still
               unclear. This review will give an overview of antiviral
               signaling pathways leading to the activation of IRF3 and discuss
               recent developments in our understanding of its proximal
               regulation.",
  journal   = "Biochem. Pharmacol.",
  publisher = "Elsevier BV",
  volume    =  200,
  number    =  115026,
  pages     = "115026",
  month     =  jun,
  year      =  2022,
  keywords  = "IKK$\epsilon$; IRF3; NAP1; TANK; TBK1; TBKBP1",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Saleh2017-fv,
  title     = "Kinase activities of {RIPK1} and {RIPK3} can direct
               {IFN-$\beta$} synthesis induced by lipopolysaccharide",
  author    = "Saleh, Danish and Najjar, Malek and Zelic, Matija and Shah,
               Saumil and Nogusa, Shoko and Polykratis, Apostolos and Paczosa,
               Michelle K and Gough, Peter J and Bertin, John and Whalen,
               Michael and Fitzgerald, Katherine A and Slavov, Nikolai and
               Pasparakis, Manolis and Balachandran, Siddharth and Kelliher,
               Michelle and Mecsas, Joan and Degterev, Alexei",
  abstract  = "The innate immune response is a central element of the initial
               defense against bacterial and viral pathogens. Macrophages are
               key innate immune cells that upon encountering
               pathogen-associated molecular patterns respond by producing
               cytokines, including IFN-$\beta$. In this study, we identify a
               novel role for RIPK1 and RIPK3, a pair of homologous
               serine/threonine kinases previously implicated in the regulation
               of necroptosis and pathologic tissue injury, in directing
               IFN-$\beta$ production in macrophages. Using genetic and
               pharmacologic tools, we show that catalytic activity of RIPK1
               directs IFN-$\beta$ synthesis induced by LPS in mice.
               Additionally, we report that RIPK1 kinase-dependent IFN-$\beta$
               production may be elicited in an analogous fashion using LPS in
               bone marrow-derived macrophages upon inhibition of caspases.
               Notably, this regulation requires kinase activities of both
               RIPK1 and RIPK3, but not the necroptosis effector protein, MLKL.
               Mechanistically, we provide evidence that necrosome-like RIPK1
               and RIPK3 aggregates facilitate canonical TRIF-dependent
               IFN-$\beta$ production downstream of the LPS receptor TLR4.
               Intriguingly, we also show that RIPK1 and RIPK3 kinase-dependent
               synthesis of IFN-$\beta$ is markedly induced by avirulent
               strains of Gram-negative bacteria, Yersinia and Klebsiella, and
               less so by their wild-type counterparts. Overall, these
               observations identify unexpected roles for RIPK1 and RIPK3
               kinases in the production of IFN-$\beta$ during the host
               inflammatory responses to bacterial infection and suggest that
               the axis in which these kinases operate may represent a target
               for bacterial virulence factors.",
  journal   = "J. Immunol.",
  publisher = "The American Association of Immunologists",
  volume    =  198,
  number    =  11,
  pages     = "4435--4447",
  month     =  jun,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Gack2009-nw,
  title     = "Influenza A virus {NS1} targets the ubiquitin ligase {TRIM25} to
               evade recognition by the host viral {RNA} sensor {RIG-I}",
  author    = "Gack, Michaela Ulrike and Albrecht, Randy Allen and Urano,
               Tomohiko and Inn, Kyung-Soo and Huang, I-Chueh and Carnero,
               Elena and Farzan, Michael and Inoue, Satoshi and Jung, Jae Ung
               and Garc{\'\i}a-Sastre, Adolfo",
  journal   = "Cell Host Microbe",
  publisher = "Elsevier BV",
  volume    =  5,
  number    =  5,
  pages     = "439--449",
  month     =  may,
  year      =  2009,
  copyright = "https://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@ARTICLE{Liao2021-aj,
  title     = "Role of alternative splicing in regulating host response to
               viral infection",
  author    = "Liao, Kuo-Chieh and Garcia-Blanco, Mariano A",
  abstract  = "The importance of transcriptional regulation of host genes in
               innate immunity against viral infection has been widely
               recognized. More recently, post-transcriptional regulatory
               mechanisms have gained appreciation as an additional and
               important layer of regulation to fine-tune host immune
               responses. Here, we review the functional significance of
               alternative splicing in innate immune responses to viral
               infection. We describe how several central components of the
               Type I and III interferon pathways encode spliced isoforms to
               regulate IFN activation and function. Additionally, the
               functional roles of splicing factors and modulators in antiviral
               immunity are discussed. Lastly, we discuss how cell death
               pathways are regulated by alternative splicing as well as the
               potential role of this regulation on host immunity and viral
               infection. Altogether, these studies highlight the importance of
               RNA splicing in regulating host-virus interactions and suggest a
               role in downregulating antiviral innate immunity; this may be
               critical to prevent pathological inflammation.",
  journal   = "Cells",
  publisher = "MDPI AG",
  volume    =  10,
  number    =  7,
  pages     = "1720",
  month     =  jul,
  year      =  2021,
  keywords  = "alternative splicing; antiviral response; cell death pathways;
               innate immunity",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Lad2008-jd,
  title     = "Identification of {MAVS} splicing variants that interfere with
               {RIGI/MAVS} pathway signaling",
  author    = "Lad, Sonya P and Yang, Guang and Scott, David A and Chao,
               Ta-Hsiang and Correia, Jean da Silva and de la Torre, Juan
               Carlos and Li, Erguang",
  abstract  = "The mitochondrial anti-viral signaling protein (MAVS), also
               known as CARDIF, IPS-1, KIAA1271 and VISA, is a mitochondria
               associated protein that regulates type I interferon production
               through coordinated activation of NF-kappaB and IRF3. The
               N-terminal CARD domain of MAVS interacts with RIGI helicase of
               upcapped RNA detection and the putative TRAF2 and TRAF6 binding
               motifs modulate protein interaction for NF-kappaB activation.
               MAVS is encoded by a single gene composed of 6 exons but is
               generally detected as multiple protein bands after separation by
               SDS-PAGE. In an effort to identify MAVS variants with diverse
               biological functions, we isolated three splicing variants and
               named them MAVS 1a (exon 2 deletion), 1b (exon 3 deletion) and
               1c (exon 6 deletion), respectively. MAVS 1a and 1b, due to a
               frame shift by exon deletion, encode 131 and 124 aa residues,
               respectively. Except the first 39 aa residues encoded by exon 1,
               MAVS 1a does not share sequence homology with known proteins, it
               instead contains a putative TRAF2-binding motif and interacts
               with TRAF2 and RIP1. MAVS 1b shares the first 97 residues with
               wt MAVS and 27 aa residues of unknown protein. Unlike MAVS that
               activates both NF-kappaB and IRF3 pathways, expression of MAVS
               1b selectively activates an IFNbeta but not an IL8 promoter.
               MAVS 1b interacts with RIP1 and FADD and exhibits anti-viral
               activity against VSV infection. This study uncovers MAVS
               splicing variants of diverse biological function.",
  journal   = "Mol. Immunol.",
  publisher = "Elsevier BV",
  volume    =  45,
  number    =  8,
  pages     = "2277--2287",
  month     =  apr,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Wagner2021-fl,
  title     = "Global transcriptomics uncovers distinct contributions from
               splicing regulatory proteins to the macrophage innate immune
               response",
  author    = "Wagner, Allison R and Scott, Haley M and West, Kelsi O and Vail,
               Krystal J and Fitzsimons, Timothy C and Coleman, Aja K and
               Carter, Kaitlyn E and Watson, Robert O and Patrick, Kristin L",
  abstract  = "Pathogen sensing via pattern recognition receptors triggers
               massive reprogramming of macrophage gene expression. While the
               signaling cascades and transcription factors that activate these
               responses are well-known, the role of post-transcriptional RNA
               processing in modulating innate immune gene expression remains
               understudied. Given their crucial role in regulating pre-mRNA
               splicing and other RNA processing steps, we hypothesized that
               members of the SR/hnRNP protein families regulate innate immune
               gene expression in distinct ways. We analyzed steady state gene
               expression and alternatively spliced isoform production in ten
               SR/hnRNP knockdown RAW 264.7 macrophage-like cell lines
               following infection with the bacterial pathogen Salmonella
               enterica serovar Typhimurium (Salmonella). We identified
               thousands of transcripts whose abundance is increased or
               decreased by SR/hnRNP knockdown in macrophages. Notably, we
               observed that SR and hnRNP proteins influence expression of
               different genes in uninfected versus Salmonella-infected
               macrophages, suggesting functionalization of these proteins upon
               pathogen sensing. Likewise, we found that knockdown of SR/hnRNPs
               promoted differential isoform usage (DIU) for thousands of
               macrophage transcripts and that these alternative splicing
               changes were distinct in uninfected and Salmonella-infected
               macrophages. Finally, having observed a surprising degree of
               similarity between the differentially expressed genes (DEGs) and
               DIUs in hnRNP K and U knockdown macrophages, we found that hnRNP
               K and U knockdown macrophages are both more restrictive to
               Vesicular Stomatitis Virus (VSV), while hnRNP K knockdown
               macrophages are more permissive to Salmonella Typhimurium. Based
               on these findings, we conclude that many innate immune genes
               evolved to rely on one or more SR/hnRNPs to ensure the proper
               magnitude of their induction, supporting a model wherein
               pre-mRNA splicing is critical for regulating innate immune gene
               expression and controlling infection outcomes in macrophages ex
               vivo.",
  journal   = "Front. Immunol.",
  publisher = "Frontiers Media SA",
  volume    =  12,
  pages     = "656885",
  month     =  jul,
  year      =  2021,
  keywords  = "RNA binding protein; SR protein; Salmonella Typhimurium; hnRNP;
               inflammation; pre-mRNA splicing",
  copyright = "https://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Urbut2019-gf,
  title     = "Flexible statistical methods for estimating and testing effects
               in genomic studies with multiple conditions",
  author    = "Urbut, Sarah M and Wang, Gao and Carbonetto, Peter and Stephens,
               Matthew",
  abstract  = "We introduce new statistical methods for analyzing genomic data
               sets that measure many effects in many conditions (for example,
               gene expression changes under many treatments). These new
               methods improve on existing methods by allowing for arbitrary
               correlations in effect sizes among conditions. This flexible
               approach increases power, improves effect estimates and allows
               for more quantitative assessments of effect-size heterogeneity
               compared to simple shared or condition-specific assessments. We
               illustrate these features through an analysis of locally acting
               variants associated with gene expression (cis expression
               quantitative trait loci (eQTLs)) in 44 human tissues. Our
               analysis identifies more eQTLs than existing approaches,
               consistent with improved power. We show that although genetic
               effects on expression are extensively shared among tissues,
               effect sizes can still vary greatly among tissues. Some shared
               eQTLs show stronger effects in subsets of biologically related
               tissues (for example, brain-related tissues), or in only one
               tissue (for example, testis). Our methods are widely applicable,
               computationally tractable for many conditions and available
               online.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  51,
  number    =  1,
  pages     = "187--195",
  month     =  jan,
  year      =  2019,
  language  = "en"
}



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% PCD chapter: pcd prevalence
@ARTICLE{Tabangin2009-gs,
  title     = "The effect of minor allele frequency on the likelihood of
               obtaining false positives",
  author    = "Tabangin, Meredith E and Woo, Jessica G and Martin, Lisa J",
  abstract  = "Determining the most promising single-nucleotide polymorphisms
               (SNPs) presents a challenge in genome-wide association studies,
               when hundreds of thousands of association tests are conducted.
               The power to detect genetic effects is dependent on minor allele
               frequency (MAF), and genome-wide association studies SNP arrays
               include SNPs with a wide distribution of MAFs. Therefore, it is
               critical to understand MAF's effect on the false positive
               rate.Data from the Framingham Heart Study simulated data
               (Problem 3, with answers) was used to examine the effects of
               varying MAFs on the likelihood of false positives. Replication
               set 1 was used to generate 1 million permutations of
               case/control status in unrelated individuals. Logistic
               regression was used to test for the association between each SNP
               and myocardial infarction using an additive model. We report the
               number of ``significant'' tests by MAF at alpha = 10-4, 10-5,
               and 10-6.Common SNPs exhibited fewer false positives than
               expected. At alpha = 10-4, SNPs with MAF 25\% and 50\% resulted
               in 69.2 [95\%CI: 62.8-75.6] and 70.8 [95\%CI: 61.3-80.4] false
               positives, respectively, compared to 100 expected. Rare SNPs
               exhibited more variability but did not show more false-positive
               results than expected by chance. However, at alpha = 10-4, MAF =
               5\% exhibited significantly more false positives (105.5 [95\%CI:
               81-130.1]) than MAF = 25\% and 50\%. Similar results were seen
               at the other alpha values.These results suggest that removal of
               low MAF SNPs from analysis due to concerns about inflated
               false-positive results may not be appropriate.",
  journal   = "BMC Proc.",
  publisher = "Springer Nature",
  volume    = "3 Suppl 7",
  number    = "S7",
  pages     = "S41",
  month     =  dec,
  year      =  2009,
  language  = "en"
}
@ARTICLE{Unuvar_Purcu2022-zq,
  title     = "Effect of stimulation time on the expression of human macrophage
               polarization markers",
  author    = "Unuvar Purcu, Duygu and Korkmaz, Asli and Gunalp, Sinem and
               Helvaci, Derya Goksu and Erdal, Yonca and Dogan, Yavuz and
               Suner, Asli and Wingender, Gerhard and Sag, Duygu",
  abstract  = "Macrophages are highly plastic cells that can polarize into
               functionally distinct subsets in vivo and in vitro in response
               to environmental signals. The development of protocols to model
               macrophage polarization in vitro greatly contributes to our
               understanding of macrophage biology. Macrophages are divided
               into two main groups: Pro-inflammatory M1 macrophages
               (classically activated) and anti-inflammatory M2 macrophages
               (alternatively activated), based on several key surface markers
               and the production of inflammatory mediators. However, the
               expression of these common macrophage polarization markers is
               greatly affected by the stimulation time used. Unfortunately,
               there is no consensus yet regarding the optimal stimulation
               times for particular macrophage polarization markers in in vitro
               experiments. This situation is problematic, (i) as analysing a
               particular marker at a suboptimal time point can lead to
               false-negative results, and (ii) as it clearly impedes the
               comparison of different studies. Using human monocyte-derived
               macrophages (MDMs) in vitro, we analysed how the expression of
               the main polarization markers for M1 (CD64, CD86, CXCL9, CXCL10,
               HLA-DR, IDO1, IL1$\beta$, IL12, TNF), M2a (CD200R, CD206, CCL17,
               CCL22, IL-10, TGM2), and M2c (CD163, IL-10, TGF$\beta$)
               macrophages changes over time at mRNA and protein levels. Our
               data establish the most appropriate stimulation time for the
               analysis of the expression of human macrophage polarization
               markers in vitro. Providing such a reference guide will likely
               facilitate the investigation of macrophage polarization and its
               reproducibility.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  17,
  number    =  3,
  pages     = "e0265196",
  month     =  mar,
  year      =  2022,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Sharif2007-np,
  title     = "Transcriptional profiling of the {LPS} induced {NF-kappaB}
               response in macrophages",
  author    = "Sharif, Omar and Bolshakov, Viacheslav N and Raines, Stephanie
               and Newham, Peter and Perkins, Neil D",
  abstract  = "BACKGROUND: Exposure of macrophages to bacterial products such
               as lipopolysaccharide (LPS) results in activation of the
               NF-kappaB transcription factor, which orchestrates a gene
               expression programme that underpins the macrophage-dependent
               immune response. These changes include the induction or
               repression of a wide range of genes that regulate inflammation,
               cell proliferation, migration and cell survival. This process is
               tightly regulated and loss of control is associated with
               conditions such as septic shock, inflammatory diseases and
               cancer. To study this response, it is important to have in vitro
               model systems that reflect the behaviour of cells in vivo. In
               addition, it is necessary to understand the natural differences
               that can occur between individuals. In this report, we have
               investigated and compared the LPS response in macrophage derived
               cell lines and peripheral blood mononuclear cell (PBMC) derived
               macrophages. RESULTS: Gene expression profiles were determined
               following LPS treatment of THP-1 cells for 1 and 4 hours. LPS
               significantly induced or repressed 72 out of 465 genes selected
               as being known or putative NF-kappaB target genes, which
               exhibited 4 temporal patterns of expression. Results for 34 of
               these genes, including several genes not previously identified
               as LPS target genes, were validated using real time PCR. A high
               correlation between microarray and real time PCR data was found.
               Significantly, the LPS induced expression profile of THP-1
               cells, as determined using real time PCR, was found to be very
               similar to that of human PBMC derived macrophages.
               Interestingly, some differences were observed in the LPS
               response between the two donor PBMC macrophage populations.
               Surprisingly, we found that the LPS response in U937 cells was
               dramatically different to both THP-1 and PBMC derived
               macrophages. CONCLUSION: This study revealed a dynamic and
               diverse transcriptional response to LPS in macrophages,
               involving both the induction and repression of gene expression
               in a time dependent manner. Moreover, we demonstrated that the
               LPS induced transcriptional response in the THP-1 cell line is
               very similar to primary PBMC derived macrophages. Therefore,
               THP-1 cells represent a good model system for studying the
               mechanisms of LPS and NF-kappaB dependent gene expression.",
  journal   = "BMC Immunol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  8,
  number    =  1,
  pages     = "1",
  month     =  jan,
  year      =  2007,
  language  = "en"
}

@ARTICLE{Garrido-Martin2021-sk,
  title     = "Identification and analysis of splicing quantitative trait loci
               across multiple tissues in the human genome",
  author    = "Garrido-Mart{\'\i}n, Diego and Borsari, Beatrice and Calvo,
               Miquel and Reverter, Ferran and Guig{\'o}, Roderic",
  abstract  = "Alternative splicing (AS) is a fundamental step in eukaryotic
               mRNA biogenesis. Here, we develop an efficient and reproducible
               pipeline for the discovery of genetic variants that affect AS
               (splicing QTLs, sQTLs). We use it to analyze the GTEx dataset,
               generating a comprehensive catalog of sQTLs in the human genome.
               Downstream analysis of this catalog provides insight into the
               mechanisms underlying splicing regulation. We report that a core
               set of sQTLs is shared across multiple tissues. sQTLs often
               target the global splicing pattern of genes, rather than
               individual splicing events. Many also affect the expression of
               the same or other genes, uncovering regulatory loci that act
               through different mechanisms. sQTLs tend to be located in
               post-transcriptionally spliced introns, which would function as
               hotspots for splicing regulation. While many variants affect
               splicing patterns by altering the sequence of splice sites, many
               more modify the binding sites of RNA-binding proteins. Genetic
               variants affecting splicing can have a stronger phenotypic
               impact than those affecting gene expression.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  1,
  pages     = "727",
  month     =  feb,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Wang2008-fb,
  title     = "Alternative isoform regulation in human tissue transcriptomes",
  author    = "Wang, Eric T and Sandberg, Rickard and Luo, Shujun and
               Khrebtukova, Irina and Zhang, Lu and Mayr, Christine and
               Kingsmore, Stephen F and Schroth, Gary P and Burge, Christopher
               B",
  abstract  = "Through alternative processing of pre-messenger RNAs, individual
               mammalian genes often produce multiple mRNA and protein isoforms
               that may have related, distinct or even opposing functions. Here
               we report an in-depth analysis of 15 diverse human tissue and
               cell line transcriptomes on the basis of deep sequencing of
               complementary DNA fragments, yielding a digital inventory of
               gene and mRNA isoform expression. Analyses in which sequence
               reads are mapped to exon-exon junctions indicated that 92-94\%
               of human genes undergo alternative splicing, 86\% with a minor
               isoform frequency of 15\% or more. Differences in
               isoform-specific read densities indicated that most alternative
               splicing and alternative cleavage and polyadenylation events
               vary between tissues, whereas variation between individuals was
               approximately twofold to threefold less common. Extreme or
               'switch-like' regulation of splicing between tissues was
               associated with increased sequence conservation in regulatory
               regions and with generation of full-length open reading frames.
               Patterns of alternative splicing and alternative cleavage and
               polyadenylation were strongly correlated across tissues,
               suggesting coordinated regulation of these processes, and
               sequence conservation of a subset of known regulatory motifs in
               both alternative introns and 3' untranslated regions suggested
               common involvement of specific factors in tissue-level
               regulation of both splicing and polyadenylation.",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  456,
  number    =  7221,
  pages     = "470--476",
  month     =  nov,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Lappalainen2013-mz,
  title     = "Transcriptome and genome sequencing uncovers functional
               variation in humans",
  author    = "Lappalainen, Tuuli and {The Geuvadis Consortium} and Sammeth,
               Michael and Friedl{\"a}nder, Marc R and `t Hoen, Peter A C and
               Monlong, Jean and Rivas, Manuel A and Gonz{\`a}lez-Porta, Mar
               and Kurbatova, Natalja and Griebel, Thasso and Ferreira, Pedro G
               and Barann, Matthias and Wieland, Thomas and Greger, Liliana and
               van Iterson, Maarten and Alml{\"o}f, Jonas and Ribeca, Paolo and
               Pulyakhina, Irina and Esser, Daniela and Giger, Thomas and
               Tikhonov, Andrew and Sultan, Marc and Bertier, Gabrielle and
               MacArthur, Daniel G and Lek, Monkol and Lizano, Esther and
               Buermans, Henk P J and Padioleau, Ismael and Schwarzmayr, Thomas
               and Karlberg, Olof and Ongen, Halit and Kilpinen, Helena and
               Beltran, Sergi and Gut, Marta and Kahlem, Katja and
               Amstislavskiy, Vyacheslav and Stegle, Oliver and Pirinen, Matti
               and Montgomery, Stephen B and Donnelly, Peter and McCarthy, Mark
               I and Flicek, Paul and Strom, Tim M and Lehrach, Hans and
               Schreiber, Stefan and Sudbrak, Ralf and Carracedo, {\'A}ngel and
               Antonarakis, Stylianos E and H{\"a}sler, Robert and Syv{\"a}nen,
               Ann-Christine and van Ommen, Gert-Jan and Brazma, Alvis and
               Meitinger, Thomas and Rosenstiel, Philip and Guig{\'o}, Roderic
               and Gut, Ivo G and Estivill, Xavier and Dermitzakis, Emmanouil T",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  501,
  number    =  7468,
  pages     = "506--511",
  month     =  sep,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Giambartolomei2014-yl,
  title     = "Bayesian test for colocalisation between pairs of genetic
               association studies using summary statistics",
  author    = "Giambartolomei, Claudia and Vukcevic, Damjan and Schadt, Eric E
               and Franke, Lude and Hingorani, Aroon D and Wallace, Chris and
               Plagnol, Vincent",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  10,
  number    =  5,
  pages     = "e1004383",
  month     =  may,
  year      =  2014,
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Buniello2019-wb,
  title     = "The {NHGRI-EBI} {GWAS} Catalog of published genome-wide
               association studies, targeted arrays and summary statistics 2019",
  author    = "Buniello, Annalisa and MacArthur, Jacqueline A L and Cerezo,
               Maria and Harris, Laura W and Hayhurst, James and Malangone,
               Cinzia and McMahon, Aoife and Morales, Joannella and Mountjoy,
               Edward and Sollis, Elliot and Suveges, Daniel and Vrousgou, Olga
               and Whetzel, Patricia L and Amode, Ridwan and Guillen, Jose A
               and Riat, Harpreet S and Trevanion, Stephen J and Hall, Peggy
               and Junkins, Heather and Flicek, Paul and Burdett, Tony and
               Hindorff, Lucia A and Cunningham, Fiona and Parkinson, Helen",
  abstract  = "The GWAS Catalog delivers a high-quality curated collection of
               all published genome-wide association studies enabling
               investigations to identify causal variants, understand disease
               mechanisms, and establish targets for novel therapies. The scope
               of the Catalog has also expanded to targeted and exome arrays
               with 1000 new associations added for these technologies. As of
               September 2018, the Catalog contains 5687 GWAS comprising 71673
               variant-trait associations from 3567 publications. New content
               includes 284 full P-value summary statistics datasets for
               genome-wide and new targeted array studies, representing 6
               $\times$ 109 individual variant-trait statistics. In the last 12
               months, the Catalog's user interface was accessed by 90000
               unique users who viewed >1 million pages. We have improved data
               access with the release of a new RESTful API to support
               high-throughput programmatic access, an improved web interface
               and a new summary statistics database. Summary statistics
               provision is supported by a new format proposed as a community
               standard for summary statistics data representation. This format
               was derived from our experience in standardizing heterogeneous
               submissions, mapping formats and in harmonizing content.
               Availability: https://www.ebi.ac.uk/gwas/.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  47,
  number    = "D1",
  pages     = "D1005--D1012",
  month     =  jan,
  year      =  2019,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Mountjoy2021-fc,
  title     = "An open approach to systematically prioritize causal variants
               and genes at all published human {GWAS} trait-associated loci",
  author    = "Mountjoy, Edward and Schmidt, Ellen M and Carmona, Miguel and
               Schwartzentruber, Jeremy and Peat, Gareth and Miranda, Alfredo
               and Fumis, Luca and Hayhurst, James and Buniello, Annalisa and
               Karim, Mohd Anisul and Wright, Daniel and Hercules, Andrew and
               Papa, Eliseo and Fauman, Eric B and Barrett, Jeffrey C and Todd,
               John A and Ochoa, David and Dunham, Ian and Ghoussaini, Maya",
  abstract  = "Genome-wide association studies (GWASs) have identified many
               variants associated with complex traits, but identifying the
               causal gene(s) is a major challenge. In the present study, we
               present an open resource that provides systematic fine mapping
               and gene prioritization across 133,441 published human GWAS
               loci. We integrate genetics (GWAS Catalog and UK Biobank) with
               transcriptomic, proteomic and epigenomic data, including
               systematic disease-disease and disease-molecular trait
               colocalization results across 92 cell types and tissues. We
               identify 729 loci fine mapped to a single-coding causal variant
               and colocalized with a single gene. We trained a
               machine-learning model using the fine-mapped genetics and
               functional genomics data and 445 gold-standard curated GWAS loci
               to distinguish causal genes from neighboring genes,
               outperforming a naive distance-based model. Our prioritized
               genes were enriched for known approved drug targets (odds ratio
               = 8.1, 95\% confidence interval = 5.7, 11.5). These results are
               publicly available through a web portal (
               http://genetics.opentargets.org ), enabling users to easily
               prioritize genes at disease-associated loci and assess their
               potential as drug targets.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  11,
  pages     = "1527--1533",
  month     =  nov,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Symoens2011-ew,
  title     = "A novel splice variant in the N-propeptide of {COL5A1} causes an
               {EDS} phenotype with severe kyphoscoliosis and eye involvement",
  author    = "Symoens, Sofie and Malfait, Fransiska and Vlummens, Philip and
               Hermanns-L{\^e}, Trinh and Syx, Delfien and De Paepe, Anne",
  abstract  = "BACKGROUND: The Ehlers-Danlos Syndrome (EDS) is a heritable
               connective tissue disorder characterized by hyperextensible
               skin, joint hypermobility and soft tissue fragility. The classic
               subtype of EDS is caused by mutations in one of the type V
               collagen genes (COL5A1 and COL5A2). Most mutations affect the
               type V collagen helical domain and lead to a diminished or
               structurally abnormal type V collagen protein. Remarkably, only
               two mutations were reported to affect the extended, highly
               conserved N-propeptide domain, which plays an important role in
               the regulation of the heterotypic collagen fibril diameter. We
               identified a novel COL5A1 N-propeptide mutation, resulting in an
               unusual but severe classic EDS phenotype and a remarkable
               splicing outcome. METHODOLOGY/PRINCIPAL FINDINGS: We identified
               a novel COL5A1 N-propeptide acceptor-splice site mutation
               (IVS6-2A>G, NM\_000093.3\_c.925-2A>G) in a patient with
               cutaneous features of EDS, severe progressive scoliosis and eye
               involvement. Two mutant transcripts were identified, one with an
               exon 7 skip and one in which exon 7 and the upstream exon 6 are
               deleted. Both transcripts are expressed and secreted into the
               extracellular matrix, where they can participate in and perturb
               collagen fibrillogenesis, as illustrated by the presence of
               dermal collagen cauliflowers. Determination of the order of
               intron removal and computational analysis showed that
               simultaneous skipping of exons 6 and 7 is due to the combined
               effect of delayed splicing of intron 7, altered pre-mRNA
               secondary structure, low splice site strength and possibly
               disturbed binding of splicing factors. CONCLUSIONS/SIGNIFICANCE:
               We report a novel COL5A1 N-propeptide acceptor-splice site
               mutation in intron 6, which not only affects splicing of the
               adjacent exon 7, but also causes a splicing error of the
               upstream exon 6. Our findings add further insights into the
               COL5A1 splicing order and show for the first time that a single
               COL5A1 acceptor-splice site mutation can perturb splicing of the
               upstream exon.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  6,
  number    =  5,
  pages     = "e20121",
  month     =  may,
  year      =  2011,
  language  = "en"
}
#####
@ARTICLE{Abramowicz2018-by,
  title     = "Splicing mutations in human genetic disorders: examples,
               detection, and confirmation",
  author    = "Abramowicz, Anna and Gos, Monika",
  journal   = "J. Appl. Genet.",
  publisher = "Springer Nature",
  volume    =  59,
  number    =  3,
  pages     = "253--268",
  month     =  aug,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Sanz2017-re,
  title     = "{Cas9/gRNA} targeted excision of cystic fibrosis-causing
               deep-intronic splicing mutations restores normal splicing of
               {CFTR} {mRNA}",
  author    = "Sanz, David J and Hollywood, Jennifer A and Scallan, Martina F
               and Harrison, Patrick T",
  abstract  = "Cystic Fibrosis is an autosomal recessive disorder caused by
               mutations in the CFTR gene. CRISPR mediated, template-dependent
               homology-directed gene editing has been used to correct the most
               common mutation, c.1521\_1523delCTT / p.Phe508del (F508del)
               which affects ~70\% of individuals, but the efficiency was
               relatively low. Here, we describe a high efficiency strategy for
               editing of three different rare CFTR mutations which together
               account for about 3\% of individuals with Cystic Fibrosis. The
               mutations cause aberrant splicing of CFTR mRNA due to the
               creation of cryptic splice signals that result in the formation
               of pseudoexons containing premature stop codons c.1679+1634A>G
               (1811+1.6kbA>G) and c.3718-2477C>T (3849+10kbC>T), or an
               out-of-frame 5' extension to an existing exon c.3140-26A>G
               (3272-26A>G). We designed pairs of Cas9 guide RNAs to create
               targeted double-stranded breaks in CFTR either side of each
               mutation which resulted in high efficiency excision of the
               target genomic regions via non-homologous end-joining repair.
               When evaluated in a mini-gene splicing assay, we showed that
               targeted excision restored normal splicing for all three
               mutations. This approach could be used to correct aberrant
               splicing signals or remove disruptive transcription regulatory
               motifs caused by deep-intronic mutations in a range of other
               genetic disorders.",
  journal   = "PLoS One",
  publisher = "Public Library of Science (PLoS)",
  volume    =  12,
  number    =  9,
  pages     = "e0184009",
  month     =  sep,
  year      =  2017,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Nellore2016-fj,
  title     = "Human splicing diversity and the extent of unannotated splice
               junctions across human {RNA-seq} samples on the Sequence Read
               Archive",
  author    = "Nellore, Abhinav and Jaffe, Andrew E and Fortin, Jean-Philippe
               and Alquicira-Hern{\'a}ndez, Jos{\'e} and Collado-Torres,
               Leonardo and Wang, Siruo and Phillips, III, Robert A and
               Karbhari, Nishika and Hansen, Kasper D and Langmead, Ben and
               Leek, Jeffrey T",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  17,
  number    =  1,
  month     =  dec,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Pickrell2010-lz,
  title     = "Noisy splicing drives {mRNA} isoform diversity in human cells",
  author    = "Pickrell, Joseph K and Pai, Athma A and Gilad, Yoav and
               Pritchard, Jonathan K",
  abstract  = "While the majority of multiexonic human genes show some evidence
               of alternative splicing, it is unclear what fraction of observed
               splice forms is functionally relevant. In this study, we examine
               the extent of alternative splicing in human cells using deep RNA
               sequencing and de novo identification of splice junctions. We
               demonstrate the existence of a large class of low abundance
               isoforms, encompassing approximately 150,000 previously
               unannotated splice junctions in our data. Newly-identified
               splice sites show little evidence of evolutionary conservation,
               suggesting that the majority are due to erroneous splice site
               choice. We show that sequence motifs involved in the recognition
               of exons are enriched in the vicinity of unconserved splice
               sites. We estimate that the average intron has a splicing error
               rate of approximately 0.7\% and show that introns in highly
               expressed genes are spliced more accurately, likely due to their
               shorter length. These results implicate noisy splicing as an
               important property of genome evolution.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  6,
  number    =  12,
  pages     = "e1001236",
  month     =  dec,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Parlato2020-lh,
  title     = "Loss-of-function mutation in {PTPN2} causes aberrant activation
               of {JAK} signaling via {STAT} and very early onset intestinal
               inflammation",
  author    = "Parlato, Marianna and Nian, Qing and Charbit-Henrion, Fabienne
               and Ruemmele, Frank M and Rodrigues-Lima, Fernando and
               Cerf-Bensussan, Nadine and {Immunobiota Study Group}",
  journal   = "Gastroenterology",
  publisher = "Elsevier BV",
  volume    =  159,
  number    =  5,
  pages     = "1968--1971.e4",
  month     =  nov,
  year      =  2020,
  keywords  = "Autoimmunity; Immune Regulation; PTPN2; VEO-IBD",
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Pike2018-wn,
  title     = "Protein tyrosine phosphatases: Regulators of {CD4} {T} cells in
               inflammatory bowel disease",
  author    = "Pike, Kelly A and Tremblay, Michel L",
  abstract  = "Protein tyrosine phosphatases (PTPs) play a critical role in
               co-ordinating the signaling networks that maintain lymphocyte
               homeostasis and direct lymphocyte activation. By
               dephosphorylating tyrosine residues, PTPs have been shown to
               modulate enzyme activity and both mediate and disrupt
               protein-protein interactions. Through these molecular
               mechanisms, PTPs ultimately impact lymphocyte responses to
               environmental cues such as inflammatory cytokines and
               chemokines, as well as antigenic stimulation. Mouse models of
               acute and chronic intestinal inflammation have been shown to be
               exacerbated in the absence of PTPs such as PTPN2 and PTPN22.
               This increase in disease severity is due in part to
               hyper-activation of lymphocytes in the absence of PTP activity.
               In accordance, human PTPs have been linked to intestinal
               inflammation. Genome wide association studies (GWAS) identified
               several PTPs within risk loci for inflammatory bowel disease
               (IBD). Therapeutically targeting PTP substrates and their
               associated signaling pathways, such as those implicated in CD4+
               T cell responses, has demonstrated clinical efficacy. The
               current review focuses on the role of PTPs in controlling CD4+ T
               cell activity in the intestinal mucosa and how disruption of PTP
               activity in CD4+ T cells can contribute to intestinal
               inflammation.",
  journal   = "Front. Immunol.",
  publisher = "Frontiers Media SA",
  volume    =  9,
  pages     = "2504",
  month     =  oct,
  year      =  2018,
  keywords  = "CD4 T cells; JAK-STAT; cytokine; inflammatory bowel disease;
               protein tyrosine phosphatase",
  language  = "en"
}

@ARTICLE{Spalinger2018-mb,
  title     = "{PTPN2} regulates inflammasome activation and controls onset of
               intestinal inflammation and colon cancer",
  author    = "Spalinger, Marianne R and Manzini, Roberto and Hering, Larissa
               and Riggs, Julianne B and Gottier, Claudia and Lang, Silvia and
               Atrott, Kirstin and Fettelschoss, Antonia and Olomski, Florian
               and K{\"u}ndig, Thomas M and Fried, Michael and McCole, Declan F
               and Rogler, Gerhard and Scharl, Michael",
  abstract  = "Variants in the gene locus encoding protein tyrosine phosphatase
               non-receptor type 2 (PTPN2) are associated with inflammatory
               disorders, including inflammatory bowel diseases, rheumatoid
               arthritis, and type 1 diabetes. The anti-inflammatory role of
               PTPN2 is highlighted by the fact that PTPN2-deficient mice die a
               few weeks after birth because of systemic inflammation and
               severe colitis. However, the tissues, cells, and molecular
               mechanisms that contribute to this phenotype remain unclear.
               Here, we demonstrate that myeloid cell-specific deletion of
               PTPN2 in mice (PTPN2-LysMCre) promotes intestinal inflammation
               but protects from colitis-associated tumor formation in an
               IL-1$\beta$-dependent manner. Elevated levels of mature
               IL-1$\beta$ production in PTPN2-LysMCre mice are a consequence
               of increased inflammasome assembly due to elevated
               phosphorylation of the inflammasome adaptor molecule ASC. Thus,
               we have identified a dual role for myeloid PTPN2 in directly
               regulating inflammasome activation and IL-1$\beta$ production to
               suppress pro-inflammatory responses during colitis but promote
               intestinal tumor development.",
  journal   = "Cell Rep.",
  publisher = "Elsevier BV",
  volume    =  22,
  number    =  7,
  pages     = "1835--1848",
  month     =  feb,
  year      =  2018,
  keywords  = "IBD; TC-PTP; colitis; inflammasome; inflammatory bowel disease;
               interleukin-1-alpha",
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Spalinger2022-xj,
  title     = "Loss of protein tyrosine phosphatase non-receptor type 2 reduces
               {IL-4-driven} alternative macrophage activation",
  author    = "Spalinger, Marianne R and Crawford, Meli'sa and Bobardt, Sarah D
               and Li, Jiang and Sayoc-Becerra, Anica and Santos, Alina N and
               Shawki, Ali and Chatterjee, Pritha and Nair, Meera G and McCole,
               Declan F",
  abstract  = "Macrophages are a heterogeneous population of innate immune
               cells that are often divided into two major subsets: classically
               activated, typically pro-inflammatory (M1) macrophages that
               mediate host defense, and alternatively activated,
               tolerance-inducing (M2) macrophages that exert homeostatic and
               tissue-regenerative functions. Disturbed macrophage
               function/differentiation results either in inadequate, excessive
               immune activation or in a failure to induce efficient protective
               immune responses against pathogens. Loss-of-function variants in
               protein tyrosine phosphatase non-receptor type 2 (PTPN2) are
               associated with chronic inflammatory disorders, but the effect
               of macrophage-intrinsic PTPN2 loss is still poorly understood.
               Here we report that PTPN2-deficient macrophages fail to acquire
               an alternatively activated/M2 phenotype. This was the
               consequence of reduced IL-6 receptor expression and a failure to
               induce IL-4 receptor in response to IL-6, resulting in an
               inability to respond to the key M2-inducing cytokine IL-4.
               Ultimately, failure to adequately respond to IL-6 and IL-4
               resulted in increased levels of M1 macrophage marker expression
               in vitro and exacerbated lung inflammation upon infection with
               Nippostrongylus brasiliensis in vivo. These results demonstrate
               that PTPN2 loss interferes with the ability of macrophages to
               adequately respond to inflammatory stimuli and might explain the
               increased susceptibility of PTPN2 loss-of-function carriers to
               developing inflammatory diseases.",
  journal   = "Mucosal Immunol.",
  publisher = "Elsevier BV",
  volume    =  15,
  number    =  1,
  pages     = "74--83",
  month     =  jan,
  year      =  2022,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Sigismund2021-cu,
  title     = "Endocytosis in the context-dependent regulation of individual
               and collective cell properties",
  author    = "Sigismund, Sara and Lanzetti, Letizia and Scita, Giorgio and Di
               Fiore, Pier Paolo",
  abstract  = "Endocytosis allows cells to transport particles and molecules
               across the plasma membrane. In addition, it is involved in the
               termination of signalling through receptor downmodulation and
               degradation. This traditional outlook has been substantially
               modified in recent years by discoveries that endocytosis and
               subsequent trafficking routes have a profound impact on the
               positive regulation and propagation of signals, being key for
               the spatiotemporal regulation of signal transmission in cells.
               Accordingly, endocytosis and membrane trafficking regulate
               virtually every aspect of cell physiology and are frequently
               subverted in pathological conditions. Two key aspects of
               endocytic control over signalling are coming into focus:
               context-dependency and long-range effects. First,
               endocytic-regulated outputs are not stereotyped but heavily
               dependent on the cell-specific regulation of endocytic networks.
               Second, endocytic regulation has an impact not only on
               individual cells but also on the behaviour of cellular
               collectives. Herein, we will discuss recent advancements in
               these areas, highlighting how endocytic trafficking impacts
               complex cell properties, including cell polarity and collective
               cell migration, and the relevance of these mechanisms to
               disease, in particular cancer.",
  journal   = "Nat. Rev. Mol. Cell Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  9,
  pages     = "625--643",
  month     =  sep,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Steger2016-yl,
  title     = "Phosphoproteomics reveals that Parkinson's disease kinase
               {LRRK2} regulates a subset of Rab {GTPases}",
  author    = "Steger, Martin and Tonelli, Francesca and Ito, Genta and Davies,
               Paul and Trost, Matthias and Vetter, Melanie and Wachter,
               Stefanie and Lorentzen, Esben and Duddy, Graham and Wilson,
               Stephen and Baptista, Marco A S and Fiske, Brian K and Fell,
               Matthew J and Morrow, John A and Reith, Alastair D and Alessi,
               Dario R and Mann, Matthias",
  abstract  = "Mutations in Park8, encoding for the multidomain Leucine-rich
               repeat kinase 2 (LRRK2) protein, comprise the predominant
               genetic cause of Parkinson's disease (PD). G2019S, the most
               common amino acid substitution activates the kinase two- to
               threefold. This has motivated the development of LRRK2 kinase
               inhibitors; however, poor consensus on physiological LRRK2
               substrates has hampered clinical development of such
               therapeutics. We employ a combination of phosphoproteomics,
               genetics, and pharmacology to unambiguously identify a subset of
               Rab GTPases as key LRRK2 substrates. LRRK2 directly
               phosphorylates these both in vivo and in vitro on an
               evolutionary conserved residue in the switch II domain.
               Pathogenic LRRK2 variants mapping to different functional
               domains increase phosphorylation of Rabs and this strongly
               decreases their affinity to regulatory proteins including Rab
               GDP dissociation inhibitors (GDIs). Our findings uncover a key
               class of bona-fide LRRK2 substrates and a novel regulatory
               mechanism of Rabs that connects them to PD.",
  journal   = "Elife",
  publisher = "eLife Sciences Organisation, Ltd.",
  volume    =  5,
  month     =  jan,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/"
}
###
@ARTICLE{Bae2018-pu,
  title     = "{LRRK2} kinase regulates $\alpha$-synuclein propagation via
               {RAB35} phosphorylation",
  author    = "Bae, Eun-Jin and Kim, Dong-Kyu and Kim, Changyoun and Mante,
               Michael and Adame, Anthony and Rockenstein, Edward and Ulusoy,
               Ayse and Klinkenberg, Michael and Jeong, Ga Ram and Bae, Jae
               Ryul and Lee, Cheolsoon and Lee, He-Jin and Lee, Byung-Dae and
               Di Monte, Donato A and Masliah, Eliezer and Lee, Seung-Jae",
  abstract  = "Propagation of $\alpha$-synuclein aggregates has been suggested
               as a contributing factor in Parkinson's disease (PD)
               progression. However, the molecular mechanisms underlying
               $\alpha$-synuclein aggregation are not fully understood. Here,
               we demonstrate in cell culture, nematode, and rodent models of
               PD that leucine-rich repeat kinase 2 (LRRK2), a PD-linked
               kinase, modulates $\alpha$-synuclein propagation in a kinase
               activity-dependent manner. The PD-linked G2019S mutation in
               LRRK2, which increases kinase activity, enhances propagation
               efficiency. Furthermore, we show that the role of LRRK2 in
               $\alpha$-synuclein propagation is mediated by RAB35
               phosphorylation. Constitutive activation of RAB35 overrides the
               reduced $\alpha$-synuclein propagation phenotype in lrk-1 mutant
               C. elegans. Finally, in a mouse model of synucleinopathy,
               administration of an LRRK2 kinase inhibitor reduced
               $\alpha$-synuclein aggregation via enhanced interaction of
               $\alpha$-synuclein with the lysosomal degradation pathway. These
               results suggest that LRRK2-mediated RAB35 phosphorylation is a
               potential therapeutic target for modifying disease progression.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  9,
  number    =  1,
  pages     = "3465",
  month     =  aug,
  year      =  2018,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Bonet-Ponce2020-ri,
  title     = "{LRRK2} mediates tubulation and vesicle sorting from lysosomes",
  author    = "Bonet-Ponce, Luis and Beilina, Alexandra and Williamson, Chad D
               and Lindberg, Eric and Kluss, Jillian H and Saez-Atienzar, Sara
               and Landeck, Natalie and Kumaran, Ravindran and Mamais,
               Adamantios and Bleck, Christopher K E and Li, Yan and Cookson,
               Mark R",
  abstract  = "Genetic variation around the LRRK2 gene affects risk of both
               familial and sporadic Parkinson's disease (PD). However, the
               biological functions of LRRK2 remain incompletely understood.
               Here, we report that LRRK2 is recruited to lysosomes after
               exposure of cells to the lysosome membrane-rupturing agent
               LLOME. Using an unbiased proteomic screen, we identified the
               motor adaptor protein JIP4 as an LRRK2 partner at the lysosomal
               membrane. LRRK2 can recruit JIP4 to lysosomes in a
               kinase-dependent manner via the phosphorylation of RAB35 and
               RAB10. Using super-resolution live-cell imaging microscopy and
               FIB-SEM, we demonstrate that JIP4 promotes the formation of
               LAMP1-negative tubules that release membranous content from
               lysosomes. Thus, we describe a new process orchestrated by
               LRRK2, which we name LYTL (LYsosomal Tubulation/sorting driven
               by LRRK2), by which lysosomal tubulation is used to release
               vesicles from lysosomes. Given the central role of the lysosome
               in PD, LYTL is likely to be disease relevant.",
  journal   = "Sci. Adv.",
  publisher = "American Association for the Advancement of Science (AAAS)",
  volume    =  6,
  number    =  46,
  pages     = "eabb2454",
  month     =  nov,
  year      =  2020,
  copyright = "https://creativecommons.org/licenses/by-nc/4.0/",
  language  = "en"
}



@ARTICLE{Lee2021-ff,
  title    = "Inflammatory bowel disease and Parkinson's disease: common
              pathophysiological links",
  author   = "Lee, Ho-Su and Lobbestael, Evy and Vermeire, S{\'e}verine and
              Sabino, Jo{\~a}o and Cleynen, Isabelle",
  abstract = "Inflammatory bowel disease and Parkinson's disease are chronic
              progressive disorders that mainly affect different organs: the
              gut and brain, respectively. Accumulating evidence has suggested
              a bidirectional link between gastrointestinal inflammation and
              neurodegeneration, in accordance with the concept of the
              'gut-brain axis'. Moreover, recent population-based studies have
              shown that inflammatory bowel disease might increase the risk of
              Parkinson's disease. Although the precise mechanisms underlying
              gut-brain interactions remain elusive, some of the latest
              findings have begun to explain the link. Several genetic loci are
              shared between both disorders with a similar direction of effect
              on the risk of both diseases. The most interesting example is
              LRRK2 (leucine-rich repeat kinase 2), initially identified as a
              causal gene in Parkinson's disease, and recently also implicated
              in Crohn's disease. In this review, we highlight recent findings
              on the link between these seemingly unrelated diseases with
              shared genetic susceptibility. We discuss supporting and
              conflicting data obtained from epidemiological and genetic
              studies along with remaining questions and concerns. In addition,
              we discuss possible biological links including the gut-brain
              axis, microbiota, autoimmunity, mitochondrial function and
              autophagy.",
  journal  = "Gut",
  volume   =  70,
  number   =  2,
  pages    = "408--417",
  month    =  feb,
  year     =  2021,
  keywords = "IBD - genetics; IBD basic research; Parkinson's disease;
              epidemiology; inflammatory bowel disease",
  language = "en"
}

@ARTICLE{Mrozowska2016-lm,
  title     = "Regulation of podocalyxin trafficking by Rab small {GTPases} in
               epithelial cells",
  author    = "Mrozowska, Paulina S and Fukuda, Mitsunori",
  journal   = "Small GTPases",
  publisher = "Informa UK Limited",
  volume    =  7,
  number    =  4,
  pages     = "231--238",
  month     =  oct,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Kinoshita2020-yl,
  title     = "{Rab35-GEFs}, {DENND1A} and folliculin differentially regulate
               podocalyxin trafficking in two- and three-dimensional epithelial
               cell cultures",
  author    = "Kinoshita, Riko and Homma, Yuta and Fukuda, Mitsunori",
  abstract  = "Polarized epithelial cells have functionally distinct apical and
               basolateral membranes through which they communicate with
               external and internal bodily environments, respectively. The
               establishment and maintenance of this asymmetric structure
               depend on polarized trafficking of specific cargos, but the
               precise molecular mechanism is incompletely understood. We
               previously showed that Rab35, a member of the Rab family small
               GTPases, differentially regulates the trafficking of an apical
               cargo, podocalyxin (PODXL), in two-dimensional (2D) and
               three-dimensional (3D) Madin-Darby canine kidney (MDCK) II cell
               cultures through specific interactions with two distinct
               effectors, OCRL inositol polyphosphate-5-phosphatase (OCRL) and
               ArfGAP with coiled-coil, ankyrin repeat and pleckstrin homology
               domains 2 (ACAP2), respectively. However, whether the upstream
               regulators of Rab35 also differ depending on the culture
               conditions remains completely unknown. Here, we investigated
               four known guanine nucleotide exchange factors (GEFs) of Rab35,
               namely DENN domain-containing 1A (DENND1A), DENND1B, DENND1C,
               and folliculin (FLCN), and demonstrate that DENND1A and FLCN
               exhibit distinct requirements for Rab35-dependent PODXL
               trafficking under the two culture conditions. In 3D cell
               cultures, only DENDN1A-knockout cysts exhibited the inverted
               localization of PODXL similar to that of Rab35-knockout cysts.
               Moreover, the DENN domain, harboring GEF activity toward Rab35,
               was required for proper PODXL trafficking to the apical
               membrane. By contrast, FLCN-knockdown cells specifically
               accumulated PODXL in actin-rich structures similar to the
               Rab35-knockdown cells in 2D cell cultures. Our findings indicate
               that two distinct functional cascades of Rab35, the
               FLCN-Rab35-OCRL and the DENND1A-Rab35-ACAP2 axes, regulate PODXL
               trafficking in 2D and 3D MDCK II cell cultures, respectively.",
  journal   = "J. Biol. Chem.",
  publisher = "Elsevier BV",
  volume    =  295,
  number    =  11,
  pages     = "3652--3663",
  month     =  mar,
  year      =  2020,
  keywords  = "3D cell culture; Rab; cell polarity; epithelial cell; guanine
               nucleotide exchange factor (GEF); membrane trafficking;
               podocalyxin; small GTPase; tissue development",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Mu2021-ar,
  title     = "The impact of cell type and context-dependent regulatory
               variants on human immune traits",
  author    = "Mu, Zepeng and Wei, Wei and Fair, Benjamin and Miao, Jinlin and
               Zhu, Ping and Li, Yang I",
  abstract  = "BACKGROUND: The vast majority of trait-associated variants
               identified using genome-wide association studies (GWAS) are
               noncoding, and therefore assumed to impact gene regulation.
               However, the majority of trait-associated loci are unexplained
               by regulatory quantitative trait loci (QTLs). RESULTS: We
               perform a comprehensive characterization of the putative
               mechanisms by which GWAS loci impact human immune traits. By
               harmonizing four major immune QTL studies, we identify 26,271
               expression QTLs (eQTLs) and 23,121 splicing QTLs (sQTLs)
               spanning 18 immune cell types. Our colocalization analyses
               between QTLs and trait-associated loci from 72 GWAS reveals that
               genetic effects on RNA expression and splicing in immune cells
               colocalize with 40.4\% of GWAS loci for immune-related traits,
               in many cases increasing the fraction of colocalized loci by two
               fold compared to previous studies. Notably, we find that the
               largest contributors of this increase are splicing QTLs, which
               colocalize on average with 14\% of all GWAS loci that do not
               colocalize with eQTLs. By contrast, we find that cell
               type-specific eQTLs, and eQTLs with small effect sizes
               contribute very few new colocalizations. To investigate the 60\%
               of GWAS loci that remain unexplained, we collect H3K27ac
               CUT\&Tag data from rheumatoid arthritis and healthy controls,
               and find large-scale differences between immune cells from the
               different disease contexts, including at regions overlapping
               unexplained GWAS loci. CONCLUSION: Altogether, our work supports
               RNA splicing as an important mediator of genetic effects on
               immune traits, and suggests that we must expand our study of
               regulatory processes in disease contexts to improve functional
               interpretation of as yet unexplained GWAS loci.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  1,
  pages     = "122",
  month     =  apr,
  year      =  2021,
  keywords  = "Colocalization; GWAS; eQTL; sQTL",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Melamud2009-my,
  title     = "Structural implication of splicing stochastics",
  author    = "Melamud, Eugene and Moult, John",
  abstract  = "Even though nearly every human gene has at least one alternative
               splice form, very little is so far known about the structure and
               function of resulting protein products. It is becoming
               increasingly clear that a significant fraction of all isoforms
               are products of noisy selection of splice sites and thus
               contribute little to actual functional diversity, and may
               potentially be deleterious. In this study, we examine the impact
               of alternative splicing on protein sequence and structure in
               three datasets: alternative splicing events conserved across
               multiple species, alternative splicing events in genes that are
               strongly linked to disease and all observed alternative splicing
               events. We find that the vast majority of all alternative
               isoforms result in unstable protein conformations. In contrast
               to that, the small subset of isoforms conserved across species
               tends to maintain protein structural integrity to a greater
               extent. Alternative splicing in disease-associated genes
               produces unstable structures just as frequently as all other
               genes, indicating that selection to reduce the effects of
               alternative splicing on this set is not especially pronounced.
               Overall, the properties of alternative spliced proteins are
               consistent with the outcome of noisy selection of splice sites
               by splicing machinery.",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford University Press (OUP)",
  volume    =  37,
  number    =  14,
  pages     = "4862--4872",
  month     =  aug,
  year      =  2009,
  copyright = "http://creativecommons.org/licenses/by-nc/2.0/uk/",
  language  = "en"
}

@ARTICLE{Wright2022-gp,
  title     = "Long read sequencing reveals novel isoforms and insights into
               splicing regulation during cell state changes",
  author    = "Wright, David J and Hall, Nicola A L and Irish, Naomi and Man,
               Angela L and Glynn, Will and Mould, Arne and Angeles, Alejandro
               De Los and Angiolini, Emily and Swarbreck, David and Gharbi,
               Karim and Tunbridge, Elizabeth M and Haerty, Wilfried",
  abstract  = "BACKGROUND: Alternative splicing is a key mechanism underlying
               cellular differentiation and a driver of complexity in mammalian
               neuronal tissues. However, understanding of which isoforms are
               differentially used or expressed and how this affects cellular
               differentiation remains unclear. Long read sequencing allows
               full-length transcript recovery and quantification, enabling
               transcript-level analysis of alternative splicing processes and
               how these change with cell state. Here, we utilise Oxford
               Nanopore Technologies sequencing to produce a custom annotation
               of a well-studied human neuroblastoma cell line SH-SY5Y, and to
               characterise isoform expression and usage across
               differentiation. RESULTS: We identify many previously
               unannotated features, including a novel transcript of the
               voltage-gated calcium channel subunit gene, CACNA2D2. We show
               differential expression and usage of transcripts during
               differentiation identifying candidates for future research into
               state change regulation. CONCLUSIONS: Our work highlights the
               potential of long read sequencing to uncover previously unknown
               transcript diversity and mechanisms influencing alternative
               splicing.",
  journal   = "BMC Genomics",
  publisher = "Springer Science and Business Media LLC",
  volume    =  23,
  number    =  1,
  pages     = "42",
  month     =  jan,
  year      =  2022,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Rotival2019-ic,
  title     = "Defining the genetic and evolutionary architecture of
               alternative splicing in response to infection",
  author    = "Rotival, Maxime and Quach, H{\'e}l{\`e}ne and Quintana-Murci,
               Lluis",
  abstract  = "Host and environmental factors contribute to variation in human
               immune responses, yet the genetic and evolutionary drivers of
               alternative splicing in response to infection remain largely
               uncharacterised. Leveraging 970 RNA-sequencing profiles of
               resting and stimulated monocytes from 200 individuals of
               African- and European-descent, we show that immune activation
               elicits a marked remodelling of the isoform repertoire, while
               increasing the levels of erroneous splicing. We identify 1,464
               loci associated with variation in isoform usage (sQTLs), 9\% of
               them being stimulation-specific, which are enriched in
               disease-related loci. Furthermore, we detect a longstanding
               increased plasticity of immune gene splicing, and show that
               positive selection and Neanderthal introgression have both
               contributed to diversify the splicing landscape of human
               populations. Together, these findings suggest that differential
               isoform usage has been an important substrate of innovation in
               the long-term evolution of immune responses and a more recent
               vehicle of population local adaptation.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  10,
  number    =  1,
  pages     = "1671",
  month     =  apr,
  year      =  2019,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Mazin2021-lb,
  title     = "Alternative splicing during mammalian organ development",
  author    = "Mazin, Pavel V and Khaitovich, Philipp and Cardoso-Moreira,
               Margarida and Kaessmann, Henrik",
  abstract  = "Alternative splicing (AS) is pervasive in mammalian genomes, yet
               cross-species comparisons have been largely restricted to adult
               tissues and the functionality of most AS events remains unclear.
               We assessed AS patterns across pre- and postnatal development of
               seven organs in six mammals and a bird. Our analyses revealed
               that developmentally dynamic AS events, which are especially
               prevalent in the brain, are substantially more conserved than
               nondynamic ones. Cassette exons with increasing inclusion
               frequencies during development show the strongest signals of
               conserved and regulated AS. Newly emerged cassette exons are
               typically incorporated late in testis development, but those
               retained during evolution are predominantly brain specific. Our
               work suggests that an intricate interplay of programs
               controlling gene expression levels and AS is fundamental to
               organ development, especially for the brain and heart. In these
               regulatory networks, AS affords substantial functional
               diversification of genes through the generation of tissue- and
               time-specific isoforms from broadly expressed genes.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  6,
  pages     = "925--934",
  month     =  jun,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}
###
@ARTICLE{Deininger2011-cx,
  title     = "Alu elements: know the {SINEs}",
  author    = "Deininger, Prescott",
  abstract  = "Alu elements are primate-specific repeats and comprise 11\% of
               the human genome. They have wide-ranging influences on gene
               expression. Their contribution to genome evolution, gene
               regulation and disease is reviewed.",
  journal   = "Genome Biol.",
  publisher = "Springer Nature",
  volume    =  12,
  number    =  12,
  pages     = "236",
  month     =  dec,
  year      =  2011,
  language  = "en"
}

@ARTICLE{Attig2016-mj,
  title     = "Splicing repression allows the gradual emergence of new
               Alu-exons in primate evolution",
  author    = "Attig, Jan and Ruiz de los Mozos, Igor and Haberman, Nejc and
               Wang, Zhen and Emmett, Warren and Zarnack, Kathi and K{\"o}nig,
               Julian and Ule, Jernej",
  abstract  = "Alu elements are retrotransposons that frequently form new exons
               during primate evolution. Here, we assess the interplay of
               splicing repression by hnRNPC and nonsense-mediated mRNA decay
               (NMD) in the quality control and evolution of new Alu-exons. We
               identify 3100 new Alu-exons and show that NMD more efficiently
               recognises transcripts with Alu-exons compared to other exons
               with premature termination codons. However, some Alu-exons
               escape NMD, especially when an adjacent intron is retained,
               highlighting the importance of concerted repression by splicing
               and NMD. We show that evolutionary progression of 3' splice
               sites is coupled with longer repressive uridine tracts. Once the
               3' splice site at ancient Alu-exons reaches a stable phase,
               splicing repression by hnRNPC decreases, but the exons generally
               remain sensitive to NMD. We conclude that repressive motifs are
               strongest next to cryptic exons and that gradual weakening of
               these motifs contributes to the evolutionary emergence of new
               alternative exons.",
  journal   = "Elife",
  publisher = "eLife Sciences Publications, Ltd",
  volume    =  5,
  month     =  nov,
  year      =  2016,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Singer2004-km,
  title     = "From ``junk'' to gene: curriculum vitae of a primate receptor
               isoform gene",
  author    = "Singer, Silke S and M{\"a}nnel, Daniela N and Hehlgans, Thomas
               and Brosius, J{\"u}rgen and Schmitz, J{\"u}rgen",
  abstract  = "Exonization of Alu retroposons awakens public opinion,
               particularly when causing genetic diseases. However, often
               neglected, alternative ``Alu-exons'' also carry the potential to
               greatly enhance genetic diversity by increasing the
               transcriptome of primates chiefly via alternative splicing.Here,
               we report a 5' exon generated from one of the two alternative
               transcripts in human tumor necrosis factor receptor gene type 2
               (p75TNFR) that contains an ancient Alu-SINE, which provides an
               alternative N-terminal protein-coding domain. We follow the
               primate evolution over the past 63 million years to reconstruct
               the key events that gave rise to a novel receptor isoform. The
               Alu integration and start codon formation occurred between 58
               and 40 million years ago (MYA) in the common ancestor of
               anthropoid primates. Yet a functional gene product could not be
               generated until a novel splice site and an open reading frame
               were introduced between 40 and 25 MYA on the catarrhine lineage
               (Old World monkeys including apes).",
  journal   = "J. Mol. Biol.",
  publisher = "Elsevier BV",
  volume    =  341,
  number    =  4,
  pages     = "883--886",
  month     =  aug,
  year      =  2004,
  language  = "en"
}

@ARTICLE{Mercuri2018-pi,
  title     = "Nusinersen versus sham control in later-onset spinal muscular
               atrophy",
  author    = "Mercuri, Eugenio and Darras, Basil T and Chiriboga, Claudia A
               and Day, John W and Campbell, Craig and Connolly, Anne M and
               Iannaccone, Susan T and Kirschner, Janbernd and Kuntz, Nancy L
               and Saito, Kayoko and Shieh, Perry B and Tulinius, M{\'a}r and
               Mazzone, Elena S and Montes, Jacqueline and Bishop, Kathie M and
               Yang, Qingqing and Foster, Richard and Gheuens, Sarah and
               Bennett, C Frank and Farwell, Wildon and Schneider, Eugene and
               De Vivo, Darryl C and Finkel, Richard S",
  journal   = "N. Engl. J. Med.",
  publisher = "Massachusetts Medical Society",
  volume    =  378,
  number    =  7,
  pages     = "625--635",
  month     =  feb,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Roberts2020-rx,
  title     = "Advances in oligonucleotide drug delivery",
  author    = "Roberts, Thomas C and Langer, Robert and Wood, Matthew J A",
  abstract  = "Oligonucleotides can be used to modulate gene expression via a
               range of processes including RNAi, target degradation by RNase
               H-mediated cleavage, splicing modulation, non-coding RNA
               inhibition, gene activation and programmed gene editing. As
               such, these molecules have potential therapeutic applications
               for myriad indications, with several oligonucleotide drugs
               recently gaining approval. However, despite recent technological
               advances, achieving efficient oligonucleotide delivery,
               particularly to extrahepatic tissues, remains a major
               translational limitation. Here, we provide an overview of
               oligonucleotide-based drug platforms, focusing on key approaches
               - including chemical modification, bioconjugation and the use of
               nanocarriers - which aim to address the delivery challenge.",
  journal   = "Nat. Rev. Drug Discov.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  19,
  number    =  10,
  pages     = "673--694",
  month     =  oct,
  year      =  2020,
  language  = "en"
}

@ARTICLE{Alasoo2018-pv,
  title     = "Shared genetic effects on chromatin and gene expression indicate
               a role for enhancer priming in immune response",
  author    = "Alasoo, Kaur and {HIPSCI Consortium} and Rodrigues, Julia and
               Mukhopadhyay, Subhankar and Knights, Andrew J and Mann, Alice L
               and Kundu, Kousik and Hale, Christine and Dougan, Gordon and
               Gaffney, Daniel J",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  3,
  pages     = "424--431",
  month     =  mar,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Lavin2014-fb,
  title     = "Tissue-resident macrophage enhancer landscapes are shaped by the
               local microenvironment",
  author    = "Lavin, Yonit and Winter, Deborah and Blecher-Gonen, Ronnie and
               David, Eyal and Keren-Shaul, Hadas and Merad, Miriam and Jung,
               Steffen and Amit, Ido",
  abstract  = "Macrophages are critical for innate immune defense and also
               control organ homeostasis in a tissue-specific manner. They
               provide a fitting model to study the impact of ontogeny and
               microenvironment on chromatin state and whether chromatin
               modifications contribute to macrophage identity. Here, we
               profile the dynamics of four histone modifications across seven
               tissue-resident macrophage populations. We identify 12,743
               macrophage-specific enhancers and establish that tissue-resident
               macrophages have distinct enhancer landscapes beyond what can be
               explained by developmental origin. Combining our enhancer
               catalog with gene expression profiles and open chromatin
               regions, we show that a combination of tissue- and
               lineage-specific transcription factors form the regulatory
               networks controlling chromatin specification in tissue-resident
               macrophages. The environment is capable of shaping the chromatin
               landscape of transplanted bone marrow precursors, and even
               differentiated macrophages can be reprogrammed when transferred
               into a new microenvironment. These results provide a
               comprehensive view of macrophage regulatory landscape and
               highlight the importance of the microenvironment, along with
               pioneer factors in orchestrating identity and plasticity.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  159,
  number    =  6,
  pages     = "1312--1326",
  month     =  dec,
  year      =  2014,
  copyright = "http://www.elsevier.com/open-access/userlicense/1.0/",
  language  = "en"
}

@UNPUBLISHED{AlKhafaji2021-af,
  title    = "High-throughput {RNA} isoform sequencing using programmable
              {cDNA} concatenation",
  author   = "Al'Khafaji, Aziz M and Smith, Jonathan T and Garimella, Kiran V
              and Babadi, Mehrtash and Sade-Feldman, Moshe and Gatzen, Michael
              and Sarkizova, Siranush and Schwartz, Marc A and Popic, Victoria
              and Blaum, Emily M and Day, Allyson and Costello, Maura and
              Bowers, Tera and Gabriel, Stacey and Banks, Eric and Philippakis,
              Anthony A and Boland, Genevieve M and Blainey, Paul C and
              Hacohen, Nir",
  abstract = "AbstractAlternative splicing is a core biological process that
              enables profound and essential diversification of gene function.
              Short-read RNA sequencing approaches fail to resolve RNA isoforms
              and therefore primarily enable gene expression measurements - an
              isoform unaware representation of the transcriptome. Conversely,
              full-length RNA sequencing using long-read technologies are able
              to capture complete transcript isoforms, but their utility is
              deeply constrained due to throughput limitations. Here, we
              introduce MAS-ISO-seq, a technique for programmably concatenating
              cDNAs into single molecules optimal for long-read sequencing,
              boosting the throughput >15 fold to nearly 40 million cDNA reads
              per run on the Sequel IIe sequencer. We validated unambiguous
              isoform assignment with MAS-ISO-seq using a synthetic RNA isoform
              library and applied this approach to single-cell RNA sequencing
              of tumor-infiltrating T cells. Results demonstrated a >30 fold
              boosted discovery of differentially spliced genes and robust cell
              clustering, as well as canonical PTPRC splicing patterns across T
              cell subpopulations and the concerted expression of the
              associated hnRNPLL splicing factor. Methods such as MAS-ISO-seq
              will drive discovery of novel isoforms and the transition from
              gene expression to transcript isoform expression analyses.",
  journal  = "bioRxiv",
  month    =  oct,
  year     =  2021
}

@ARTICLE{Amarasinghe2020-ci,
  title     = "Opportunities and challenges in long-read sequencing data
               analysis",
  author    = "Amarasinghe, Shanika L and Su, Shian and Dong, Xueyi and Zappia,
               Luke and Ritchie, Matthew E and Gouil, Quentin",
  abstract  = "Long-read technologies are overcoming early limitations in
               accuracy and throughput, broadening their application domains in
               genomics. Dedicated analysis tools that take into account the
               characteristics of long-read data are thus required, but the
               fast pace of development of such tools can be overwhelming. To
               assist in the design and analysis of long-read sequencing
               projects, we review the current landscape of available tools and
               present an online interactive database, long-read-tools.org, to
               facilitate their browsing. We further focus on the principles of
               error correction, base modification detection, and long-read
               transcriptomics analysis and highlight the challenges that
               remain.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  21,
  number    =  1,
  pages     = "30",
  month     =  feb,
  year      =  2020,
  keywords  = "Data analysis; Long-read sequencing; Oxford Nanopore; PacBio",
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Hu2021-bv,
  title     = "{LIQA}: long-read isoform quantification and analysis",
  author    = "Hu, Yu and Fang, Li and Chen, Xuelian and Zhong, Jiang F and Li,
               Mingyao and Wang, Kai",
  abstract  = "Long-read RNA sequencing (RNA-seq) technologies can sequence
               full-length transcripts, facilitating the exploration of
               isoform-specific gene expression over short-read RNA-seq. We
               present LIQA to quantify isoform expression and detect
               differential alternative splicing (DAS) events using long-read
               direct mRNA sequencing or cDNA sequencing data. LIQA
               incorporates base pair quality score and isoform-specific read
               length information in a survival model to assign different
               weights across reads, and uses an expectation-maximization
               algorithm for parameter estimation. We apply LIQA to long-read
               RNA-seq data from the Universal Human Reference, acute myeloid
               leukemia, and esophageal squamous epithelial cells and
               demonstrate its high accuracy in profiling alternative splicing
               events.",
  journal   = "Genome Biol.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  22,
  number    =  1,
  pages     = "182",
  month     =  jun,
  year      =  2021,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}

@ARTICLE{Zhao2014-ve,
  title     = "{CrossMap}: a versatile tool for coordinate conversion between
               genome assemblies",
  author    = "Zhao, Hao and Sun, Zhifu and Wang, Jing and Huang, Haojie and
               Kocher, Jean-Pierre and Wang, Liguo",
  abstract  = "MOTIVATION: Reference genome assemblies are subject to change
               and refinement from time to time. Generally, researchers need to
               convert the results that have been analyzed according to old
               assemblies to newer versions, or vice versa, to facilitate
               meta-analysis, direct comparison, data integration and
               visualization. Several useful conversion tools can convert
               genome interval files in browser extensible data or general
               feature format, but none have the functionality to convert files
               in sequence alignment map or BigWig format. This is a
               significant gap in computational genomics tools, as these
               formats are the ones most widely used for representing
               high-throughput sequencing data, such as RNA-seq, chromatin
               immunoprecipitation sequencing, DNA-seq, etc. RESULTS: Here we
               developed CrossMap, a versatile and efficient tool for
               converting genome coordinates between assemblies. CrossMap
               supports most of the commonly used file formats, including BAM,
               sequence alignment map, Wiggle, BigWig, browser extensible data,
               general feature format, gene transfer format and variant call
               format. AVAILABILITY AND IMPLEMENTATION: CrossMap is written in
               Python and C. Source code and a comprehensive user's manual are
               freely available at: http://crossmap.sourceforge.net/.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  30,
  number    =  7,
  pages     = "1006--1007",
  month     =  apr,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Price2006-kr,
  title     = "Principal components analysis corrects for stratification in
               genome-wide association studies",
  author    = "Price, Alkes L and Patterson, Nick J and Plenge, Robert M and
               Weinblatt, Michael E and Shadick, Nancy A and Reich, David",
  abstract  = "Population stratification--allele frequency differences between
               cases and controls due to systematic ancestry differences-can
               cause spurious associations in disease studies. We describe a
               method that enables explicit detection and correction of
               population stratification on a genome-wide scale. Our method
               uses principal components analysis to explicitly model ancestry
               differences between cases and controls. The resulting correction
               is specific to a candidate marker's variation in frequency
               across ancestral populations, minimizing spurious associations
               while maximizing power to detect true associations. Our simple,
               efficient approach can easily be applied to disease studies with
               hundreds of thousands of markers.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  38,
  number    =  8,
  pages     = "904--909",
  month     =  aug,
  year      =  2006,
  language  = "en"
}


##
@ARTICLE{Dobin2013-hs,
  title     = "{STAR}: ultrafast universal {RNA-seq} aligner",
  author    = "Dobin, Alexander and Davis, Carrie A and Schlesinger, Felix and
               Drenkow, Jorg and Zaleski, Chris and Jha, Sonali and Batut,
               Philippe and Chaisson, Mark and Gingeras, Thomas R",
  abstract  = "MOTIVATION: Accurate alignment of high-throughput RNA-seq data
               is a challenging and yet unsolved problem because of the
               non-contiguous transcript structure, relatively short read
               lengths and constantly increasing throughput of the sequencing
               technologies. Currently available RNA-seq aligners suffer from
               high mapping error rates, low mapping speed, read length
               limitation and mapping biases. RESULTS: To align our large (>80
               billon reads) ENCODE Transcriptome RNA-seq dataset, we developed
               the Spliced Transcripts Alignment to a Reference (STAR) software
               based on a previously undescribed RNA-seq alignment algorithm
               that uses sequential maximum mappable seed search in
               uncompressed suffix arrays followed by seed clustering and
               stitching procedure. STAR outperforms other aligners by a factor
               of >50 in mapping speed, aligning to the human genome 550
               million 2 $\times$ 76 bp paired-end reads per hour on a modest
               12-core server, while at the same time improving alignment
               sensitivity and precision. In addition to unbiased de novo
               detection of canonical junctions, STAR can discover
               non-canonical splices and chimeric (fusion) transcripts, and is
               also capable of mapping full-length RNA sequences. Using Roche
               454 sequencing of reverse transcription polymerase chain
               reaction amplicons, we experimentally validated 1960 novel
               intergenic splice junctions with an 80-90\% success rate,
               corroborating the high precision of the STAR mapping strategy.
               AVAILABILITY AND IMPLEMENTATION: STAR is implemented as a
               standalone C++ code. STAR is free open source software
               distributed under GPLv3 license and can be downloaded from
               http://code.google.com/p/rna-star/.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  29,
  number    =  1,
  pages     = "15--21",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Van_de_Geijn2015-lb,
  title     = "{WASP}: allele-specific software for robust molecular
               quantitative trait locus discovery",
  author    = "van de Geijn, Bryce and McVicker, Graham and Gilad, Yoav and
               Pritchard, Jonathan K",
  abstract  = "Allele-specific sequencing reads provide a powerful signal for
               identifying molecular quantitative trait loci (QTLs), but they
               are challenging to analyze and are prone to technical artifacts.
               Here we describe WASP, a suite of tools for unbiased
               allele-specific read mapping and discovery of molecular QTLs.
               Using simulated reads, RNA-seq reads and chromatin
               immunoprecipitation sequencing (ChIP-seq) reads, we demonstrate
               that WASP has a low error rate and is far more powerful than
               existing QTL-mapping approaches.",
  journal   = "Nat. Methods",
  publisher = "Springer Science and Business Media LLC",
  volume    =  12,
  number    =  11,
  pages     = "1061--1063",
  month     =  nov,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Li2009-yk,
  title     = "The Sequence {Alignment/Map} format and {SAMtools}",
  author    = "Li, Heng and Handsaker, Bob and Wysoker, Alec and Fennell, Tim
               and Ruan, Jue and Homer, Nils and Marth, Gabor and Abecasis,
               Goncalo and Durbin, Richard and {1000 Genome Project Data
               Processing Subgroup}",
  abstract  = "SUMMARY: The Sequence Alignment/Map (SAM) format is a generic
               alignment format for storing read alignments against reference
               sequences, supporting short and long reads (up to 128 Mbp)
               produced by different sequencing platforms. It is flexible in
               style, compact in size, efficient in random access and is the
               format in which alignments from the 1000 Genomes Project are
               released. SAMtools implements various utilities for
               post-processing alignments in the SAM format, such as indexing,
               variant caller and alignment viewer, and thus provides universal
               tools for processing read alignments. AVAILABILITY:
               http://samtools.sourceforge.net.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  25,
  number    =  16,
  pages     = "2078--2079",
  month     =  aug,
  year      =  2009,
  copyright = "http://creativecommons.org/licenses/by-nc/2.0/uk/",
  language  = "en"
}

@ARTICLE{Cotto2023-yp,
  title    = "Integrated analysis of genomic and transcriptomic data for the
              discovery of splice-associated variants in cancer",
  author   = "Cotto, Kelsy C and Feng, Yang-Yang and Ramu, Avinash and
              Richters, Megan and Freshour, Sharon L and Skidmore, Zachary L
              and Xia, Huiming and McMichael, Joshua F and Kunisaki, Jason and
              Campbell, Katie M and Chen, Timothy Hung-Po and Rozycki, Emily B
              and Adkins, Douglas and Devarakonda, Siddhartha and Sankararaman,
              Sumithra and Lin, Yiing and Chapman, William C and Maher,
              Christopher A and Arora, Vivek and Dunn, Gavin P and Uppaluri,
              Ravindra and Govindan, Ramaswamy and Griffith, Obi L and
              Griffith, Malachi",
  abstract = "Somatic mutations within non-coding regions and even exons may
              have unidentified regulatory consequences that are often
              overlooked in analysis workflows. Here we present RegTools (
              www.regtools.org ), a computationally efficient, free, and
              open-source software package designed to integrate somatic
              variants from genomic data with splice junctions from bulk or
              single cell transcriptomic data to identify variants that may
              cause aberrant splicing. We apply RegTools to over 9000 tumor
              samples with both tumor DNA and RNA sequence data. RegTools
              discovers 235,778 events where a splice-associated variant
              significantly increases the splicing of a particular junction,
              across 158,200 unique variants and 131,212 unique junctions. To
              characterize these somatic variants and their associated splice
              isoforms, we annotate them with the Variant Effect Predictor,
              SpliceAI, and Genotype-Tissue Expression junction counts and
              compare our results to other tools that integrate genomic and
              transcriptomic data. While many events are corroborated by the
              aforementioned tools, the flexibility of RegTools also allows us
              to identify splice-associated variants in known cancer drivers,
              such as TP53, CDKN2A, and B2M, and other genes.",
  journal  = "Nat. Commun.",
  volume   =  14,
  number   =  1,
  pages    = "1589",
  month    =  mar,
  year     =  2023,
  language = "en"
}

@ARTICLE{Delaneau2017-dg,
  title     = "A complete tool set for molecular {QTL} discovery and analysis",
  author    = "Delaneau, Olivier and Ongen, Halit and Brown, Andrew A and Fort,
               Alexandre and Panousis, Nikolaos I and Dermitzakis, Emmanouil T",
  abstract  = "Population scale studies combining genetic information with
               molecular phenotypes (for example, gene expression) have become
               a standard to dissect the effects of genetic variants onto
               organismal phenotypes. These kinds of data sets require
               powerful, fast and versatile methods able to discover molecular
               Quantitative Trait Loci (molQTL). Here we propose such a
               solution, QTLtools, a modular framework that contains multiple
               new and well-established methods to prepare the data, to
               discover proximal and distal molQTLs and, finally, to integrate
               them with GWAS variants and functional annotations of the
               genome. We demonstrate its utility by performing a complete
               expression QTL study in a few easy-to-perform steps. QTLtools is
               open source and available at
               https://qtltools.github.io/qtltools/.",
  journal   = "Nat. Commun.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  8,
  number    =  1,
  pages     = "15452",
  month     =  may,
  year      =  2017,
  copyright = "https://creativecommons.org/licenses/by/4.0",
  language  = "en"
}
@ARTICLE{Storey2003-zd,
  title     = "Statistical significance for genomewide studies",
  author    = "Storey, John D and Tibshirani, Robert",
  abstract  = "With the increase in genomewide experiments and the sequencing
               of multiple genomes, the analysis of large data sets has become
               commonplace in biology. It is often the case that thousands of
               features in a genomewide data set are tested against some null
               hypothesis, where a number of features are expected to be
               significant. Here we propose an approach to measuring
               statistical significance in these genomewide studies based on
               the concept of the false discovery rate. This approach offers a
               sensible balance between the number of true and false positives
               that is automatically calibrated and easily interpreted. In
               doing so, a measure of statistical significance called the q
               value is associated with each tested feature. The q value is
               similar to the well known p value, except it is a measure of
               significance in terms of the false discovery rate rather than
               the false positive rate. Our approach avoids a flood of false
               positive results, while offering a more liberal criterion than
               what has been used in genome scans for linkage.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "Proceedings of the National Academy of Sciences",
  volume    =  100,
  number    =  16,
  pages     = "9440--9445",
  month     =  aug,
  year      =  2003,
  language  = "en"
}



@ARTICLE{Zhou2018-jh,
  title     = "Efficiently controlling for case-control imbalance and sample
               relatedness in large-scale genetic association studies",
  author    = "Zhou, Wei and Nielsen, Jonas B and Fritsche, Lars G and Dey,
               Rounak and Gabrielsen, Maiken E and Wolford, Brooke N and
               LeFaive, Jonathon and VandeHaar, Peter and Gagliano, Sarah A and
               Gifford, Aliya and Bastarache, Lisa A and Wei, Wei-Qi and Denny,
               Joshua C and Lin, Maoxuan and Hveem, Kristian and Kang, Hyun Min
               and Abecasis, Goncalo R and Willer, Cristen J and Lee, Seunggeun",
  abstract  = "In genome-wide association studies (GWAS) for thousands of
               phenotypes in large biobanks, most binary traits have
               substantially fewer cases than controls. Both of the widely used
               approaches, the linear mixed model and the recently proposed
               logistic mixed model, perform poorly; they produce large type I
               error rates when used to analyze unbalanced case-control
               phenotypes. Here we propose a scalable and accurate generalized
               mixed model association test that uses the saddlepoint
               approximation to calibrate the distribution of score test
               statistics. This method, SAIGE (Scalable and Accurate
               Implementation of GEneralized mixed model), provides accurate P
               values even when case-control ratios are extremely unbalanced.
               SAIGE uses state-of-art optimization strategies to reduce
               computational costs; hence, it is applicable to GWAS for
               thousands of phenotypes by large biobanks. Through the analysis
               of UK Biobank data of 408,961 samples from white British
               participants with European ancestry for > 1,400 binary
               phenotypes, we show that SAIGE can efficiently analyze large
               sample data, controlling for unbalanced case-control ratios and
               sample relatedness.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  50,
  number    =  9,
  pages     = "1335--1341",
  month     =  sep,
  year      =  2018,
  language  = "en"
}
@ARTICLE{Liu2019-fv,
  title     = "Abundant associations with gene expression complicate {GWAS}
               follow-up",
  author    = "Liu, Boxiang and Gloudemans, Michael J and Rao, Abhiram S and
               Ingelsson, Erik and Montgomery, Stephen B",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  51,
  number    =  5,
  pages     = "768--769",
  month     =  may,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Gu2016-oc,
  title     = "Complex heatmaps reveal patterns and correlations in
               multidimensional genomic data",
  author    = "Gu, Zuguang and Eils, Roland and Schlesner, Matthias",
  abstract  = "Abstract Summary: Parallel heatmaps with carefully designed
               annotation graphics are powerful for efficient visualization of
               patterns and relationships among high dimensional genomic data.
               Here we present the ComplexHeatmap package that provides rich
               functionalities for customizing heatmaps, arranging multiple
               parallel heatmaps and including user-defined annotation
               graphics. We demonstrate the power of ComplexHeatmap to easily
               reveal patterns and correlations among multiple sources of
               information with four real-world datasets. Availability and
               Implementation: The ComplexHeatmap package and documentation are
               freely available from the Bioconductor project:
               http://www.bioconductor.org/packages/devel/bioc/html/ComplexHeatmap.html.
               Contact: m.schlesner@dkfz.de Supplementary information:
               Supplementary data are available at Bioinformatics online.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  32,
  number    =  18,
  pages     = "2847--2849",
  month     =  sep,
  year      =  2016,
  language  = "en"
}

%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%End Macromap%%%%
%%%%%%%%%%%%%%%%%%%%%%%%
@online{ukibdgc-info,
    title = {UK IBD Genetics Consortium Aims},  
    author = {The UK IBD Genetics Consortium},  
    year = {2023},
    url = {https://www.ibdresearch.co.uk/what-is-inflammatory-bowel-disease-ibd/aims/},   
    urldate      = {30/09/2023}
}
@online{ibdbr-further-info,
    title = {What is the IBD BioResource?},  
    author = {The IBD BioResource},  
    year = {2022},
    url = {https://www.ibdbioresource.nihr.ac.uk/index.php/patients/further-information/},   
    urldate      = {30/09/2023}
}
@online{ibdbr-questionnaire-v7,
    title = {The IBD BioResource Questionnaire Version 7},  
    author = {The IBD BioResource},  
    year = {2021},
    url = {https://www.ibdbioresource.nihr.ac.uk/wp-content/uploads/2022/02/PIS-V7.pdf},   
    urldate      = {30/09/2023}
}
@online{ibdbr-protocol-v8,
    title = {The IBD BioResource Protocol Version 8},  
    author = {The IBD BioResource},  
    year = {2021},
    url = {https://www.ibdbioresource.nihr.ac.uk/wp-content/uploads/2022/02/Protocol-V8.pdf},   
    urldate      = {30/09/2023}
}
@ARTICLE{Scharl2013-uf,
  title     = "Interleukin-13 and transforming growth factor $\beta$ synergise
               in the pathogenesis of human intestinal fistulae",
  author    = "Scharl, Michael and Frei, Sandra and Pesch, Theresa and
               Kellermeier, Silvia and Arikkat, Joba and Frei, Pascal and
               Fried, Michael and Weber, Achim and Jehle, Ekkehard and
               R{\"u}hl, Anne and Rogler, Gerhard",
  abstract  = "OBJECTIVE: Epithelial to mesenchymal transition (EMT) seems to
               play an important role in the pathogenesis of fistulae, a common
               clinical complication of Crohn's disease (CD). TGF$\beta$ and
               interleukin-13 (IL-13) have been correlated with the onset of
               EMT-associated organ fibrosis and high levels of TGF$\beta$ have
               been shown in transitional cells (TCs) lining CD fistula tracts.
               This study investigated whether IL-13 could be involved in the
               pathogenesis of CD-associated fistulae. DESIGN: Protein or mRNA
               levels in HT29 intestinal epithelial cells (IECs) or colonic
               lamina propria fibroblasts (CLPFs) were studied by western
               blotting or real-time PCR. CLPFs were isolated from
               non-inflammatory disease controls or patients with CD with or
               without fistulae and IL-13 levels were analysed in surgically
               removed fistula specimens by immunohistochemistry. RESULTS:
               TGF$\beta$ induced IL-13 secretion in CLPFs from patients with
               fistulising CD. In fistula specimens high levels of IL-13 were
               detected in TCs covering fistula tracts. In HT29 IEC monolayers,
               IL-13 induced SLUG and $\beta$6-integrin mRNA, which are
               associated with cell invasion. HT29 spheroids completely
               disintegrated when treated with TGF$\beta$ for 7 days, whereas
               IL-13-treated spheroids did not show morphological changes.
               Here, TGF$\beta$ induced mRNA expression of SNAIL1 and IL-13,
               whereas IL-13 elevated SLUG and $\beta$6-integrin mRNA. An
               anti-IL-13 antibody was able to prevent IL-13-induced SLUG
               expression in HT29 IECs. CONCLUSIONS: TGF$\beta$ induces IL-13
               expression and an EMT-like phenotype of IECs, while IL-13
               promotes the expression of genes associated with cell invasion.
               These findings suggest that TGF$\beta$ and IL-13 play a
               synergistic role in the pathogenesis of fistulae and inhibition
               of IL-13 might represent a novel therapeutic approach for
               fistula treatment.",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  62,
  number    =  1,
  pages     = "63--72",
  month     =  jan,
  year      =  2013,
  language  = "en"
}

@ARTICLE{Peyrin-Biroulet2010-mf,
  title     = "The natural history of adult Crohn's disease in population-based
               cohorts",
  author    = "Peyrin-Biroulet, Laurent and Loftus, Jr, Edward V and Colombel,
               Jean-Frederic and Sandborn, William J",
  abstract  = "OBJECTIVES: Natural history studies provide invaluable data on
               the disease course. First, they help define the end points for
               clinical trials that are designed to test drugs for the end
               point of disease modification in chronic disabling diseases.
               Natural history studies can also help to identify subsets of
               patients in whom the disease prognosis can be stratified
               according to clinical features. This comprehensive review
               summarizes our current knowledge of the natural history of
               Crohn's disease in adults as reported in population-based
               studies that include long-term follow-up results. METHODS: We
               conducted a literature search of English and non-English
               language publications listed in the electronic databases of
               MEDLINE (source PUBMED, 1935 to December 2008). RESULTS:
               One-third of the patients had ileitis, colitis, or ileocolitis
               at the time of diagnosis. Disease location remained broadly
               stable over time. Up to one-third of the patients had evidence
               of a stricturing or penetrating intestinal complication at
               diagnosis, and half of all patients had experienced an
               intestinal complication within 20 years after diagnosis. Ten
               percent of the patients had prolonged clinical remission.
               Steroid dependency occurred in one-third of the patients, and
               surgery was required in one-third after initiation of steroid
               therapy. The annual incidence of hospitalizations was 20\%. Half
               of the patients required surgery within 10 years after
               diagnosis. The risk of postoperative recurrence was 44-55\%
               after 10 years. CONCLUSIONS: Crohn's disease is a disabling
               condition over time. The impact of changing treatment paradigms
               with increased use of immunosuppressants and biological agents
               on its natural history is poorly known.",
  journal   = "Am. J. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  105,
  number    =  2,
  pages     = "289--297",
  month     =  feb,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Scharl2017-sp,
  title     = "Fistulizing Crohn's disease",
  author    = "Scharl, Michael and Rogler, Gerhard and Biedermann, Luc",
  abstract  = "Fistulas still represent one of the most important complications
               in patients with Crohn's disease (CD). At least one third of CD
               patients suffer from fistulas during their disease course and
               amongst them longstanding remission of complex fistulas occurs
               only in about one third. So far, fistula pathogenesis is only
               partially understood. From a histopathological view, a fistula
               is a tube covered by flat epithelial cells. Current research
               suggests that the driving force for fistula development is
               epithelial-to-mesenchymal transition (EMT). Around the fistula,
               high levels of tumor necrosis factor (TNF), IL-13, and
               TGF$\beta$ can be detected and recent studies indicated an
               involvement of the intestinal microbiota. Fistula diagnosis
               requires clinical and surgical assessment, radiologic
               investigations, e.g., magnet resonance imaging and endoscopy.
               Routine medical treatment of fistulas includes antibiotics,
               immunosuppressives, and anti-TNF antibodies. There is no
               well-established role for calcineurin inhibitors in fistula
               treatment, corticosteroids appear to be even contra-productive.
               A promising novel approach might be the application of adipose
               tissue-derived or bone marrow-derived mesenchymal stem cells
               that have been studied recently. Due to insufficient efficacy of
               medical treatment and recurrence of fistulas, surgical
               interventions are frequently necessary. Further research is
               needed to better understand fistula pathogenesis aiming to
               develop novel treatment option for our patients.",
  journal   = "Clin. Transl. Gastroenterol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  8,
  number    =  7,
  pages     = "e106",
  month     =  jul,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Eglinton2012-hh,
  title     = "The spectrum of perianal Crohn's disease in a population-based
               cohort",
  author    = "Eglinton, Tim W and Barclay, Murray L and Gearry, Richard B and
               Frizelle, Frank A",
  abstract  = "BACKGROUND: Perianal Crohn's disease represents a phenotype
               distinct from luminal Crohn's disease and may follow a different
               course. To date, the only detailed classifications of perianal
               Crohn's disease arise from referral center cohorts that do not
               reflect the spectrum of disease in the population as a whole.
               OBJECTIVES: The aim of this study was to document the rate,
               classification, and time course of symptomatic perianal Crohn's
               disease in a population-based cohort. DESIGN: This is a
               population-based cohort study. SETTING: : This study was
               conducted in the Canterbury region of New Zealand. PATIENTS: All
               patients with IBD in Canterbury, New Zealand, were eligible for
               recruitment over a 3-year period. MAIN OUTCOME MEASURES: The
               clinical records of all patients with Crohn's disease were
               reviewed, and all symptomatic perianal disease was classified
               according to the American Gastroenterological Society position
               statement. The rate of perianal involvement and timing of onset
               relative to Crohn's diagnosis was determined. RESULTS:
               Ninety-one percent of IBD patients in the region were recruited.
               Seven hundred fifteen patients had Crohn's disease, of which 190
               (26.6\%) patients had symptomatic perianal disease. The median
               age of patients with perianal disease was 37 years (range, 4-82
               years) and 58.4\% were female. Median follow-up was 9 years
               (range, 2 months to 45 years) from Crohn's disease diagnosis.
               Onset of perianal disease ranged from 18 years pre-Crohn's
               diagnosis to 33 years post-Crohn's diagnosis. Fistulas were the
               most common lesion (50\% of patients), followed by perianal
               abscesses (42.1\%), fissures (32.6\%), skin tags (11.1\%),
               strictures (7.4\%), and hemorrhoids (1.6\%). The cumulative
               probability at 20 years of any perianal Crohn's disease was
               42.7\% and of a perianal fistula 28.3\%. LIMITATIONS: This study
               assumed all noted perianal lesions were related to Crohn's
               disease and the retrospective classification may have been
               inaccurate in some cases. CONCLUSIONS: This study provides the
               first detailed classification of perianal Crohn's disease in a
               population-based cohort.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  55,
  number    =  7,
  pages     = "773--777",
  month     =  jul,
  year      =  2012,
  language  = "en"
}

@article {Irvine1995-ej,
	Title = {Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group},
	Author = {Irvine, EJ},
	Number = {1},
	Volume = {20},
	Month = {January},
	Year = {1995},
	Journal = {Journal of clinical gastroenterology},
	ISSN = {0192-0790},
	Pages = {2732},
	Abstract = {Troublesome perianal disease occurs in approximately 35% of patients with Crohn's disease, yet conventional disease activity indices do not reflect the severity of this feature. To assess the degree of impairment and response to therapy, we identified five simple elements and graded each on a 5-point Likert scale in 37 patients at 124 visits. At each visit a Crohn's Disease (CDAI) or Simple Activity Index (HBDAI), Perianal Disease Activity Index (PDAI), and treatment were recorded. The PDAI was validated against physician (MDGA) and patient (PGA) global assessments, and treatment was prescribed for the perianal disease. Measurement error was evaluated in 19 patients who were clinically stable at two consecutive visits. The ability of the PDAI to detect important clinical change was tested in 20 subjects exhibiting a change on PGA at consecutive visits. There were strong correlations between PDAI, MDGA, and PGA scores at all visits (R = 0.66-0.72; p &lt; 0.001), whereas the CDAI and HBDAI correlated poorly with PDAI (R &lt; 0.23). Physicians prescribed more aggressive therapy for higher PDAI scores (r = 0.53). Mean PDAI scores between visits in clinically stable subjects were not significantly different [5.58 +/- 2.79 (initial); 5.42 +/- 2.55 (follow-up); p = 0.63]. PDAI significantly improved between visits when the perianal disease had improved (PDAI score difference 3.05 +/- 2.96; P = .0002). We conclude that the PDAI is simple and clinically useful for patient management. It should now be assessed in a clinical trial.},
	URL = {http://europepmc.org/abstract/MED/7884173}
}


@ARTICLE{Hughes1992-kc,
  title     = "Clinical classification of perianal Crohn's disease",
  author    = "Hughes, Leslie E",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  35,
  number    =  10,
  pages     = "928--932",
  month     =  oct,
  year      =  1992,
  language  = "en"
}

@ARTICLE{Safar2007-dk,
  title     = "Perianal Crohn's disease",
  author    = "Safar, Bashar and Sands, Dana",
  abstract  = "Crohn's disease is commonly complicated by perianal
               manifestations. The surgeon plays a pivotal role in caring for
               these patients; a detailed history along with a thorough
               clinical exam provides the treating physician with invaluable
               information upon which to base further investigations and
               management decisions. Other than abscess drainage, medical
               management to control proximal disease often precedes any
               surgical attempt to cure the disease. Surgical interventions are
               indicated in selective patients, but are often complicated by
               poor wound healing and recurrences. A sizable percentage of
               these patients may need a proctectomy.",
  journal   = "Clin. Colon Rectal Surg.",
  publisher = "Georg Thieme Verlag KG",
  volume    =  20,
  number    =  4,
  pages     = "282--293",
  month     =  nov,
  year      =  2007,
  keywords  = "Crohn's disease; fistula; perianal",
  language  = "en"
}

@ARTICLE{Scheurlen2023-gk,
  title    = "State-of-the-art surgery for Crohn's disease: part {III-perianal}
              Crohn's disease",
  author   = "Scheurlen, Katharina M and MacLeod, Anne and Kavalukas, Sandra L
              and Galandiuk, Susan",
  abstract = "PURPOSE: Diagnosis and treatment of perianal Crohn's disease is
              challenging and requires its own domain of therapy. Different
              types of perianal disease require a spectrum of treatment
              strategies. Treatment options range from conservative therapy,
              including immunosuppressives, biologics, or stem cell therapy, to
              surgical treatment with specific indications depending on the
              underlying lesion. This is part III of the series
              ``state-of-the-art surgery for Crohn's disease,'' focusing on the
              management of perianal disease. We discuss the definition and
              diagnosis of perianal Crohn's disease, the treatment of perianal
              lesions, and specific surgical indications and techniques.
              RESULTS AND CONCLUSION: Pitfalls and complications play a
              substantial role in the treatment of perianal Crohn's disease,
              and surgical therapy may fail. Realistic treatment goals and an
              individual patient-oriented treatment approach are crucial in the
              treatment of perianal Crohn's disease.",
  journal  = "Langenbecks Arch. Surg.",
  volume   =  408,
  number   =  1,
  pages    = "132",
  month    =  mar,
  year     =  2023,
  keywords = "Anal canal; Colonic Crohn's disease; Mesenchymal stem cells;
              Rectal diseases; Rectal fistula; Recurrence",
  language = "en"
}

@ARTICLE{Pikarsky2002-gf,
  title     = "Perianal Crohn disease",
  author    = "Pikarsky, Alon J and Gervaz, Pascal and Wexner, Steven D",
  journal   = "Arch. Surg.",
  publisher = "American Medical Association (AMA)",
  volume    =  137,
  number    =  7,
  month     =  jul,
  year      =  2002,
  language  = "en"
}

@ARTICLE{Eglinton2012-vx,
  title     = "The spectrum of perianal Crohn's disease in a population-based
               cohort",
  author    = "Eglinton, Tim W and Barclay, Murray L and Gearry, Richard B and
               Frizelle, Frank A",
  abstract  = "BACKGROUND: Perianal Crohn's disease represents a phenotype
               distinct from luminal Crohn's disease and may follow a different
               course. To date, the only detailed classifications of perianal
               Crohn's disease arise from referral center cohorts that do not
               reflect the spectrum of disease in the population as a whole.
               OBJECTIVES: The aim of this study was to document the rate,
               classification, and time course of symptomatic perianal Crohn's
               disease in a population-based cohort. DESIGN: This is a
               population-based cohort study. SETTING: : This study was
               conducted in the Canterbury region of New Zealand. PATIENTS: All
               patients with IBD in Canterbury, New Zealand, were eligible for
               recruitment over a 3-year period. MAIN OUTCOME MEASURES: The
               clinical records of all patients with Crohn's disease were
               reviewed, and all symptomatic perianal disease was classified
               according to the American Gastroenterological Society position
               statement. The rate of perianal involvement and timing of onset
               relative to Crohn's diagnosis was determined. RESULTS:
               Ninety-one percent of IBD patients in the region were recruited.
               Seven hundred fifteen patients had Crohn's disease, of which 190
               (26.6\%) patients had symptomatic perianal disease. The median
               age of patients with perianal disease was 37 years (range, 4-82
               years) and 58.4\% were female. Median follow-up was 9 years
               (range, 2 months to 45 years) from Crohn's disease diagnosis.
               Onset of perianal disease ranged from 18 years pre-Crohn's
               diagnosis to 33 years post-Crohn's diagnosis. Fistulas were the
               most common lesion (50\% of patients), followed by perianal
               abscesses (42.1\%), fissures (32.6\%), skin tags (11.1\%),
               strictures (7.4\%), and hemorrhoids (1.6\%). The cumulative
               probability at 20 years of any perianal Crohn's disease was
               42.7\% and of a perianal fistula 28.3\%. LIMITATIONS: This study
               assumed all noted perianal lesions were related to Crohn's
               disease and the retrospective classification may have been
               inaccurate in some cases. CONCLUSIONS: This study provides the
               first detailed classification of perianal Crohn's disease in a
               population-based cohort.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  55,
  number    =  7,
  pages     = "773--777",
  month     =  jul,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Adegbola2020-nd,
  title     = "Burden of disease and adaptation to life in patients with
               Crohn's perianal fistula: a qualitative exploration",
  author    = "Adegbola, Samuel O and Dibley, Lesley and Sahnan, Kapil and
               Wade, Tiffany and Verjee, Azmina and Sawyer, Rachel and Mannick,
               Sameer and McCluskey, Damian and Yassin, Nuha and Phillips,
               Robin K S and Tozer, Philip J and Norton, Christine and Hart,
               Ailsa L",
  abstract  = "BACKGROUND: Perianal fistulas are a challenging manifestation of
               Crohn's disease. Best medical and surgical therapy results in
               only about a third of patients remaining in remission at one
               year on maintenance treatment and sustained healing is often
               elusive. There is little published data on patient perspective
               of living with the condition or coping strategies in the face of
               non-curative/non-definitive treatment. We aimed to understand
               the experience of living with perianal fistula(s) and their
               impact on quality of life and routine functioning. METHODS: This
               exploratory qualitative study used purposive sampling to recruit
               participants with current / previous diagnosis of Crohn's anal
               fistulas, from national IBD / bowel disease charities. The
               ``standards for reporting qualitative research'' (SRQR)
               recommendations were followed. Unstructured individual
               face-to-face interviews were audio recorded, transcribed and
               analysed thematically. Early themes were reviewed by the study
               team including patient advocates, clinicians and qualitative
               researchers. RESULTS: Twelve interviews were conducted,
               achieving apparent data saturation. Three broad themes were
               uncovered: Burden of symptoms; Burden of treatment; and Impact
               on emotional, physical and social well-being. Each included
               several sub-themes, with considerable interplay between these.
               The impact of perianal fistula(s) on patients with CD is intense
               and wide reaching, negatively affecting intimate, close and
               social relationships. Fistulas cause losses in life and
               work-related opportunities, and treatments can be difficult to
               tolerate. CONCLUSION: Crohn's perianal fistulas exert a heavy
               negative physical and emotional impact on patients. These
               findings will inform development of a patient reported outcome
               measure to assess treatment effectiveness and quality of life
               for patients living with this challenging condition.",
  journal   = "Health Qual. Life Outcomes",
  publisher = "Springer Science and Business Media LLC",
  volume    =  18,
  number    =  1,
  pages     = "370",
  month     =  nov,
  year      =  2020,
  keywords  = "Crohn's anal fistula; Patient reported outcomes; Quality of life",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Panes2018-su,
  title     = "Burden and outcomes for complex perianal fistulas in Crohn's
               disease: Systematic review",
  author    = "Panes, Julian and Reinisch, Walter and Rupniewska, Ewa and Khan,
               Shahnaz and Forns, Joan and Khalid, Javaria Mona and Bojic,
               Daniela and Patel, Haridarshan",
  abstract  = "AIM: To systematically review the literature on epidemiology,
               disease burden, and treatment outcomes for Crohn's disease (CD)
               patients with complex perianal fistulas. METHODS: PubMed,
               Embase, and Cochrane were searched for relevant articles
               (published 2000-November 2016) and congress abstracts (published
               2011-November 2016). RESULTS: Of 535 records reviewed, 62
               relevant sources were identified (mostly small observational
               studies). The cumulative incidence of complex perianal fistulas
               in CD from two referral-centre studies was 12\%-14\% (follow-up
               time, 12 years in one study; not reported in the second study).
               Complex perianal fistulas result in greatly diminished quality
               of life; up to 59\% of patients are at risk of faecal
               incontinence. Treatments include combinations of medical and
               surgical interventions and expanded allogeneic adipose-derived
               stem cells. High proportions of patients experience lack of or
               inadequate response to treatment (failure and relapse rates,
               respectively: medical, 12\%-73\% and 0\%-41\%; surgical:
               0\%-100\% and 11\%-20\%; combined medical/surgical: 0\%-80\% and
               0\%-50\%; stem cells: 29\%-47\% and not reported). Few studies
               (1 of infliximab; 3 of surgical interventions) have been
               conducted in treatment-refractory patients, a population with
               high unmet needs. Limited data exist on the clinical value of
               anti-tumour necrosis factor-$\alpha$ dose escalation in patients
               with complex perianal fistulas in CD. CONCLUSION: Complex
               perianal fistulas in CD pose substantial clinical and humanistic
               burden. There is a need for effective treatments, especially for
               patients refractory to anti-tumour necrosis factor-$\alpha$
               agents, as evidenced by high failure and relapse rates.",
  journal   = "World J. Gastroenterol.",
  publisher = "Baishideng Publishing Group Inc.",
  volume    =  24,
  number    =  42,
  pages     = "4821--4834",
  month     =  nov,
  year      =  2018,
  keywords  = "Burden; Complex perianal fistulas; Crohn's disease;
               Epidemiology; Outcomes; Systematic literature review; Treatment",
  language  = "en"
}

@ARTICLE{Braithwaite2017-zo,
  title     = "Prognostic factors affecting outcomes in fistulating perianal
               Crohn's disease: a systematic review",
  author    = "Braithwaite, G C and Lee, M J and Hind, D and Brown, S R",
  journal   = "Tech. Coloproctol.",
  publisher = "Springer Nature",
  volume    =  21,
  number    =  7,
  pages     = "501--519",
  month     =  jul,
  year      =  2017
}

@ARTICLE{Ng2016-al,
  title     = "Changing epidemiological trends of inflammatory bowel disease in
               Asia",
  author    = "Ng, Wee Khoon and Wong, Sunny H and Ng, Siew C",
  abstract  = "Inflammatory bowel disease (IBD) has become more common in Asia
               over the past few decades. The rate of increase in prevalence of
               the disease varies greatly in Asia, with several countries in
               East Asia experiencing a more than doubled increase in IBD
               prevalence over the past decade. Historically, ulcerative
               colitis (UC) is more common than Crohn's disease (CD) in Asia.
               However, a reverse trend is beginning to appear in more
               developed countries in Asia such as Japan, Korea, and Hong Kong.
               While Asian IBD patients share many similarities with their
               Western counterparts, there are important differences with
               significant clinical implications. In Asia, there are more men
               with CD, more ileo-colonic involvement in CD, less familial
               aggregation, fewer extra-intestinal manifestations and worse
               clinical outcomes for older-onset patients with UC. These
               differences are likely related to the different genetic makeup
               and environmental exposures in different regions. Evaluation of
               the differences and rates in epidemiologic trends may help
               researchers and clinicians estimate disease burden and
               understand the reasons behind these differences, which may hold
               the key to unravel the etiology of IBD.",
  journal   = "Intest. Res.",
  publisher = "Korean Association for the Study of Intestinal Diseases",
  volume    =  14,
  number    =  2,
  pages     = "111--119",
  month     =  apr,
  year      =  2016,
  keywords  = "Asia; Colitis, ulcerative; Crohn disease; Epidemiology;
               Inflammatory bowel diseases",
  language  = "en"
}

@ARTICLE{Wils2021-ao,
  title     = "Fistulizing perianal lesions in a French population with Crohn's
               disease",
  author    = "Wils, Pauline and Leroyer, Ariane and Fumery, Mathurin and
               Fernandez-Nistal, Alonso and Gower-Rousseau, Corinne and
               Pariente, Benjamin",
  journal   = "Dig. Liver Dis.",
  publisher = "Elsevier BV",
  volume    =  53,
  number    =  5,
  pages     = "661--665",
  month     =  may,
  year      =  2021,
  copyright = "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  language  = "en"
}

@ARTICLE{Pogacnik2019-aj,
  title     = "Perianal Crohn's disease",
  author    = "Pogacnik, Javier Salgado and Salgado, Gervasio",
  abstract  = "This article provides an overview of the principles in the
               evaluation and management of perianal Crohn's disease (CD).
               Manifestation-specific treatment is addressed including abscess,
               fistula, skin tags, hemorrhoids, fissure, ulcers, strictures,
               ano-, and rectovaginal fistulas as well CD-associated
               hidradenitis suppurativa.",
  journal   = "Clin. Colon Rectal Surg.",
  publisher = "Georg Thieme Verlag KG",
  volume    =  32,
  number    =  5,
  pages     = "377--385",
  month     =  sep,
  year      =  2019,
  keywords  = "Crohn's disease; abscess; evaluation; fistula; management;
               perianal",
  language  = "en"
}

@ARTICLE{Mizushima2021-hk,
  title     = "Diagnostic features of perianal fistula in patients with Crohn's
               disease: Analysis of a Japanese claims database",
  author    = "Mizushima, Tsunekazu and Ota, Mihoko and Fujitani, Yasushi and
               Kanauchi, Yuya and Iwakiri, Ryuichi",
  abstract  = "Background: Perianal fistula (PAF) is a disabling complication
               of Crohn's disease (CD) which greatly impacts the quality of
               life. To address a scarcity of data in Asian populations, we
               determined the prevalence of CD-associated PAF in Japan, the
               order of diagnosis, and medical history of patients. Methods: A
               retrospective, longitudinal, observational cohort study was
               conducted, using an employer-based health insurance claims
               database. The study included patients diagnosed with CD and/or
               PAF from October 2013 to September 2019. Results: The age- and
               gender-adjusted prevalence rates of CD-associated PAF increased
               from 10.33 per 100 000 in 2014, to 13.68 per 100 000 in 2019.
               Among patients with CD-associated PAF, 15.7\% were diagnosed
               with PAF after diagnosis of CD, 68.6\% were diagnosed with PAF
               before diagnosis with CD, and 15.7\% were diagnosed with CD and
               PAF within the same month. Of the patients diagnosed with CD
               after PAF, approximately 30\% were diagnosed with PAF by the age
               of 20 years, whereas less than 10\% of PAF patients without CD
               were diagnosed with PAF by the age of 20 years. Conclusions: The
               study reveals the prevalence of CD-associated PAF in Japan and
               that most individuals were diagnosed with CD after the diagnosis
               of PAF. Crohn's disease may be underdiagnosed in patients with
               PAF; patients diagnosed with PAF at a young age should be
               monitored to allow timely diagnosis of CD.",
  journal   = "Crohns Colitis 360",
  publisher = "Oxford University Press (OUP)",
  volume    =  3,
  number    =  3,
  pages     = "otab055",
  month     =  jul,
  year      =  2021,
  keywords  = "Crohn's disease; Japan; perianal fistula",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}

@ARTICLE{Brochard2022-kz,
  title     = "Natural history of perianal Crohn's disease: Long-term follow-up
               of a population-based cohort",
  author    = "Brochard, Charl{\`e}ne and Rabilloud, Marie-Laure and Hamonic,
               St{\'e}phanie and Bajeux, Emma and Pagenault, Ma{\"e}l and
               Dabadie, Alain and Gerfaud, Agathe and Viel, Jean-Fran{\c c}ois
               and Tron, Isabelle and Robaszkiewicz, Michel and Bretagne,
               Jean-Fran{\c c}ois and Siproudhis, Laurent and Bouguen,
               Guillaume and {Groupe ABERMAD}",
  abstract  = "BACKGROUND AND AIMS: The natural history of perianal Crohn's
               disease (PCD) remains poorly described and is mainly based on
               retrospective studies from referral centers. The aim of this
               study was to assess the incidence, outcomes and predictors of
               the onset of PCD. METHODS: All incident cases of patients
               diagnosed with possible CD were prospectively registered from
               1994 to 1997 in Brittany, a limited area in France. At
               diagnosis, the clinical features of perianal disease were
               recorded. All patient charts were reviewed from the diagnosis to
               the last clinic visit in 2015. RESULTS: Among the 272 out of 331
               incident CD patients followed up, 51 (18.7\%) patients had PCD
               at diagnosis. After a mean follow-up of 12.8 years, 93 (34\%)
               patients developed PCD. The cumulative probabilities of perianal
               CD occurrence were 22\%, 29\%, and 32\% after 1 year, 5 years,
               and 10 years, respectively. The cumulative probabilities of anal
               ulceration were 14\%, and 19\% after 1 year and 10 years,
               respectively. Extraintestinal manifestations were associated
               with the occurrence of anal ulceration. The cumulative
               probabilities of fistulizing PCD were 11\%, 16\%, and 19\% after
               1 year, 5 years, and 10 years, respectively. Extraintestinal
               manifestations, rectal involvement and anal ulceration were
               predictors of fistulizing PCD. The cumulative probability of
               developing anal stricture was 4\% after 10 years. CONCLUSIONS:
               PCD is frequently observed during CD, in approximately one-third
               of patients. These data underline the need for targeted
               therapeutic research on primary perianal lesions (proctitis,
               anal ulceration) to avoid the onset of fistulizing perianal
               disease.",
  journal   = "Clin. Gastroenterol. Hepatol.",
  publisher = "Elsevier BV",
  volume    =  20,
  number    =  2,
  pages     = "e102--e110",
  month     =  feb,
  year      =  2022,
  keywords  = "Natural History; Outcomes; Perianal Crohn's Disease; Population
               Based",
  language  = "en"
}

@ARTICLE{Bruckner2018-ag,
  title     = "Incidence and risk factors for perianal disease in pediatric
               Crohn disease patients followed in {CEDATA-GPGE} registry",
  author    = "Br{\"u}ckner, Annecarin and Werkstetter, Katharina J and de
               Laffolie, Jan and Wendt, Claudia and Prell, Christine and
               Weidenhausen, Tanja and Zimmer, Klaus P and Koletzko, Sibylle",
  journal   = "J. Pediatr. Gastroenterol. Nutr.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  66,
  number    =  1,
  pages     = "73--78",
  month     =  jan,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Gottgens2017-df,
  title     = "Time trends in the epidemiology and outcome of perianal
               fistulizing Crohn's disease in a population-based cohort",
  author    = "G{\"o}ttgens, Kevin W A and Jeuring, Steven F G and Sturkenboom,
               Rosel and Romberg-Camps, Mari{\"e}lle J L and Oostenbrug,
               Liekele E and Jonkers, Daisy M A E and Stassen, Laurents P S and
               Masclee, Ad A M and Pierik, Marieke J and Breukink,
               St{\'e}phanie O",
  journal   = "Eur. J. Gastroenterol. Hepatol.",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  29,
  number    =  5,
  pages     = "595--601",
  month     =  may,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Tsai2022-kz,
  title     = "Epidemiology and natural history of perianal Crohn's disease: A
               systematic review and meta-analysis of population-based cohorts",
  author    = "Tsai, Lester and McCurdy, Jeffrey D and Ma, Christopher and
               Jairath, Vipul and Singh, Siddharth",
  abstract  = "BACKGROUND AND AIMS: Perianal Crohn's disease (pCD) is a
               potentially severe phenotype of CD. We conducted a systematic
               review with meta-analysis to estimate cumulative incidence, risk
               factors, and outcomes of pCD in population-based cohort studies.
               METHODS: Through a systematic literature review through March 1,
               2021, we identified population-based inception cohort studies
               reporting cumulative incidence of perianal disease (primarily
               abscess and/or fistula) in patients with CD. We estimated the
               cumulative incidence of pCD at presentation and 1-, 5-, and
               10-year follow-up, and risk factors for perianal disease and
               outcomes including risk of major (bowel resection, proctectomy,
               ostomy) and minor perianal (incision and drainage, seton
               placement, etc.) surgery. RESULTS: In 12 population-based
               studies, prevalence of pCD was 18.7\% (95\% confidence interval
               [CI], 12.5\%-27.0\%) with 1-, 5-, and 10-year risk of perianal
               disease being 14.3\% (95\% CI, 7.9\%-24.6\%), 17.6\% (95\% CI,
               11.3\%-26.5\%), and 18.9\% (95\% CI, 15.0\%-23.4\%),
               respectively. Approximately 11.5\% of patients (95\% CI,
               6.7\%-19.0\%) had perianal disease at or before CD diagnosis.
               Colonic disease location and rectal involvement were associated
               with higher risk of pCD. Overall, 63.3\% of patients (95\% CI,
               53.3-72.3) required minor perianal surgery and 6.4\% of patients
               (95\% CI, 1.8\%-20.6\%) required major abdominal surgery for
               pCD. Use of biologic therapy for pCD is common and has steadily
               increased throughout the years. CONCLUSIONS: Approximately 1 in
               5 patients with CD develops perianal disease within 10 years of
               CD diagnosis, including 11.5\% who have perianal disease at
               presentation. Approximately two-thirds of patients require
               perianal surgery, with a smaller fraction requiring major
               abdominal surgery.",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  28,
  number    =  10,
  pages     = "1477--1484",
  month     =  oct,
  year      =  2022,
  keywords  = "Montreal classification; anti-TNF; epidemiology; fistula;
               natural history",
  copyright = "https://academic.oup.com/pages/standard-publication-reuse-rights",
  language  = "en"
}
%%%
@ARTICLE{Adegbola2018-ha,
  title     = "Medical and surgical management of perianal Crohn's disease",
  author    = "Adegbola, Samuel",
  journal   = "Ann. Gastroenterol.",
  publisher = "Hellenic Society of Gastroenterology",
  year      =  2018
}
@ARTICLE{Jones1966-tt,
  title     = "Corticosteroids and corticotrophin in the treatment of Crohn's
               disease",
  author    = "Jones, J H and Lennard-Jones, J E",
  journal   = "Gut",
  publisher = "BMJ",
  volume    =  7,
  number    =  2,
  pages     = "181--187",
  month     =  apr,
  year      =  1966,
  language  = "en"
}
@ARTICLE{Haennig2015-pj,
  title     = "The results of seton drainage combined with {anti-TNF$\alpha$}
               therapy for anal fistula in Crohn's disease",
  author    = "Haennig, A and Staumont, G and Lepage, B and Faure, P and Alric,
               L and Buscail, L and Bournet, B and Moreau, J",
  abstract  = "AIM: Combined infliximab and sphincter-sparing surgery can be
               effective in perianal fistula associated with Crohn's disease
               (CD). This study aimed to assess the efficacy of local surgery
               combined with infliximab on sustained fistula closure and to
               identify predictive factors for response after this combined
               treatment. METHOD: Between 2000 and 2010, 81 patients with
               fistulising perianal CD were included in this observational
               study. Drainage with a loose seton was followed by infliximab
               therapy. The primary end-points were the rate of complete
               fistula closure and time required for this to occur. RESULTS:
               The fistula was complex in 71 (88\%) of the 81 patients. Local
               proctological surgery was carried out in 77 (95\%), including
               seton drainage in 62 (80.5\%) of these. This was continued for a
               median duration of 3.8 months and the patient then received
               infliximab therapy. The median follow-up after treatment was 64
               months (2-263). Initial complete closure of the fistula occurred
               in 71 (88\%) cases at a median interval of 12.4 months (1-147)
               from the start of treatment. Recurrence was observed in 29
               (41\%) patients at a median interval of 38.5 months (2-48) from
               the start of treatment. They were treated again with combined
               treatment with successful closure in 19 (65.5\%) patients. The
               total rate of closure of the fistula was 75.3\%. Female gender,
               anal stenosis, rectovaginal and complex fistula formation were
               factors independently associated with failure of combined
               treatment. CONCLUSION: Seton drainage for several months
               combined with infliximab therapy is effective in closing the
               fistula in 75\% of patients with complex perianal fistula
               formation associated with CD.",
  journal   = "Colorectal Dis.",
  publisher = "Wiley",
  volume    =  17,
  number    =  4,
  pages     = "311--319",
  month     =  apr,
  year      =  2015,
  keywords  = "Crohn's disease; infliximab; perianal fistula; setons",
  language  = "en"
}

@ARTICLE{Gaertner2007-wb,
  title     = "Does infliximab infusion impact results of operative treatment
               for Crohn's perianal fistulas?",
  author    = "Gaertner, Wolfgang B and Decanini, Alejandra and Mellgren,
               Anders and Lowry, Ann C and Goldberg, Stanley M and Madoff,
               Robert D and Spencer, Michael P",
  abstract  = "PURPOSE: Infliximab is an effective treatment for active
               intestinal Crohn's disease; however, the efficacy of infliximab
               in perianal Crohn's disease is controversial. This study was
               designed to compare patients with Crohn's disease who underwent
               perianal fistula surgery with or without infliximab infusion.
               METHODS: A retrospective chart review of 226 consecutive
               patients with Crohn's disease who underwent operative treatment
               with or without infliximab (3-6 infusions of 5 mg/kg) from March
               1991 through December 2005 was completed. Patients were
               classified as completely healed, minimally symptomatic (seton
               placement with minimal drainage and/or infliximab dependence),
               and failure (persistent or recurrent symptomatic fistula,
               diverting procedure, or proctectomy). RESULTS: A total of 226
               patients underwent operative treatment alone (n = 147) or in
               combination with infliximab infusion (n = 79). Age, gender, and
               preoperative history of intestinal and perianal Crohn's disease
               were similar between groups. Mean follow-up was 30 (range,
               6-216) months. Operative treatment consisted of seton drainage
               (n = 112), conventional fistulotomy (n = 92), fibrin glue
               injection (n = 14), advancement flap (n = 5), collagen plug
               insertion (n = 2), and transperineal repair (n = 1).
               Eighty-eight patients (60 percent) healed completely with
               operative treatment alone, and 47 patients (59 percent) healed
               after operative treatment in combination with infliximab (P =
               not significant). CONCLUSIONS: Operative treatment of perianal
               fistulas in patients with Crohn's disease resulted in complete
               healing in approximately 60 percent of patients. Preoperative
               infliximab infusion did not affect overall healing rates.",
  journal   = "Dis. Colon Rectum",
  publisher = "Ovid Technologies (Wolters Kluwer Health)",
  volume    =  50,
  number    =  11,
  pages     = "1754--1760",
  month     =  nov,
  year      =  2007,
  language  = "en"
}
@ARTICLE{Kotze2014-fh,
  title     = "Perianal complete remission with combined therapy (seton
               placement and {anti-TNF} agents) in Crohn's disease: a Brazilian
               multicenter observational study",
  author    = "Kotze, Paulo Gustavo and Albuquerque, Idblan Carvalho de and da
               Luz Moreira, Andr{\'e} and Tonini, Wanessa Bertrami and
               Olandoski, Marcia and Coy, Claudio Saddy Rodrigues",
  abstract  = "BACKGROUND: Perianal fistulizing Crohn's disease is one of the
               most severe phenotypes of inflammatory bowel diseases. Combined
               therapy with seton placement and anti-TNF therapy is the most
               common strategy for this condition. OBJECTIVES: The aim of this
               study was to analyze the rates of complete perianal remission
               after combined therapy for perianal fistulizing Crohn's disease.
               METHODS: This was a retrospective observational study with
               perianal fistulizing Crohn's disease patients submitted to
               combined therapy from four inflammatory bowel diseases referral
               centers. We analyzed patients' demographic characteristics,
               Montreal classification, concomitant medication, classification
               of the fistulae, occurrence of perianal complete remission and
               recurrence after remission. Complete perianal remission was
               defined as absence of drainage from the fistulae associated with
               seton removal. DISCUSSION: A total of 78 patients were included,
               44 (55.8\%) females with a mean age of 33.8 ($\pm$15) years.
               Most patients were treated with Infliximab, 66.2\%, than with
               Adalimumab, 33.8\%. Complex fistulae were found in 52/78
               patients (66.7\%). After a medium follow-up of 48.2 months,
               41/78 patients (52.6\%) had complete perianal remission (95\%
               CI: 43.5\%-63.6\%). Recurrence occurred in four (9.8\%) patients
               (95\% CI: 0.7\%-18.8\%) in an average period of 74.8 months.
               CONCLUSIONS: Combined therapy lead to favorable and durable
               results in perianal fistulizing Crohn's disease.",
  journal   = "Arq. Gastroenterol.",
  publisher = "FapUNIFESP (SciELO)",
  volume    =  51,
  number    =  4,
  pages     = "284--289",
  month     =  oct,
  year      =  2014,
  language  = "en"
}
@ARTICLE{Regueiro2003-lf,
  title     = "Treatment of perianal fistulizing crohn's disease with
               infliximab alone or as an adjunct to exam under anesthesia with
               Seton placement",
  author    = "Regueiro, Miguel and Mardini, Houssam",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  9,
  number    =  2,
  pages     = "98--103",
  month     =  mar,
  year      =  2003,
  language  = "en"
}
@ARTICLE{Duricova2014-gf,
  title     = "Age-related differences in presentation and course of
               inflammatory bowel disease: an update on the population-based
               literature",
  author    = "Duricova, Dana and Burisch, Johan and Jess, Tine and
               Gower-Rousseau, Corinne and Lakatos, Peter L and {ECCO-EpiCom}",
  abstract  = "Current data indicate a change in the epidemiology of
               inflammatory bowel diseases. The disease has become more
               widespread and the rise in the incidence has been reported in
               all age groups including early childhood and according to recent
               data also the elderly population. Some earlier studies have
               suggested that the phenotype and natural history of the disease
               may be different according to age of onset. Recently the
               importance of age at onset was reported in two population-based
               studies from France and Hungary including both paediatric and
               adult onset inception cohorts. Early onset disease was
               associated with more frequent disease extension in both Crohn's
               disease and ulcerative colitis and in most but not all studies
               with higher frequency of complicated disease behaviour. This is
               also accompanied by striking differences in the medical
               management with earlier and more prevalent (2-3-fold) use of
               immunosuppressives and to some extent biologicals in patients
               with early compared to elderly-onset disease, especially in
               Crohn's disease. However, the results of population-based
               studies on impact of age on surgery rates in Crohns disease as
               well as ulcerative colitis are conflicting. Furthermore,
               published data indicate that relative but not absolute risk of
               developing cancer and mortality is higher in patients with an
               early onset disease. Critical reviews that focus on the
               importance of age at onset in inflammatory bowel disease are
               rare. Therefore, the aim of this review is to describe the
               differences in epidemiology, clinical characteristics, and
               natural history of paediatric and elderly-onset inflammatory
               bowel disease based on studies performed in general population.",
  journal   = "J. Crohns. Colitis",
  publisher = "Oxford University Press (OUP)",
  volume    =  8,
  number    =  11,
  pages     = "1351--1361",
  month     =  nov,
  year      =  2014,
  keywords  = "Age at onset;; Disease phenotype;; Incidence;; Inflammatory
               bowel disease;; Mortality; Surgery;",
  language  = "en"
}
@ARTICLE{Kaur2016-bs,
  title     = "Perianal crohn's disease is associated with distal colonic
               disease, stricturing disease behavior, {IBD-associated}
               serologies and genetic variation in the {JAK-STAT} pathway",
  author    = "Kaur, Manreet and Panikkath, Deepa and Yan, Xiaofei and Liu,
               Zhenqiu and Berel, Dror and Li, Dalin and Vasiliauskas, Eric A
               and Ippoliti, Andrew and Dubinsky, Marla and Shih, David Q and
               Melmed, Gil Y and Haritunians, Talin and Fleshner, Phillip and
               Targan, Stephan R and McGovern, Dermot P B",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  22,
  number    =  4,
  pages     = "862--869",
  month     =  apr,
  year      =  2016
}

@ARTICLE{Van_Drongelen2017-dh,
  title     = "Human leukocyte antigen--disease associations in rheumatoid
               arthritis",
  author    = "van Drongelen, Vincent and Holoshitz, Joseph",
  journal   = "Rheum. Dis. Clin. North Am.",
  publisher = "Elsevier BV",
  volume    =  43,
  number    =  3,
  pages     = "363--376",
  month     =  aug,
  year      =  2017,
  language  = "en"
}
@ARTICLE{Raychaudhuri2012-em,
  title     = "Five amino acids in three {HLA} proteins explain most of the
               association between {MHC} and seropositive rheumatoid arthritis",
  author    = "Raychaudhuri, Soumya and Sandor, Cynthia and Stahl, Eli A and
               Freudenberg, Jan and Lee, Hye-Soon and Jia, Xiaoming and
               Alfredsson, Lars and Padyukov, Leonid and Klareskog, Lars and
               Worthington, Jane and Siminovitch, Katherine A and Bae,
               Sang-Cheol and Plenge, Robert M and Gregersen, Peter K and de
               Bakker, Paul I W",
  abstract  = "The genetic association of the major histocompatibility complex
               (MHC) to rheumatoid arthritis risk has commonly been attributed
               to alleles in HLA-DRB1. However, debate persists about the
               identity of the causal variants in HLA-DRB1 and the presence of
               independent effects elsewhere in the MHC. Using existing
               genome-wide SNP data in 5,018 individuals with seropositive
               rheumatoid arthritis (cases) and 14,974 unaffected controls, we
               imputed and tested classical alleles and amino acid
               polymorphisms in HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1,
               HLA-DQA1, HLA-DQB1 and HLA-DRB1, as well as 3,117 SNPs across
               the MHC. Conditional and haplotype analyses identified that
               three amino acid positions (11, 71 and 74) in HLA-DR$\beta$1 and
               single-amino-acid polymorphisms in HLA-B (at position 9) and
               HLA-DP$\beta$1 (at position 9), which are all located in
               peptide-binding grooves, almost completely explain the MHC
               association to rheumatoid arthritis risk. This study shows how
               imputation of functional variation from large reference panels
               can help fine map association signals in the MHC.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  44,
  number    =  3,
  pages     = "291--296",
  month     =  jan,
  year      =  2012,
  copyright = "https://www.springernature.com/gp/researchers/text-and-data-mining",
  language  = "en"
}


@ARTICLE{Akhlaghpour2023-jw,
  title    = "Genetic coding variant in complement factor {B} ({CFB}) is
              associated with increased risk for perianal Crohn's disease and
              leads to impaired {CFB} cleavage and phagocytosis",
  author   = "Akhlaghpour, Marzieh and Haritunians, Talin and More, Shyam K and
              Thomas, Lisa S and Stamps, Dalton T and Dube, Shishir and Li,
              Dalin and Yang, Shaohong and Landers, Carol J and Mengesha,
              Emebet and Hamade, Hussein and Murali, Ramachandran and Potdar,
              Alka A and Wolf, Andrea J and Botwin, Gregory J and Khrom,
              Michelle and {International IBD Genetics Consortium} and
              Ananthakrishnan, Ashwin N and Faubion, William A and Jabri, Bana
              and Lira, Sergio A and Newberry, Rodney D and Sandler, Robert S
              and Sartor, R Balfour and Xavier, Ramnik J and Brant, Steven R
              and Cho, Judy H and Duerr, Richard H and Lazarev, Mark G and
              Rioux, John D and Schumm, L Philip and Silverberg, Mark S and
              Zaghiyan, Karen and Fleshner, Phillip and Melmed, Gil Y and
              Vasiliauskas, Eric A and Ha, Christina and Rabizadeh, Shervin and
              Syal, Gaurav and Bonthala, Nirupama N and Ziring, David A and
              Targan, Stephan R and Long, Millie D and McGovern, Dermot P B and
              Michelsen, Kathrin S",
  abstract = "OBJECTIVE: Perianal Crohn's disease (pCD) occurs in up to 40\% of
              patients with CD and is associated with poor quality of life,
              limited treatment responses and poorly understood aetiology. We
              performed a genetic association study comparing CD subjects with
              and without perianal disease and subsequently performed
              functional follow-up studies for a pCD associated SNP in
              Complement Factor B (CFB). DESIGN: Immunochip-based meta-analysis
              on 4056 pCD and 11 088 patients with CD from three independent
              cohorts was performed. Serological and clinical variables were
              analysed by regression analyses. Risk allele of rs4151651 was
              introduced into human CFB plasmid by site-directed mutagenesis.
              Binding of recombinant G252 or S252 CFB to C3b and its cleavage
              was determined in cell-free assays. Macrophage phagocytosis in
              presence of recombinant CFB or serum from CFB risk, or protective
              CD or healthy subjects was assessed by flow cytometry. RESULTS:
              Perianal complications were associated with colonic involvement,
              OmpC and ASCA serology, and serology quartile sum score. We
              identified a genetic association for pCD (rs4151651), a
              non-synonymous SNP (G252S) in CFB, in all three cohorts.
              Recombinant S252 CFB had reduced binding to C3b, its cleavage was
              impaired, and complement-driven phagocytosis and cytokine
              secretion were reduced compared with G252 CFB. Serine 252
              generates a de novo glycosylation site in CFB. Serum from
              homozygous risk patients displayed significantly decreased
              macrophage phagocytosis compared with non-risk serum. CONCLUSION:
              pCD-associated rs4151651 in CFB is a loss-of-function mutation
              that impairs its cleavage, activation of alternative complement
              pathway, and pathogen phagocytosis thus implicating the
              alternative complement pathway and CFB in pCD aetiology.",
  journal  = "Gut",
  month    =  apr,
  year     =  2023,
  keywords = "IBD - GENETICS; INFLAMMATORY BOWEL DISEASE; META-ANALYSIS",
  language = "en"
}
% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kaur2016-ut,
  title     = "Perianal crohn's disease is associated with distal colonic
               disease, stricturing disease behavior, {IBD-associated}
               serologies and genetic variation in the {JAK-STAT} pathway",
  author    = "Kaur, Manreet and Panikkath, Deepa and Yan, Xiaofei and Liu,
               Zhenqiu and Berel, Dror and Li, Dalin and Vasiliauskas, Eric A
               and Ippoliti, Andrew and Dubinsky, Marla and Shih, David Q and
               Melmed, Gil Y and Haritunians, Talin and Fleshner, Phillip and
               Targan, Stephan R and McGovern, Dermot P B",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  22,
  number    =  4,
  pages     = "862--869",
  month     =  apr,
  year      =  2016
}

@ARTICLE{Park2019-kj,
  title     = "Update on the natural course of fistulizing perianal Crohn's
               disease in a population-based cohort",
  author    = "Park, Sang Hyoung and Aniwan, Satimai and Scott Harmsen, W and
               Tremaine, William J and Lightner, Amy L and Faubion, William A
               and Loftus, Edward V",
  abstract  = "BACKGROUND: This study sought to re-estimate the cumulative
               incidence of perianal or rectovaginal fistulas and the
               associated proctectomy rate in the prebiologic era vs the
               biologic era using a population-based cohort of Crohn's disease
               (CD) patients. METHODS: The medical records of 414 residents of
               Olmsted County, Minnesota, who were diagnosed with CD between
               1970 and 2010 were reviewed. The cumulative incidence of
               perianal or rectovaginal fistulas from time of CD diagnosis and
               the cumulative rate of proctectomy from date of first perianal
               or rectovaginal fistula diagnosis were estimated using the
               Kaplan-Meier method. RESULTS: Eighty-five patients (20.5\%)
               diagnosed with CD between 1970 and 2010 had at least 1 perianal
               or rectovaginal fistula episode between January 1, 1970, and
               June 30, 2016. The cumulative incidence of perianal or
               rectovaginal fistulas was 18\% after 10 years, 23\% after 20
               years, and 24\% after 30-40 years from CD diagnosis. The
               cumulative incidence of perianal or rectovaginal fistulas was
               significantly lower in patients diagnosed in 1998 or after than
               in patients diagnosed before 1998 (P = 0.03, log-rank). Among 85
               patients developing perianal or rectovaginal fistulas, 16
               patients (18.8\%) underwent proctectomy for the treatment of
               perianal or rectovaginal fistulas during follow-up. CONCLUSIONS:
               In a population-based inception cohort of CD, one-fifth of
               patients were diagnosed with at least 1 perianal or rectovaginal
               fistula. The cumulative probability of perianal or rectovaginal
               fistulizing disease has decreased over time.",
  journal   = "Inflamm. Bowel Dis.",
  publisher = "Oxford University Press (OUP)",
  volume    =  25,
  number    =  6,
  pages     = "1054--1060",
  month     =  may,
  year      =  2019,
  keywords  = "Crohn's disease; natural history; perianal fistula; rectovaginal
               fistula",
  copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
  language  = "en"
}
@ARTICLE{Molineros2019-mu,
  title     = "Amino acid signatures of {HLA} {Class-I} and {II} molecules are
               strongly associated with {SLE} susceptibility and autoantibody
               production in Eastern Asians",
  author    = "Molineros, Julio E and Looger, Loren L and Kim, Kwangwoo and
               Okada, Yukinori and Terao, Chikashi and Sun, Celi and Zhou,
               Xu-Jie and Raj, Prithvi and Kochi, Yuta and Suzuki, Akari and
               Akizuki, Shuji and Nakabo, Shuichiro and Bang, So-Young and Lee,
               Hye-Soon and Kang, Young Mo and Suh, Chang-Hee and Chung, Won
               Tae and Park, Yong-Beom and Choe, Jung-Yoon and Shim,
               Seung-Cheol and Lee, Shin-Seok and Zuo, Xiaoxia and Yamamoto,
               Kazuhiko and Li, Quan-Zhen and Shen, Nan and Porter, Lauren L
               and Harley, John B and Chua, Kek Heng and Zhang, Hong and
               Wakeland, Edward K and Tsao, Betty P and Bae, Sang-Cheol and
               Nath, Swapan K",
  abstract  = "Human leukocyte antigen (HLA) is a key genetic factor conferring
               risk of systemic lupus erythematosus (SLE), but precise
               independent localization of HLA effects is extremely
               challenging. As a result, the contribution of specific HLA
               alleles and amino-acid residues to the overall risk of SLE and
               to risk of specific autoantibodies are far from completely
               understood. Here, we dissected (a) overall SLE association
               signals across HLA, (b) HLA-peptide interaction, and (c)
               residue-autoantibody association. Classical alleles, SNPs, and
               amino-acid residues of eight HLA genes were imputed across 4,915
               SLE cases and 13,513 controls from Eastern Asia. We performed
               association followed by conditional analysis across HLA,
               assessing both overall SLE risk and risk of autoantibody
               production. DR15 alleles HLA-DRB1*15:01 (P = 1.4x10-27, odds
               ratio (OR) = 1.57) and HLA-DQB1*06:02 (P = 7.4x10-23, OR = 1.55)
               formed the most significant haplotype (OR = 2.33). Conditioned
               protein-residue signals were stronger than allele signals and
               mapped predominantly to HLA-DRB1 residue 13 (P = 2.2x10-75) and
               its proxy position 11 (P = 1.1x10-67), followed by HLA-DRB1-37
               (P = 4.5x10-24). After conditioning on HLA-DRB1, novel
               associations at HLA-A-70 (P = 1.4x10-8), HLA-DPB1-35 (P =
               9.0x10-16), HLA-DQB1-37 (P = 2.7x10-14), and HLA-B-9 (P =
               6.5x10-15) emerged. Together, these seven residues increased the
               proportion of explained heritability due to HLA to 2.6\%. Risk
               residues for both overall disease and hallmark autoantibodies
               (i.e., nRNP: DRB1-11, P = 2.0x10-14; DRB1-13, P = 2.9x10-13;
               DRB1-30, P = 3.9x10-14) localized to the peptide-binding groove
               of HLA-DRB1. Enrichment for specific amino-acid characteristics
               in the peptide-binding groove correlated with overall SLE risk
               and with autoantibody presence. Risk residues were in primarily
               negatively charged side-chains, in contrast with rheumatoid
               arthritis. We identified novel SLE signals in HLA Class I loci
               (HLA-A, HLA-B), and localized primary Class II signals to five
               residues in HLA-DRB1, HLA-DPB1, and HLA-DQB1. These findings
               provide insights about the mechanisms by which the risk residues
               interact with each other to produce autoantibodies and are
               involved in SLE pathophysiology.",
  journal   = "PLoS Genet.",
  publisher = "Public Library of Science (PLoS)",
  volume    =  15,
  number    =  4,
  pages     = "e1008092",
  month     =  apr,
  year      =  2019,
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{king-software,
  title     = "Robust relationship inference in genome-wide association studies",
  author    = "Manichaikul, Ani and Mychaleckyj, Josyf C and Rich, Stephen S
               and Daly, Kathy and Sale, Mich{\`e}le and Chen, Wei-Min",
  abstract  = "MOTIVATION: Genome-wide association studies (GWASs) have been
               widely used to map loci contributing to variation in complex
               traits and risk of diseases in humans. Accurate specification of
               familial relationships is crucial for family-based GWAS, as well
               as in population-based GWAS with unknown (or unrecognized)
               family structure. The family structure in a GWAS should be
               routinely investigated using the SNP data prior to the analysis
               of population structure or phenotype. Existing algorithms for
               relationship inference have a major weakness of estimating
               allele frequencies at each SNP from the entire sample, under a
               strong assumption of homogeneous population structure. This
               assumption is often untenable. RESULTS: Here, we present a rapid
               algorithm for relationship inference using high-throughput
               genotype data typical of GWAS that allows the presence of
               unknown population substructure. The relationship of any pair of
               individuals can be precisely inferred by robust estimation of
               their kinship coefficient, independent of sample composition or
               population structure (sample invariance). We present simulation
               experiments to demonstrate that the algorithm has sufficient
               power to provide reliable inference on millions of unrelated
               pairs and thousands of relative pairs (up to 3rd-degree
               relationships). Application of our robust algorithm to HapMap
               and GWAS datasets demonstrates that it performs properly even
               under extreme population stratification, while algorithms
               assuming a homogeneous population give systematically biased
               results. Our extremely efficient implementation performs
               relationship inference on millions of pairs of individuals in a
               matter of minutes, dozens of times faster than the most
               efficient existing algorithm known to us. AVAILABILITY: Our
               robust relationship inference algorithm is implemented in a
               freely available software package, KING, available for download
               at http://people.virginia.edu/wc9c/KING.",
  journal   = "Bioinformatics",
  publisher = "Oxford University Press (OUP)",
  volume    =  26,
  number    =  22,
  pages     = "2867--2873",
  month     =  nov,
  year      =  2010,
  language  = "en"
}

@ARTICLE{Mbatchou2021-qm,
  title     = "Computationally efficient whole-genome regression for
               quantitative and binary traits",
  author    = "Mbatchou, Joelle and Barnard, Leland and Backman, Joshua and
               Marcketta, Anthony and Kosmicki, Jack A and Ziyatdinov, Andrey
               and Benner, Christian and O'Dushlaine, Colm and Barber, Mathew
               and Boutkov, Boris and Habegger, Lukas and Ferreira, Manuel and
               Baras, Aris and Reid, Jeffrey and Abecasis, Goncalo and Maxwell,
               Evan and Marchini, Jonathan",
  abstract  = "Genome-wide association analysis of cohorts with thousands of
               phenotypes is computationally expensive, particularly when
               accounting for sample relatedness or population structure. Here
               we present a novel machine-learning method called REGENIE for
               fitting a whole-genome regression model for quantitative and
               binary phenotypes that is substantially faster than alternatives
               in multi-trait analyses while maintaining statistical
               efficiency. The method naturally accommodates parallel analysis
               of multiple phenotypes and requires only local segments of the
               genotype matrix to be loaded in memory, in contrast to existing
               alternatives, which must load genome-wide matrices into memory.
               This results in substantial savings in compute time and memory
               usage. We introduce a fast, approximate Firth logistic
               regression test for unbalanced case-control phenotypes. The
               method is ideally suited to take advantage of distributed
               computing frameworks. We demonstrate the accuracy and
               computational benefits of this approach using the UK Biobank
               dataset with up to 407,746 individuals.",
  journal   = "Nat. Genet.",
  publisher = "Springer Science and Business Media LLC",
  volume    =  53,
  number    =  7,
  pages     = "1097--1103",
  month     =  jul,
  year      =  2021,
  language  = "en"
}


@ARTICLE{1000gphc,
  title     = "High-coverage whole-genome sequencing of the expanded 1000
               Genomes Project cohort including 602 trios",
  author    = "Byrska-Bishop, Marta and Evani, Uday S and Zhao, Xuefang and
               Basile, Anna O and Abel, Haley J and Regier, Allison A and
               Corvelo, Andr{\'e} and Clarke, Wayne E and Musunuri, Rajeeva and
               Nagulapalli, Kshithija and Fairley, Susan and Runnels, Alexi and
               Winterkorn, Lara and Lowy, Ernesto and {Human Genome Structural
               Variation Consortium} and {Paul Flicek} and Germer, Soren and
               Brand, Harrison and Hall, Ira M and Talkowski, Michael E and
               Narzisi, Giuseppe and Zody, Michael C",
  abstract  = "The 1000 Genomes Project (1kGP) is the largest fully open
               resource of whole-genome sequencing (WGS) data consented for
               public distribution without access or use restrictions. The
               final, phase 3 release of the 1kGP included 2,504 unrelated
               samples from 26 populations and was based primarily on
               low-coverage WGS. Here, we present a high-coverage 3,202-sample
               WGS 1kGP resource, which now includes 602 complete trios,
               sequenced to a depth of 30X using Illumina. We performed
               single-nucleotide variant (SNV) and short insertion and deletion
               (INDEL) discovery and generated a comprehensive set of
               structural variants (SVs) by integrating multiple analytic
               methods through a machine learning model. We show gains in
               sensitivity and precision of variant calls compared to phase 3,
               especially among rare SNVs as well as INDELs and SVs spanning
               frequency spectrum. We also generated an improved reference
               imputation panel, making variants discovered here accessible for
               association studies.",
  journal   = "Cell",
  publisher = "Elsevier BV",
  volume    =  185,
  number    =  18,
  pages     = "3426--3440.e19",
  month     =  sep,
  year      =  2022,
  keywords  = "1000 Genomes Project; INDEL; SNV; population genetics; reference
               imputation panel; structural variation; trio sequencing;
               whole-genome sequencing",
  copyright = "http://creativecommons.org/licenses/by/4.0/",
  language  = "en"
}


% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{1000gp,
  title     = "A global reference for human genetic variation",
  author    = "The 1000 Genomes Project Consortium",
  journal   = "Nature",
  publisher = "Springer Science and Business Media LLC",
  volume    =  526,
  number    =  7571,
  pages     = "68--74",
  month     =  oct,
  year      =  2015,
  copyright = "https://creativecommons.org/licenses/by-nc-sa/3.0/",
  language  = "en"
}





